0001493152-24-020661.txt : 20240520 0001493152-24-020661.hdr.sgml : 20240520 20240520160035 ACCESSION NUMBER: 0001493152-24-020661 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 68 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REED'S, INC. CENTRAL INDEX KEY: 0001140215 STANDARD INDUSTRIAL CLASSIFICATION: BOTTLED & CANNED SOFT DRINKS CARBONATED WATERS [2086] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 352177773 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32501 FILM NUMBER: 24964269 BUSINESS ADDRESS: STREET 1: 201 MERRITT 7 CORPORATE PARK, CITY: NORWALK STATE: CT ZIP: 06851 BUSINESS PHONE: 800 997 3337 MAIL ADDRESS: STREET 1: 201 MERRITT 7 CORPORATE PARK, CITY: NORWALK STATE: CT ZIP: 06851 FORMER COMPANY: FORMER CONFORMED NAME: REED'S INC DATE OF NAME CHANGE: 20140512 FORMER COMPANY: FORMER CONFORMED NAME: REEDS INC DATE OF NAME CHANGE: 20020122 FORMER COMPANY: FORMER CONFORMED NAME: ORIGINAL BEVERAGE CORP / DATE OF NAME CHANGE: 20010508 10-Q 1 form10-q.htm
false Q1 --12-31 0001140215 0001140215 2024-01-01 2024-03-31 0001140215 2024-05-10 0001140215 2024-03-31 0001140215 2023-12-31 0001140215 us-gaap:RelatedPartyMember 2024-03-31 0001140215 us-gaap:RelatedPartyMember 2023-12-31 0001140215 2023-01-01 2023-03-31 0001140215 us-gaap:CommonStockMember 2023-12-31 0001140215 us-gaap:PreferredStockMember 2023-12-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001140215 us-gaap:RetainedEarningsMember 2023-12-31 0001140215 us-gaap:CommonStockMember 2022-12-31 0001140215 us-gaap:PreferredStockMember 2022-12-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001140215 us-gaap:RetainedEarningsMember 2022-12-31 0001140215 2022-12-31 0001140215 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001140215 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001140215 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001140215 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001140215 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001140215 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001140215 us-gaap:CommonStockMember 2024-03-31 0001140215 us-gaap:PreferredStockMember 2024-03-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001140215 us-gaap:RetainedEarningsMember 2024-03-31 0001140215 us-gaap:CommonStockMember 2023-03-31 0001140215 us-gaap:PreferredStockMember 2023-03-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001140215 us-gaap:RetainedEarningsMember 2023-03-31 0001140215 2023-03-31 0001140215 REED:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001140215 REED:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001140215 REED:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001140215 REED:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:VendorOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001140215 REED:VendorOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:VendorOneMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001140215 REED:VendorOneMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:VendorTwoMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001140215 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001140215 us-gaap:StockOptionMember 2024-01-01 2024-03-31 0001140215 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001140215 us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-03-31 0001140215 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-03-31 0001140215 REED:UnvestedRestrictedCommonStockMember 2024-01-01 2024-03-31 0001140215 REED:UnvestedRestrictedCommonStockMember 2023-01-01 2023-03-31 0001140215 REED:CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001140215 REED:CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember 2023-01-01 2023-03-31 0001140215 REED:RightOfUseAssetsUnderOperatingLeasesMember 2024-03-31 0001140215 REED:RightOfUseAssetsUnderOperatingLeasesMember 2023-12-31 0001140215 REED:ComputerHardwareAndSoftwareMember 2024-03-31 0001140215 REED:ComputerHardwareAndSoftwareMember 2023-12-31 0001140215 us-gaap:MachineryAndEquipmentMember 2024-03-31 0001140215 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001140215 us-gaap:ConstructionInProgressMember 2024-03-31 0001140215 us-gaap:ConstructionInProgressMember 2023-12-31 0001140215 REED:AlternaCapitalSolutionsMember 2024-03-31 0001140215 REED:AlternaCapitalSolutionsMember 2023-12-31 0001140215 REED:AlternaCapitalSolutionsMember 2022-03-01 2022-03-31 0001140215 REED:AlternaCapitalSolutionsMember 2022-03-31 0001140215 REED:AlternaCapitalSolutionsMember 2024-01-01 2024-03-31 0001140215 REED:NotesPayableAMember 2024-03-31 0001140215 REED:NotesPayableAMember 2023-12-31 0001140215 REED:NotesPayableBMember 2024-03-31 0001140215 REED:NotesPayableBMember 2023-12-31 0001140215 REED:SecuredConvertibleNotesPayableMember 2024-03-31 0001140215 REED:SecuredConvertibleNotesPayableMember 2023-12-31 0001140215 REED:NotePurchaseAgreementMember 2022-05-31 0001140215 REED:NotePurchaseAgreementMember 2022-05-01 2022-05-31 0001140215 2022-08-11 2022-08-11 0001140215 2023-06-30 0001140215 REED:NotePurchaseAgreementMember 2022-08-01 2022-08-31 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2023-11-01 2023-11-30 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember srt:MinimumMember 2023-11-01 2023-11-30 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember srt:MaximumMember 2023-11-01 2023-11-30 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2023-11-30 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2024-02-12 2024-02-12 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2024-02-12 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-03-31 0001140215 REED:WhiteboxAdvisorsLLCMember REED:AdditionalOptionNotesMember 2023-02-28 0001140215 REED:WhiteboxAdvisorsLLCMember REED:AdditionalOptionNotesMember 2023-05-31 0001140215 REED:WhiteboxAdvisorsLLCMember REED:AdditionalOptionNotesMember 2023-02-01 2023-05-31 0001140215 REED:WhiteboxAdvisorsLLCMember REED:AdditionalOptionNotesMember 2024-03-31 0001140215 REED:WhiteboxAdvisorsLLCMember REED:AdditionalOptionNotesMember 2023-12-31 0001140215 REED:WhiteboxAdvisorsLLCMember REED:AdditionalOptionNotesMember 2023-11-01 2023-11-30 0001140215 REED:LimitedWaiverDeferralAndAmendmentAndRestatementAgreementMember 2024-02-12 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2023-12-31 0001140215 REED:WhiteboxAdvisorsLLCMember us-gaap:ConvertibleNotesPayableMember 2024-03-31 0001140215 REED:SimpleAgreementsForFutureEquityInvestmentsMember REED:StockholdersMember 2024-01-01 2024-03-31 0001140215 REED:SimpleAgreementsForFutureEquityInvestmentsMember REED:StockholdersMember 2024-03-31 0001140215 2023-01-01 2023-12-31 0001140215 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001140215 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001140215 us-gaap:EmployeeStockOptionMember 2024-03-31 0001140215 us-gaap:WarrantMember 2023-12-31 0001140215 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001140215 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001140215 us-gaap:WarrantMember 2024-03-31 0001140215 REED:SecuritiesPurchaseAgreementMember 2024-03-31 0001140215 REED:ChristopherJReedMember REED:CaliforniaCustomBeverageLLCMember 2018-12-31 0001140215 REED:CaliforniaCustomBeverageLLCMember 2024-03-31 0001140215 REED:CaliforniaCustomBeverageLLCMember 2023-12-31 0001140215 srt:MaximumMember 2023-01-01 2023-12-31 0001140215 REED:ChrisReedMember REED:CaliforniaCustomBeverageLLCMember 2018-12-31 0001140215 REED:ChrisReedMember REED:CaliforniaCustomBeverageLLCMember 2024-03-31 0001140215 REED:ChrisReedMember REED:CaliforniaCustomBeverageLLCMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001140215 REED:SecuredConvertibleNotesPayableMember 2024-01-01 2024-03-31 0001140215 REED:SecuredConvertibleNotesPayableMember us-gaap:SubsequentEventMember 2024-07-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure REED:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2024

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934

 

For the transition period from _______ to _______

 

Commission file number: 001-32501

 

REED’S, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   35-2177773
(State of
incorporation)
  (I.R.S. Employer
Identification No.)

 

201 Merritt 7, Norwalk, CT. 06851

(Address of principal executive offices) (Zip Code)

 

(800) 997-3337

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of Each Class   Trading Symbol   Names of each exchange on which registered
         

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: There were a total of 4,187,291 shares of Common Stock outstanding as of May 10, 2024.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

 

Large Accelerated Filer ☐ Accelerated Filer ☐ Non-Accelerated Filer
Smaller Reporting Company Emerging Growth Company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the issuer is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

There are 4,187,291 shares outstanding as of May 10th, 2024.

 

 

 

 
 

 

TABLE OF CONTENTS

 

PART I - FINANCIAL INFORMATION   F-1
     
Item 1. Condensed Financial Statements   F-1
     
Condensed Balance Sheets - March 31, 2024 (Unaudited) and December 31, 2023   F-1
     
Condensed Statements of Operations for the three months ended March 31, 2024 and 2023 (Unaudited)   F-2
     
Condensed Statements of Changes in Stockholders’ Deficit for the three months ended March 31, 2024 and 2023 (Unaudited)   F-3
     
Condensed Statements of Cash Flows for the three months ended March 31, 2024 and 2023 (Unaudited)   F-4
     
Notes to Condensed Financial Statements three months ended March 31, 2024 and 2023 (Unaudited)   F-5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   1
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk   6
     
Item 4. Controls and Procedures   6
     
PART II – OTHER INFORMATION   7
     
Item 1. Legal Proceedings   7
     
Item 1A. Risk Factors   7
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   7
     
Item 3. Defaults Upon Senior Securities   7
     
Item 4. Mine Safety Disclosures   7
     
Item 5. Other Information   7
     
Item 6. Exhibits   7

 

i
 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION

 

This report contains statements reflecting our views about our future performance that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (Reform Act). Statements that constitute forward-looking statements within the meaning of the Reform Act are generally identified through the inclusion of words such as “aim,” “anticipate,” “believe,” “drive,” “estimate,” “expect,” “expressed confidence,” “forecast,” “future,” “goal,” “guidance,” “intend,” “may,” “objective,” “outlook,” “plan,” “position,” “potential,” “project,” “seek,” “should,” “strategy,” “target,” “will” or similar statements or variations of such words and other similar expressions. All statements addressing our future operating performance, and statements addressing events and developments that we expect or anticipate will occur in the future, are forward-looking statements within the meaning of the Reform Act. These forward-looking statements are based on currently available information, operating plans and projections about future events and trends. They inherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in any such forward-looking statement. These risks and uncertainties include, but are not limited to, those described in “Part I, Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (“2023 Form 10-K”) as updated by “Part II, Item 1A” of this report should be considered when evaluating our trends and future results. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. The discussion of risks in this report is by no means all-inclusive but is designed to highlight what we believe are important factors to consider when evaluating our future performance.

 

ii
 

 

Part I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

REED’S, INC,

CONDENSED BALANCE SHEETS

(Amounts in thousands, except share amounts)

 

   March 31,
2024
   December 31,
2023
 
   (Unaudited)     
ASSETS          
Current assets:          
Cash  $314   $603 
Accounts receivable, net of allowance of $258 and $860, respectively   3,251    3,571 
Inventory   12,017    11,300 
Receivable from former related party   264    259 
Prepaid expenses and other current assets   2,332    2,028 
Total current assets   18,178    17,761 
           
Property and equipment, net of accumulated depreciation of $1,136 and $1,068, respectively   441    493 
Intangible assets   631    629 
Total assets  $19,250   $18,883 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable  $8,484   $9,133 
Accrued expenses   872    1,096 
Revolving line of credit, net of capitalized financing costs of $161 and $201, respectively   7,844    9,758 
Payable to former related party   331    259 
Current portion of convertible notes payable, net of debt discount of $509 and $424, respectively   7,339    6,737 
Current portion of lease liabilities   155    207 
Total current liabilities   25,025    27,190 
           
SAFE agreements   4,097    - 
Convertible note payable, net of debt discount of $45 and $148, respectively, less current portion   10,853    10,874 
Total liabilities   39,975    38,064 
           
Stockholders’ deficit:          
Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding   94    94 
Common stock, $.0001 par value, 180,000,000 shares authorized; 4,187,291 and 4,187,291 shares issued and outstanding, respectively   -    - 
Additional paid in capital   119,581    119,452 
Accumulated deficit   (140,400)   (138,727)
Total stockholders’ deficit   (20,725)   (19,181)
Total liabilities and stockholders’ deficit  $19,250   $18,883 

 

The accompanying notes are an integral part of these financial statements.

 

F-1

 

 

REED’S, INC.

CONDENSED STATEMENTS OF OPERATIONS

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

(Amounts in thousands, except share and per share amounts)

 

   March 31,
2024
   March 31,
2023
 
Net Sales  $9,595   $11,157 
Cost of goods sold   6,182    8,459 
Gross profit   3,413    2,698 
           
Operating expenses:          
Delivery and handling expense   1,502    2,120 
Selling and marketing expense   1,093    1,447 
General and administrative expense   1,468    1,709 
Total operating expenses   4,063    5,276 
           
Loss from operations   (650)   (2,578)
           
Interest expense   (1,023)   (1,779)
           
Net loss  $(1,673)  $(4,357)
           
Net loss per share – basic and diluted  $(0.40)  $(1.70)
           
Weighted average number of shares outstanding – basic and diluted   4,187,291    2,559,855 

 

The accompanying notes are an integral part of these condensed financial statements.

 

F-2

 

 

REED’S, INC.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

(Amounts in thousands except share amounts)

 

   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
   Common Stock   Preferred Stock   Additional Paid In   Accumulated   Total Stockholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance, December 31, 2023   4,187,291   $-    9,411   $94   $119,452   $(138,727)  $(19,181)
Fair value of vested options       -         -     129    -     129 
       -         -     -     -     -  
Net loss       -     -    -    -    (1,673)   (1,673)
Balance, March 31, 2024   4,187,291   $-    9,411   $94   $119,581   $(140,400)  $(20,725)

 

   Common Stock   Preferred Stock   Additional Paid In   Accumulated   Total Stockholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
Balance, December 31, 2022   2,519,485   $-    9,411   $94   $114,635   $(123,199)  $(8,470)
                                    
Fair value of vested options                     229         229 
Fair value of vested restricted shares granted to officers   750                  4         4 
Repurchase of common stock   (274)                 (1)        (1)
Common shares issued for financing costs   82,438                  273         273 
Net loss   -    -     -    -    -    (4,357)   (4,357)
Balance, March 31, 2023   2,602,399   $     -    9,411   $94   $115,140   $(127,556)  $(12,322)

 

The accompanying notes are an integral part of these condensed financial statements.

 

F-3

 

 

REED’S, INC.

CONDENSED STATEMENTS OF CASH FLOWS

For the Three Months Ended March 31, 2024 and 2023

(Unaudited)

(Amounts in thousands)

 

   March 31,
2024
   March 31,
2023
 
Cash flows from operating activities:          
Net loss  $(1,673)  $(4,357)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation   29    47 
Amortization of debt discount   144    281 
Fair value of vested options   129    229 
Fair value of vested restricted shares granted to officers   -    4 
Change in allowance for doubtful accounts   (601)   (39)
Inventory write-downs   (783)   (228)
Accrued interest   564    1,113 
Changes in operating assets and liabilities:          
Accounts receivable   922    1,044 
Inventory   66    1,102 
Prepaid expenses and other assets   (1,305)   338 
Decrease in right of use assets   39    32 
Accounts payable   351    1,360 
Accrued expenses   (225)   235 
Lease liabilities   (52)   (44)
Net cash provided by (used in) operating activities   (2,395)   1,117 
Cash flows from investing activities:          
Trademark costs   (2)   - 
Purchase of property and equipment   (16)   - 
Net cash used in investing activities   (18)   - 
Cash flows from financing activities:          
Proceeds from line of credit   8,285    8,699 
Payments on line of credit   (10,239)   (12,120)
Proceeds from convertible note payable, net of expenses   -    2,405 
Proceeds from SAFE agreement   4,097    - 
Payment of cost recorded as debt discount   (86)     
Repurchase of common stock   -    (1)
Amounts from former related party, net   67    (166)
Net cash provided by (used in) financing activities   2,124    (1,183)
           
Net increase (decrease) in cash   (289)   (66)
Cash at beginning of period   603    533 
Cash at end of period  $314   $467 
           
Supplemental disclosures of cash flow information:          
Cash paid for interest  $318   $390 

Non-cash investing and financing activities:

          
Reclass of prepaid expenses and accounts payable 

$

1,000

  

$

0 

 

The accompanying notes are an integral part of these condensed financial statements.

 

F-4

 

 

REED’S, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

Three Months Ended March 31, 2024 and 2023 (Unaudited)

(In thousands, except share and per share amounts)

 

1. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 1, 2024. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2024, and the results of its operations and its cash flows for the three months ended March 31, 2024 and 2023. The balance sheet as of December 31, 2023 is derived from the Company’s audited financial statements.

 

The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.

 

Liquidity

 

For the three months ended March 31, 2024, the Company recorded a net loss of $1,673 and used cash in operations of $2,395. In accordance with Accounting Standards Codification (“ASC”) 205-40, Going Concern, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. As of the issuance date of these financial statements, management expects that the Company’s existing cash of $314, which includes $4,100 of additional cash received during the three months ended March 31, 2024, from investments with significant stockholders plus expected cash from operations, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners, strategic transactions or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

 

We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.

 

Recent Trends - Market Conditions

 

Although the U.S. economy continued to grow throughout 2023 and into Q1 2024, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations.

 

During the three months ended March 31, 2024, the Company experienced moderation from the elevated freight costs experienced in 2023. The average cost of shipping and handling for the three months ended March 31, 2024, was $3.01 per case, as compared to $3.46 per case for the three months ended March 31, 2023. Although the Company has experienced decreases in freight costs over the last four quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. The Company has been negatively impacted by supply chain challenges affecting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins. The Company has experienced moderation in inflation and anticipates this to continue throughout 2024.

 

F-5

 

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in the determination of the Company’s liquidity.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.

 

The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.

 

Loss per Common Share

 

Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.

 

For the periods ended March 31, 2024 and 2023, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:

   March 31,
2024
   March 31,
2023
 
Warrants   549,292    235,946 
Options   141,869    174,460 
Convertible note payable   1,557,066    1,257,491 
Unvested restricted common stock   -    710 
Common stock equivalent of Series A Convertible Preferred stock   753    753 
Total   2,248,980    1,669,360 

 

Stock Compensation Expense

 

The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

F-6

 

 

The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

 

Advertising Costs

 

Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $17 and $55 for the three months ended March 31, 2024 and 2023, respectively.

 

Concentrations

 

Net sales. During the three months ended March 31, 2024, the Company’s two largest customers accounted for 17% and 16% of net sales, respectively. During the three months ended March 31, 2023, the Company’s two largest customers accounted for 18% and 12% of net sales, respectively. No other customers exceeded 10% of net sales in either period.

 

Accounts receivable. As of March 31, 2024, the Company had accounts receivable from one customer which comprised 29% of its gross accounts receivable. As of December 31, 2023, the Company had accounts receivable from three customers which comprised 24%, 15% and 11% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.

 

The Company utilizes co-packers to produce 100% of its products. During the three months ended March 31, 2024 and the year ended December 31, 2023, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company has long-standing relationships with two different co-packers, and a third co-packing agreement with California Custom Beverage LLC (“CCB”), a former related party (see Note 11). Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.

 

Purchases from vendors. During the three months ended March 31, 2024, the Company’s largest vendor accounted for approximately 10% of all purchases. During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately 11% of all purchases. No other vendors exceeded 10% of all purchases in either period.

 

Accounts payable. As of March 31, 2024, one vendor accounted for 11% of total accounts payable. As of December 31, 2023, two vendors accounted for 10% and 10% of total accounts payable, respectively. No other vendors exceeded 10% of accounts payable in either period.

 

Fair Value of Financial Instruments

 

The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

 

Reclassifications

 

Certain prior year amounts have been reclassified for consistency with the current period presentation. Collection from customers amounting to $1,217 that was previously presented as a deduction from prepaid expenses have been reclassed as an offset against accounts receivable. These reclassifications had no effect on the reported results of operations or cash flows.

 

Recent Accounting Pronouncements

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure, which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the chief operating decision maker and included in each reported measure of a segment’s profit or loss. The update also requires all annual disclosures about a reportable segment’s profit or loss and assets to be provided in interim periods and for entities with a single reportable segment to provide all the disclosures required by ASC 280, Segment Reporting, including the significant segment expense disclosures. This standard will be effective for the Company on January 1, 2024 and interim periods beginning in fiscal year 2025, with early adoption permitted. The updates required by this standard should be applied retrospectively to all periods presented in the financial statements. The Company does not expect this standard to have a material impact on its results of operations, financial position or cash flows.

 

F-7

 

 

In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The ASU requires buyers to disclose information about their supplier finance programs. Interim and annual requirements include the disclosure of outstanding amounts under the obligations as of the end of the reporting period, and annual requirements include a roll-forward of those obligations for the annual reporting period, as well as a description of payment and other key terms of the programs. This update is effective for annual periods beginning after December 15, 2022, and interim periods within those fiscal years, except for the requirement to disclose roll-forward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted ASU 2022-04 on January 1, 2023, and there was no material impact on our financial statements.

 

Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

 

2. Inventory

 

Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Raw materials and packaging  $6,766   $6,445 
Finished products   5,251    4,855 
Total  $12,017   $11,300 

 

3. Property and Equipment

 

Property and equipment are comprised of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Right-of-use assets under operating leases  $724   $724 
Computer hardware and software   400    400 
Machinery and equipment   352    352 
Construction in progress   101    85 
Total cost   1,577    1,561 
Accumulated depreciation and amortization   (1,136)   (1,068)
Net book value  $441   $493 

 

F-8

 

 

Depreciation expense for the three months ended March 31, 2024 and 2023 was $29 and $47, respectively, and amortization of right-of-use assets for the three months ended March 31, 2024 and 2023 was $39 and $32, respectively.

 

4. Intangible Assets

 

Intangible assets consist of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Brand names  $576   $576 
Trademarks   55    53 
Total  $631   $629 

 

5. Line of Credit

 

The Company’s credit facility consisted of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Line of credit – Alterna Capital Solutions  $8,005   $9,959 
Less: capitalized financing costs   (161)   (201)
Total  $7,844   $9,758 

 

In March, 2022, the Company entered into a financing agreement for a line of credit with Alterna Capital Solutions (“ACS”) The ACS line of credit is for a term of 3 years, provides for borrowings of up to $13,000, and is secured by eligible accounts receivable and inventory, and are subject to a collateral sharing agreement with Whitebox, another secured lender (see Note 6). An over advance rider provides for up to $400 of additional borrowing above the collateralized base (the “Over Advance”) up to a total borrowing of $13,000. As of March 31, 2024, there was no remaining availability under the line of credit, and $4,995 of borrowing capacity available.

 

Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (13.25% at March 31, 2024 and 13.25% at December 31, 2023). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.90% at March 31, 2024 and 13.90% at December 31, 2023). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2024 and 18.00% at December 31, 2023). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility. A loan balance of less than $1,500 will bear interest at a rate in line with account receivables advances plus the monthly monitoring fee of $1.

 

The Company incurred $483 of direct costs of the transaction, consisting primarily of broker, bank and legal fees. These costs have been capitalized and are being amortized over the 3-year life of the ACS agreement. The unamortized debt discount balance was $201 at December 31, 2023. For the three months ended March 31, 2024, amortization of debt discount was $40, and as of March 31, 2024, the remaining unamortized debt discount balance is $161.

 

6. Secured Convertible Notes Payable

 

Amounts outstanding under the Company’s convertible notes payable are as follows (amounts in 000’s except share amounts):

  

March 31,

2024

  

December 31,

2023

 
Secured Convertible “Original” Notes Payable (A)  $10,250   $10,250 
Secured Convertible “Option”” Notes Payable (B)   4,050    4,050 
Accrued interest   1,457    1,059 
           
Accrued interest on excess debt borrowing   2,989    2,824 
Capitalized financing costs   (554)   (572)
Total  $18,192   $17,611 

 

Secured Convertible Notes

 

(A)In May 2022, the Company issued $11,250 of convertible notes payable (the “Original Notes”) to entities affiliated with Whitebox Advisors, LLC (collectively, “Whitebox”). The Original Notes bear interest at 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the notes), are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with Alterna Capital (ACS), the Company’s existing secured lender. The Original Notes mature the earlier of March 31, 2025 or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. The Original Notes together with the Option Notes are collectively referred to as the “Notes”. Upon conversion or early payment, holders of the Notes are entitled to receive an interest make-whole payment, as defined, equal to the sum of the remaining scheduled payments of interest on the Notes that would be due at maturity, payable, at the Company’s option, in cash or in shares of common stock. Effective August 11, 2022, the Notes were amended to add a 10% fee for the amount that the Company’s line of credit with ACS exceeds $6,000, as defined (the “Excess ABL Amount”). Effective June 30, 2023, the Excess ABL Amount was amended to $7,500. At March 31,2024 and December 31, 2023, the principal balance of the Original Notes was $10,250.

 

The Original Notes have an amortization feature which requires the Company to make monthly payments of principal of $200 plus accrued interest, payable in cash or in shares of the Company’s common stock at the option of the Company, based on 90% of the average prices of the Company’s common stock, as defined During 2023, Whitebox waived the requirement for the Company to pay the December 2022 to October 2023 monthly amortization payments on the Original Notes. The November 2023 amortization payment of $200 principal was paid, and the amortization payment for December 2023 to May 2024 was waived. The parties agreed that amortization period shall resume on June 1, 2024.

 

The terms of the Original Notes contained conversion terms that are expected to be amended, subject to satisfaction of certain conditions. Under the revised terms, the conversion price of the Original Notes will be between 125% and 145% of the effective price of the company’s subsequent equity offering, with the premium set based on the aggregate gross proceeds realized by the company in the offering and the conversion price subject to a cap of $7.50 per share.

 

In addition on February 12, 2024, subject to the satisfaction of certain conditions, the parties agreed that a portion of the outstanding ABL accrued fees will be satisfied through payment of $132 in cash and the issuance of shares of the Company’s common stock (up to the beneficial ownership limitation applicable to each holder) at a value per share equal to the lesser of $1.50 or the per share price of securities issued in the Company’s subsequent equity offering. The remaining balance of any outstanding accrued ABL fees will be added to the principal amount of the Notes. The $132 has not been paid nor any shares issued as of the date of these financial statements.

 

F-9

 

 

(B)In February 2023 and May 2023, the Company issued an aggregate of $4,050 of additional Option Notes to Whitebox that substantially have the same terms as the Original Notes, except the Option Notes issued in 2023 do not require any amortization payments, initially were to bear interest at 10% payable in cash, and were initially due four months after issuance. On February 12, 2024, the parties agreed to change the terms so that the Option Notes shall bear interest at a rate of 10% per annum, with 5% per annum payable in cash and 5% per annum payable (“in kind” by adding such PIK interest to the unpaid principal amount. In addition, the parties agreed, subject to certain outstanding conditions, to amend the maturity date to the earlier of March 31, 2025 or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. Once they are amended, the Company shall have the right at any time prior to the date that is the 180th day from the effective date to prepay the amended and restated Option Notes, in whole or in part, at a price equal to 102% of the principal amount plus all accrued and unpaid interest thereon to the date of prepayment. At March 31, 2024 and December 31, 2023, the principal balance of the Option Notes was $4,050.

The terms of the Original Notes contained conversion terms that are expected to be amended , subject to the satisfaction of certain conditions by the Company. Under the revised terms, the conversion price of the Option Notes will be 120% of the arithmetic average of the Daily VWAP for the five (5) VWAP Trading Days beginning on, and including, the VWAP Trading Day immediately following the consummation of an equity offering undertaken for purposes of satisfying the terms and conditions of the Waiver and Amendment

 

Waiver of Default

 

On February 12, 2024, the Company entered into a Limited Waiver, Deferral, and Amendment and Restatement Agreement (the “Waiver and Amendment”) with each holder (each an entity affiliated with Whitebox Advisors, LLC) of the Original and Option Notes payable to Whitebox (the “Notes”). Subject to the Waiver and Amendment, the holders agreed to temporarily waive certain events of default under the Notes, including the failure to pay Excess ABL Amounts and the failure to pay amortization payments due December 1, 2023 to April 30, 2024. Subject to satisfaction of certain conditions by March 31, 2024, the parties further agreed to amend and restate the Notes, to extend the maturity date of the Option Notes originally due November 28, 2023, to March 31, 2025 and to equitize certain interest and fees owing on the Notes.

 

The conversion rate under the amended and restated notes is to be based on the pricing and size of the Company’s proposed equity financing of a minimum of $3 million (which will include conversion of approximately $4.1 million of previously funded SAFE investments into equity of the Company). Delays related to the Company’s evaluation of long term financing options have delayed the proposed financing. On April 1, 2024 the parties executed the Amended Limited Waiver, Deferral, and Amendment and Restatement Agreement (“Amended Waiver”). Subject to certain terms and conditions set forth in the Amended Waiver, the holders temporarily waived certain specified events of default under the Notes to April 30, 2024 and extended the waiver of monthly amortization payments to April 30, 2024. In addition, Reed’s remitted a partial interest payment of $100 to the holders.

 

Accrued Interest

 

At December 31, 2023, the balance of accrued interest was $3,883. During the period ended March 31, 2024, the Company recorded interest of $563, made up of $398 of interest on the convertible notes, and $165 related to the excess ABL fees. At March 31, 2024, the balance of accrued interest was $4,446.

 

Debt Discount

 

At December 31, 2023, the unamortized debt discount was $572. During the period ended March 31, 2024, the Company incurred $86 of costs for the aforementioned waivers. These costs have been capitalized and are being amortized over the term of the convertible notes or waiver period. For the three months ended March 31, 2024, amortization of debt discount was $104, and as of March 31, 2024, the remaining unamortized debt discount balance is $554.

 

F-10

 

 

7. Leases Liabilities

 

During the three months ended March 31, 2024 and 2023, lease costs totaled $39 and $32, respectively.

 

As of December 31, 2023, operating lease liabilities totaled $207. During the three months ended March 31, 2024, the Company made payments of $52 towards its operating lease liability. As of March 31, 2024, operating lease liabilities totaled $155.

 

As of March 31, 2024, the weighted average remaining lease terms for an operating lease are 0.75 years. As of March 31, 2024, the weighted average discount rate on the operating lease is 12.60%.

 

8. Simple Agreements for Future Equity (“SAFE”) Investments

 

During the first quarter of 2024, the Company received $4.1 million in gross proceeds from three significant stockholders of the Company, D&D Source of Life Holding LTD (“D&D”) and Union Square Park Partners LP, and John J. Bello, the Company’s Chairman, pursuant to Simple Agreements for Future Equity (“SAFE”) agreements. The SAFE investments will convert into the next equity financing of Reed’s on the same terms and conditions as investors in Reed’s next equity financing at the lesser of $1.50 per share or the per share price in the financing. Until such time as the SAFE investments convert to equity the approximately $4.1 million received is recorded as a liability. D&D was given the right to designate a second independent director nominee to the board of directors of Reed’s and the company agreed to limit the size of its board of directors to nine (9) for so long as D&D owns 25% or more of the equity securities of the Company.

 

9. Stock-Based Compensation

 

Stock Options

 

The following table summarizes stock option activity during the three months ended March 31, 2024:

 

   Shares   Weighted-
Average
Exercise Price
   Weighted-
Average
Remaining
Contractual
Terms
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2023   145,012   $45.09    6.75   $- 
Granted   -   $-           
Exercised   -   $-           
Unvested forfeited   -   $-           
Vested forfeited   (3,143)  $45.05                   
Outstanding at March 31, 2024   141,869   $44.03    6.50   $- 
Exercisable at March 31, 2024   111,583   $51.09    6.07   $- 

 

During the three months ended March 31, 2024 and 2023, the Company recognized $129 and $229 of compensation expense relating to vested stock options. As of March 31, 2024, the aggregate amount of unvested compensation related to stock options was approximately $314 which will be recognized as an expense as the options vest in future periods through March 28, 2027.

 

As of March 31, 2024, the outstanding and exercisable options have no intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2024, which was $1.63, and the exercise price of the outstanding stock options.

 

F-11

 

 

10. Stock Warrants

 

The Company’s warrant activity during the three months ended March 31, 2024 is as follows:

 

   Shares   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
Terms
(Years)
   Aggregate
Intrinsic
Value
 
                 
Outstanding at December 31, 2023   549,292   $8.77    2.84   $- 
Granted   -    -    -      
Exercised   -    -    -      
Forfeited   -    -    -                   
Outstanding at March 31, 2024   549,292   $8.77    2.59   $- 
Exercisable at March 31, 2024   549,292   $8.77    2.59   $- 

 

As of March 31, 2024, the outstanding and exercisable warrants have no aggregate intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2024, which was $1.63, and the exercise price of the Company’s warrants to purchase common stock.

 

11. Transactions with California Custom Beverage, LLC, former related party

 

In December 2018, the Company signed a co-packing agreement with California Custom Beverage, LLC’s (“CCB”), an entity owned by Christopher J. Reed, a former related party, pursuant to which CCB agreed to produce certain products for the Company for agreed fees. The co-packing agreement, as amended, includes certain provisions for product inputs, shrinkage, and quality assurance. Also beginning in 2019, CCB agreed to pay the Company a 5% royalty through 2021 on certain private label sales made by CCB.

 

At March 31, 2024 and 2023, accounts receivable due from and accounts payable due to CCB were as follows:

 

   March 31,
2024
   December 31,
2023
 
Accounts receivable, net of provision of $1,123 and $1,123 at March 31, 2024 and December 31, 2023, respectively   264    259 
Accounts payable   (331)   (259)
Net (payable) receivable   (67)    - 

 

In addition, on April 19, 2023, the Company received a letter from CCB demanding payment of various amounts, including the $452] and $452 outstanding at March 31, 2024 and December 31, 2023, respectively. The Company has determined that the probability of realizing any loss on the demand from CCB is remote and therefore has not recorded any additional accruals related to the demand.

 

12. Commitments and Contingencies

 

During 2023, the firm engaged an investment bank to explore financing options for the Company. We have a maximum obligation of $1.2M in fees so far in this engagement. These fees will be recognized on a success basis and will be paid out only if a transaction is finalized.

 

In 2018, CCB assumed the monthly payments on our lease obligation for a Los Angeles manufacturing plant for payments through September 2024, and our release from the obligation by the lessor, however, is dependent upon CCB’s deposit of $1,200 of security with the lessor. As of March 31, 2024, $800 has been deposited with the lessor and Chris J. Reed has placed approximately 7,260 shares of the Company’s common stock valued at $12 that remain in escrow with the lessor.

 

From time to time, we are a party to claims and legal proceedings arising in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and provides for potential losses on such litigation if the amount of the loss is estimable and the loss is probable.

 

We believe that there are no material litigation matters at the current time. Although the result of such litigation matters and claims cannot be predicted with certainty, we believe that the final outcome of such claims and proceedings will not have a material adverse impact on our financial position, liquidity, or results of operations.

 

13. Subsequent Events

 

Secured Convertible Notes Payable

 

The Company has not yet satisfied conditions required for issuance of the amended and restated Notes and equitization of certain interest and fees owing on the Notes. The conversion rate under the amended and restated Notes is to be based on the pricing and size of the Company’s proposed equity financing of a minimum of $3 million (which will include conversion of approximately $4.1 million of previously funded SAFE investments into equity of the Company). Delays related to the Company’s evaluation of long term financing options have delayed the proposed financing. On May 17, 2024, Reed’s entered into a Limited Waiver, Deferral, and Amendment and Restatement Agreement (the “Waiver and Amendment”) with each holder. The holders agreed to temporarily waive certain specified events of default and the payment of Excess ABL Fees through June 10, 2024. Further, the holders agreed to waive the payment of monthly amortization payments through June 30, 2024. Amortization payments are scheduled to resume on July 1, 2024. The Company further remitted $40 representing all interest (including default interest) to the holders and reimbursed the holders for certain fees and expenses.

 

F-12

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Our discussion and analysis is intended to help the reader understand our results of operations and financial condition and is provided as an addition to, and should be read in connection with, our condensed financial statements and the accompanying notes. Cautionary statements on page [ii] of this report and in “Part I, Item 1A. Risk Factors” of our 2023 Form 10-K as updated by “Part II, Item 1A” of this report, should be considered when evaluating our trends and future results.

 

In addition to our GAAP results, the following discussion includes Modified EBITDA as a supplemental measure of our performance. We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts, and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.

 

The following discussion also includes the use of gross billing, a key performance indicator and metric. Gross billing represents invoiced amounts to distributors and retailers, excluding sales adjustments. Gross billing may include deductions from MSRP or “list price”, where applicable, and excludes promotional costs of generating such sales. Management utilizes gross billing to monitor operating performance of products and salespersons, which performance can be masked by the effect of promotional or other allowances. Management believes that the presentation of gross billing provides a useful measure of Reed’s operating performance.

 

Amounts presented in the discussion below are in thousands, except share and per share amounts.

 

Results of Operations

 

Overview

 

During the three months ended March 31, 2024, the Company continued to strengthen its supply chain, implement gross margin enhancement initiatives, drive efficiencies in transportation and warehouse costs and reduce operating expenses. In addition, it continues to build its innovation pipeline with sustained growth in Reed’s Real Ginger Ale, Virgil’s Zero Sugar handcrafted sodas, Reed’s Classic and Stormy Mule, and Reed’s Hard Ginger Ale.

 

The Company remains focused on driving sales growth, improving gross margin, and reducing freight costs. The sales growth focus is on channel expansion, increase in store placements, new product introduction and improved sales execution. The margin enhancement initiative is driven by packaging savings, co-packer upgrades, and better leveraged purchasing and improved efficiency. Underpinning these initiatives is a focus on strategically reducing operating costs particularly delivery and handling expenses. In addition, the Company continues to augment its co-packer network to drive further efficiencies and build proper levels of inventory at the appropriate location to maximize delivery metrics.

 

Recent Trends – Market Conditions

 

Although the U.S. economy continued to grow throughout 2023 and into Q1 2024, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations.

 

During the three months ended March 31, 2024, the Company experienced moderation from the elevated freight costs experienced in 2023. The average cost of shipping and handling for period March 31, 2024, was $3.01 per case, as compared to $3.46 per case for the period ended March 31, 2023. Although the Company has experienced decreases in freight costs over the last four quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. The Company has been negatively impacted by supply chain challenges affecting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins. The Company has experienced moderation in inflation and anticipates this to continue throughout 2024.

 

1

 

 

During the three months ended March 31, 2024, we continued to generate cash flows to meet our short-term liquidity needs, and we expected to maintain access to the capital markets.

 

Results of Operations – Three Months Ended March 31, 2024, as compared to March 31, 2023

 

The following table sets forth key statistics for the three months ended March 31, 2024 and 2023, respectively, in thousands.

 

   Three Months Ended
March 31,
   Pct. 
   2024   2023   Change 
Gross billing (A)  $10,379   $12,453    -17%
Less: Promotional and other allowances (B)   784    1,296    -40%
Net sales  $9,595   $11,157    -14%
                
Cost of goods sold   6,182    8,459    -27%
% of Gross billing   59%   68%     
% of Net sales   64%   76%     
Gross profit  $3,413   $2,698    28%
% of Net sales   36%   24%     
                
Expenses               
Delivery and handling  $1,502   $2,120    -29%
% of Net sales   16%   19%     
Dollar per case ($)  $3.01   $3.46      
Selling and marketing   1,093    1,447    -24%
% of Net sales   11%   13%     
General and administrative   1,468    1,709    -14%
% of Net sales   15%   15%     
Total operating expenses   4,063    5,276    -23%
                
Loss from operations  $(650)  $(2,578)   -76%
                
Interest expense and other expense  $(1,023)  $(1,779)   -42%
                
Net loss  $(1,673)  $(4,357)   -62%
                
Loss per share – basic and diluted  $(0.40)  $(1.70)   -77%
                
Weighted average shares outstanding - basic & diluted   4,187,291    2,559,855    64%

 

(A) We define gross billing as the total sales for the Company unadjusted for costs related to generating those sales. Management utilizes gross billing as an indicator of and to monitor operating performance of products and salespersons before the effect of any promotional or other allowances, which are determined in accordance with GAAP, and can mask certain performance issues. We believe that the presentation of gross billing provides a useful measure of our operating performance. Additionally, gross billing may not be comparable to similarly titled measures used by other companies, as gross billing has been defined by our internal reporting practices.

 

2

 

 

(B) We define promotional and other allowances as costs deducted from gross billing which are associated with generating those sales. Management utilizes promotional and other allowances as an indicator of and to monitor operating performance of products, salespersons, and customer agreements. We believe that the presentation of promotional and other allowances provides a useful measure of our operating performance. The presentation of promotional and other allowances facilitates an evaluation of their impact on the determination of net sales and the spending levels incurred or correlated with such sales. The expenditures described in this line item are determined in accordance with GAAP and meet GAAP requirements, the disclosure thereof does not conform to GAAP presentation requirements. Additionally, our definition of promotional and other allowances may not be comparable to similar items presented by other companies. Promotional and other allowances primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following: (i) reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products; (ii) the Company’s agreed share of fees given to distributors and/or directly to retailers for in-store marketing and promotional activities; (iii) the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers; (iv) incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined sales goals; and (v) discounted or free products. Promotional and other allowances constitute a material portion of our marketing activities. The Company’s promotional allowance programs with its numerous distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, ranging from one week to one year.

 

Sales, Cost of Sales, and Gross Margins

 

The following chart sets forth key statistics for the transition of the Company’s top line activity from the first quarter of 2023 through the first quarter of 2024.

 

      2024   2023   vs PY   Q1 Per Case 
      Q1   Q1   Q1   2024   2023   vs PY 
Cases:                           
   Reed’s   348    370    -6%               
   Virgil’s   151    241    -37%               
   Total Core   499    611    -18%               
   Non Core   -    2    -100%               
   Total   499    613    -19%               
                                  
Gross Billing:                                 
   Core  $10,377   $12,333    -16%  $20.80   $20.18    3%
   Non Core   2    120    -98%   -   $60.60-      
   Total  $10,379   $12,453    -17%   20.80    20.31    2%
                                  
Discounts:  Total  $(784)  $(1,296)   -40%  $(1.57)  $(2.11)   -26%
                                  
COGS:                                 
   Core  $(6,182)  $(8,422)   -27%  $(12.39)  $(13.78)   -10%
   Non Core   -    (37)   -100%   -   $(18.50)     
   Total  $(6,182)  $(8,459)   -27%  $(12.39)  $(13.80)   -10%
                                  
Gross Margin:     $3,413   $2,698    27%  $6.84   $4.40    55%
as % Net Sales      36%   24%                   

 

Sales, Cost of Sales, and Gross Margins

 

As part of the Company’s ongoing initiative to simplify and streamline operations the Company has identified core products on which to place its strategic focus. These core products consist of Reed’s and Virgil’s branded beverages. Non-core products consist primarily of candy and slower selling discontinued Reed’s and Virgil’s SKUs.

 

During 2023, the Company licensed its candy business to Rootstock Trading, a company founded and owned by our former Chief Sales Officer, Neal Cohane. As part of this agreement, Rootstock agrees to pay a royalty on a percentage of its net sales of licensed products. The royalty fees are 0% for 2023, 2% for 2024, 4% for 2025, and 5% thereafter.

 

Core beverage volume for the three months ended March 31, 2024, represents 100% of all beverage volume.

 

3

 

 

Core brand gross billing decreased by 16% to $10,377 compared to $12,333 during the same period last year, driven by a Reed’s volume decline of 6% and Virgil’s volume decline of 37%. The result is a decrease in total gross billing of 17%, to $10,379 during the three months ended March 31, 2024, from $12,453 in the same period last year. Price on our core brands increased 3% to $20.80 per case. The increase was a result of price increases across the channels of our product lines.

 

Discounts as a percentage of gross sales decreased to 8% from 10% in the same period last year. This decline in discounts partially offset the revenue decline. Net sales revenue decreased 14% in the three months ended March 31, 2024, to $9,595, compared to $11,157 in the same period last year.

 

Cost of Goods Sold

 

Cost of goods sold decreased $2,277 during the three months ended March 31, 2024, as compared to the same period last year. As a percentage of net sales, cost of goods sold for the three months ended March 31, 2023, was 64% as compared to 76% for the same period last year.

 

The total cost of goods per case increased to $12.39 per case in the three months ended March 31, 2024, from $13.80 per case for the same period last year. The cost of goods sold per case on core brands was $12.39 during the three months ended March 31, 2024, compared to $13.78 for the same period last year.

 

Gross Margin

 

Gross margin was 36% for the three months ended March 31, 2024, compared to 24% for the same period last year.

 

Operating Expenses

 

Delivery and Handling Expenses

 

Delivery and handling expenses consist of delivery costs to customers and warehousing costs incurred for handling our finished goods after production. Delivery and handling expenses decreased by $618 in the three months ended March 31, 2024, to $1,502 from $2,120 in the same period last year, driven by our efforts to mitigate inflationary costs. Delivery costs in the three months ended March 31, 2024, were 16% of net sales and $3.01 per case, compared to 19% of net sales and $3.46 per case during the same period last year.

 

Selling and Marketing Expenses

 

Marketing expenses consist of direct marketing, marketing labor, and marketing support costs. Selling expenses consist of all other selling-related expenses including personnel and contractor support. Total selling and marketing expenses were $1,093 during the three months ended March 31, 2024, compared to $1,447 during the same period last year. As a percentage of net sales, selling and marketing costs was 11% during the three months ended March 31, 2024, as compared to 13% during the same period last year. The decrease was primarily driven by lower employee related costs, marketing expenditures, and travel and entertainment expense, partially offset by slightly higher professional fees.

 

General and Administrative Expenses

 

General and administrative expenses consist primarily of the cost of executive, administrative, and finance personnel, as well as professional fees. General and administrative expenses decreased in the three months ended March 31, 2024, to $1,468 from $1,709, a decrease of $241 over the same period last year. As a percentage of net sales, general and administrative expenses were 15% during the three months ended March 31, 2024, as compared to 15% during the same period last year. The decrease was driven by lower employee related costs, professional fees, and stock compensation.

 

Loss from Operations

 

The loss from operations was $650 for the three months ended March 31, 2024, as compared to a loss of $2,578 in the same period last year driven by decreased gross profit offset by decreases in operating expenses discussed above.

 

Interest and Other Expense

 

Interest and other expense for the three months ended March 31, 2024, consisted of $1,023 of interest expense. During the same period last year, interest and other expense consisted of $1,779 of interest expense.

 

4

 

 

Modified EBITDA

 

In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, legal settlements, and one-time restructuring-related costs including employee severance and asset impairment.

 

Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

 

Set forth below is a reconciliation of net loss to Modified EBITDA for the three months ended March 31, 2024 and 2023 (unaudited; in thousands):

 

   Three Months Ended
March 31
 
   2024   2023 
Net loss  $(1,673)  $(4,357)
           
Modified EBITDA adjustments:          
Depreciation and amortization   68    80 
Tax expense   54      
Interest expense   1,023    1,779 
Product quality hold write-down   29      
Stock option and other noncash compensation   129    233 
Total EBITDA adjustments  $1,303   $2,092 
           
Modified EBITDA  $(370)  $(2,265)

 

We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:

 

  Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;
     
  Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
     
  Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and
     
  Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.

 

Liquidity and Capital Resources

 

For the three months ended March 31, 2024, the Company recorded a net loss of $1,673 and used cash in operations of $2,395. In accordance with Accounting Standards Codification (“ASC”) 205-40, Going Concern, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. As of the issuance date of these financial statements, management expects that the Company’s existing cash of $314, which includes $4,100 of additional cash received during the three months ended March 31, 2024, from investments with significant stockholders and expected cash flow from operations, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Management’s assessment whether there is sufficient cash on hand, together with expected capital raises, to assure operations for a period of at least twelve months from the date these financial statements are issued, is based on conditions that are known and reasonably knowable to management, considering various scenarios, projections, and estimates and certain key assumptions. These assumptions include, among other factors, management’s ability to raise additional capital, and the expected timing and nature of the Company’s forecasted cash expenditures.

 

Historically, the Company has financed its operations through public and private sales of common stock, convertible debt instruments, credit lines from financial institutions, and cash generated from operations. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

 

5

 

 

Critical Accounting Policies and Estimates

 

The preparation of the Company’s financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in estimates for reserves of uncollectible accounts, inventory obsolescence, depreciable lives of property and equipment, analysis of impairments of recorded long-term tangible and intangible assets, realization of deferred tax assets, accruals for potential liabilities and assumptions made in valuing stock instruments issued for services. There were no changes to our critical accounting policies described in the condensed financial statements included in our 2023 10-K that impacted our condensed financial statements and related notes included herein.

 

Recent Accounting Pronouncements

 

See Note 2 of the Notes to Condensed Financial Statements for a discussion of recent accounting pronouncements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

A smaller reporting company is not required to provide the information required by this Item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of March 31, 2023, to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes in the Company’s internal control over financial reporting during the three months ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

6

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are subject to a variety of variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations from time to time in the ordinary course of business. Management evaluates, and periodically re-evaluates, whether the final result of any of the foregoing may be expected to have a material adverse effect on our financial condition, results of operations or cash flows. Management has determined that no disclosure is required under this Item 1.

 

Item 1A. Risk Factors

 

Except as set forth below, there have been no material changes with respect to the risk factors disclosed in our 2023 Form 10-K.

 

Risks Related to Our Debt Service Obligations

 

Our ability to service our indebtedness will depend on our ability to generate cash in the future.

 

At March 31, 2024, our outstanding obligation on our 10% Secured Convertible Notes (“Notes”) was approximately $18.7 million and the balance on our ABL line of credit was approximately $8 million. Our Note holders have been amenable to making accommodations under the Notes by waiving conditions and financial covenants in exchange for certain negotiated penalties in lieu of declaring default. Our business may not generate sufficient cash to fund our working capital requirements, capital expenditure, debt service and other liquidity needs, which could result in our inability to comply with financial and other covenants contained in our debt agreements, our being unable to repay or pay interest and penalties on our indebtedness, and our inability to fund our other liquidity needs. If we are unable to service our debt obligations and maintain compliance with our financial and other covenants or, in the alternative, continue to negotiate suitable accommodations and fund our other liquidity needs, we could be forced to curtail our operations, our creditors could accelerate our indebtedness and exercise other remedies. We could be required to pursue one or more alternative strategies, such as selling assets or refinancing or restructuring our indebtedness. However, such alternatives may not be feasible or adequate.

 

Holders of our Notes have been amenable to making accommodations under the Notes by waiving conditions and financial covenants in exchange for certain negotiated penalties in lieu of declaring default. If do not meet our obligations under the Notes and are unable to negotiate accommodations in the future, the Note holders may declare a default, which would likely force us into bankruptcy.

 

At March 31, 2024, our outstanding obligation under the Notes was approximately $18.7 million. The Notes are secured by substantially all of the Company’s assets. The indebtedness under the Notes limits our growth, and management of the debt requires a significant amount of time and effort of our executive officers. While we have been successful negotiating waivers and amendments under the Notes, we may not be able to continue to do so in the future. We have further been exploring our options to refinance these Notes. If we are unable to service or repay these obligations at maturity and we are otherwise unable to extend the maturity dates or refinance these obligations, we may default. A default would trigger acceleration under the Notes, and it is unlikely that we would have sufficient funds to make these payments. Upon a default, the holders have the right to exercise their remedies to collect, including foreclosing on our assets. Accordingly, we would likely be forced to seek bankruptcy protection in the event of default.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None that have not been previously disclosed in a Current Report on Form 8-K.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

The Company has not yet satisfied conditions required for issuance of the amended and restated Notes and equitization of certain interest and fees owing on the Notes. The conversion rate under the amended and restated Notes is to be based on the pricing and size of the Company’s proposed equity financing of a minimum of $3 million (which will include conversion of approximately $4.1 million of previously funded SAFE investments into equity of the Company). Delays related to the Company’s evaluation of long term financing options have delayed the proposed financing. On May 17, 2024, Reed’s entered into a Limited Waiver, Deferral, and Amendment and Restatement Agreement (the “Waiver and Amendment”) with each holder. The holders agreed to temporarily waive certain specified events of default and the payment of Excess ABL Fees through June 10, 2024. Further, the holders agreed to waive the payment of monthly amortization payments through June 30, 2024. Amortization payments are scheduled to resume on July 1, 2024. The Company further remitted $40 representing all interest (including default interest) to the holders and reimbursed the holders for certain fees and expenses.

 

Item 6. Exhibits

 

See Exhibit Index on page. [8].

 

7

 

 

INDEX TO EXHIBITS

ITEM 15(a)(3)

 

The following is a list of the exhibits filed as part of this Form 10-Q. The documents incorporated by reference can be viewed on the SEC’s website at http://www.sec.gov.

 

Exhibit

 

3(i) Certificate of Incorporation of Reeds, Inc. which is incorporated herein by reference to exhibit 3(iv) to Form 10-K filed with SEC on May 15, 2023.
3(ii) Amended and Restated Bylaws of Reed’s, Inc. which is incorporated by reference to Exhibit 3.8 to Form 10-K/A filed with the SEC on April 8, 2020.
4.1 Simple Agreement for Future Equity by and between Reed’s, Inc. and D&D Source of Life Holding Ltd. dated February 8, 2024 which is incorporated by reference to Exhibit 4.7 to Form 10-K as filed with the SEC on April 1, 2024.
4.2 Simple Agreement for Future Equity by and between Reed’s, Inc. and John J. Bello dated March 7, 2024 which is incorporated by reference to Exhibit 4.8 to Form 10-K as filed with the SEC on April 1, 2024.
4.3 Simple Agreement for Future Equity by and between Reed’s, Inc. and Union Square Park Partners LP dated February 8, 2024 which is incorporated by reference to Exhibit 4.9 to Form 10-K as filed with the SEC on April 1, 2024.
10.1 Limited Waiver, Deferral, and Amendment and Restatement Agreement by and between Reed’s, Inc. and each holder and Wilmington Savings Fund Society, FSB, holder representative and collateral agent dated February 12, 2024 which is incorporated by reference to Exhibit 10.3 to Form 8-K as filed with the SEC February 13, 2024.
10.2 Amendment to Limited Waiver, Deferral, and Amendment and Restatement Agreement by and between Reed’s, Inc. and each holder and Wilmington Savings Fund Society, FSB, holder representative and collateral agent dated April 1, 2024 which is incorporated by reference to Exhibit 10.1 to Form 8-K/A as filed with the SEC on April 3, 2024.
10.3 Limited Waiver and Deferral Agreement by and between Reed’s, Inc. and each holder and Wilmington Savings Fund Society, FSB, holder representative and collateral agent dated May 17, 2024.
31 Certification of our Chief Executive Officer and our Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32 Certification of our Chief Executive Officer and our Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101 The following materials from Reed’s, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Balance Sheets, (ii) the Condensed Statements of Operations, (iii) the Condensed Statements of Changes in Stockholders (Deficit), (iv) the Condensed Statements of Cash Flows, and (v) Notes to Condensed Financial Statements.
104 The cover page from the Reed’s, Inc. Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, formatted in Inline XBRL and contained in Exhibit 101.

 

8

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Reed’s, Inc.
(Registrant)
   
Date: May 20, 2024 /s/ Norman E. Snyder, Jr.
  Norman E. Snyder, Jr.
  Chief Executive Officer
  (Principal Executive Officer)
   
Date: May 20, 2024 /s/ Joann Tinnelly
  Joann Tinnelly
  Chief Financial Officer
  (Principal Financial Officer)

 

9

EX-10.3 2 ex10-3.htm

 

Exhibit 10.3

 

LIMITED WAIVER AND DEFERRAL AGREEMENT

 

THIS LIMITED WAIVER AND DEFERRAL AGREEMENT (this “Waiver”) is dated and effective as of May 17, 2024 between REED’S, INC., a Delaware corporation (the “Company”), the Holders party hereto, and WILMINGTON SAVINGS FUND SOCIETY, FSB, as Holder Representative and Collateral Agent (the “Agent”).

 

WHEREAS, on May 9, 2022, the Company, the Holder Representative and each purchaser on the schedule of purchasers thereto entered into that certain Note Purchase Agreement, (as amended, the “Note Purchase Agreement”), pursuant to which the Company issued 10% Secured Convertible Notes, (as amended each, a “Note”, and collectively, the “Notes”), and as of the date hereof, the outstanding Notes include Note No. 1, Note No. 2, Note No. 3 and Note No. 4 (the “Original Notes”) and Note No. 9, Note No. 10, Note No. 11, Note No. 12, Note No. 13, Note No. 14, Note No. 15 and Note No. 16 (the “Option Notes”).

 

WHEREAS, on February 10, 2023, the Company, the Holders and the Agent entered into a Limited Waiver and Deferral Agreement (the “February 2023 Limited Waiver”), pursuant to which the parties agreed to, among other things, (i) waive certain provisions of the Notes relating to a Fundamental Change resulting from a delisting of the Common Stock, (ii) waiving certain Events of Default, (iii) foregoing certain Amortization Payments through June 30, 2023 and (iv) deferring certain fees payable under the Notes with regard to the Indebtedness of the ABL Lenders arising under the ABL Debt Documents at each calendar month end exceeding the applicable amount set forth in clause (n) of the definition of Permitted Indebtedness.

 

WHEREAS, on April 11, 2023, the Company, the Holders and the Agent entered into a Limited Waiver, pursuant to which the parties agreed to further waive certain provisions of the Notes relating to the Fundamental Change resulting from the delisting of the Common Stock from the Nasdaq Stock Market (the “Delisting”).

 

WHEREAS, on May 30, 2023, the Company, the Holders and the Agent entered into a Limited Waiver and Deferral Agreement (the “May 2023 Limited Waiver”), pursuant to which the parties agreed to, among other things, (i) further defer the Deferred ABL Fees (as defined in the February 2023 Limited Waiver) to September 29, 2023, and (ii) rescind the Holders’ election to receive monthly Amortization Payments otherwise due and payable during the period from December 1, 2022 until September 29, 2023.

 

WHEREAS, on October 5, 2023, the Company, the Holders and the Agent entered into a Limited Waiver and Deferral Agreement (the “October 2023 Limited Waiver”), pursuant to which the parties agreed to, among other things, (i) further defer the Updated Deferred ABL Fees (as defined in the October 2023 Limited Waiver) to November 28, 2023, and (ii) rescind the Holders’ election to receive monthly Amortization Payments otherwise due and payable during the period from December 1, 2022 until October 31, 2023.

 

WHEREAS, on February 12, 2024, the Company, the Holders and the Agent entered into a Limited Waiver, Deferral and Amendment and Restatement Agreement (as such agreement was subsequently amended, the “A&R Agreement”), pursuant to which the parties agreed to, among other things, (i) waive certain Defaults and Events of Default with respect to the Notes and (ii) subject to the satisfaction of certain conditions precedent (the “A&R Conditions Precedent”), to amend and restate the Notes and to equitize certain interest and fees owing on the Notes as set forth in the A&R Agreement.

 

WHEREAS, the A&R Conditions Precedent were never satisfied (and as a result the A&R Effective Date (as defined in the A&R Agreement) never occurred) and the waivers provided by the A&R Agreement have expired.

 

 

 

 

WHEREAS, the Company (i) has paid all accrued and unpaid Cash Interest (other than Default Interest (as defined below)) on the Original Notes through May 9, 2024 and (ii) assuming the satisfaction of the conditions set forth in Section 6 of this Waiver, will have paid all accrued and unpaid Cash Interest (other than Default Interest) on the Option Notes through April 30, 2024.

 

NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration (the receipt and sufficiency of which is hereby acknowledged), the parties hereto, intending to be legally bound hereby, agree as follows:

 

1. Incorporation of Terms. All capitalized terms not otherwise defined herein shall have the same meaning as in the Notes.

 

2. Representations and Warranties. The Company hereby represents and warrants that after giving effect to this Waiver, all representations and warranties contained in the Notes are true and correct, in all material respects, on and as of the date hereof, except (a) to the extent that such representations and warranties specifically refer to an earlier date, in which case they shall be true and correct as of such earlier date, and (b) in the case of any representation and warranty qualified by materiality, they shall be true and correct in all respects.

 

3. Waivers.

 

(a) Subject to the satisfaction of the conditions precedent set forth in Section 6 of this Waiver, Agent (as directed by all Holders below) and the Holders party hereto hereby temporarily waive the Specified Events of Default under the Notes (as listed on Annex A hereto) through and including the earlier to occur of (i) the date that any Event of Default (other than a Specified Event of Default) occurs under the Notes or any other Note Document and (ii) June 10, 2024 (such period, the “Waiver Period”).

 

(b) Except as set forth in Section 3(a), in the event that the Specified Events of Default have not been resolved in a manner acceptable to the Majority Holders on or before the expiration of the applicable Waiver Period, (i) the waiver provided in Section 3(a) shall terminate immediately, and (ii) the Specified Events of Default shall be deemed to have occurred and be continuing for all purposes of the Notes and the other Note Documents.

 

(c) Subject to the satisfaction of the conditions precedent set forth in Section 6 of this Waiver, Agent (as directed by all Holders below) and the Holders party hereto hereby temporarily waive any requirement pursuant to Section 6 of the Notes that the Company conduct a repurchase of Notes as a result of the Delisting prior to June 10, 2024, provided, that, for all purposes under the Notes, the Company shall treat the Delisting, and the resulting Fundamental Change and Make-Whole Fundamental Change, as if they occurred and became effective on and as of June 10, 2024.

 

(d) This Section 3 shall be effective only to the extent specifically set forth herein and shall not be construed as a consent to or waiver of any breach or Default other than as specifically waived herein and shall not (i) affect the right of Agent or any of the Holders to demand strict compliance by Company with all terms and conditions of the Notes, except as specifically consented to, modified or waived by the terms hereof, (ii) be deemed a consent to or waiver of any future transaction or action on the part of any Note Party requiring the Holders’ or the Majority Holders’ consent or approval under the Notes, or (iii) diminish, prejudice or waive any of Agent’s or any Holders’ rights and remedies under the Notes or applicable law, whether arising as a consequence of any Event of Default which may now exist or otherwise, and Agent and each of the Holders hereby reserve all of such rights and remedies. For the avoidance of doubt and notwithstanding anything herein to the contrary, to the extent any provision of the Notes is qualified by, or requires the absence of, any Default or Event of Default, a Default or Event of Default shall be deemed to not have occurred for purposes of such provisions.

 

 2 

 

 

4. Certain ABL Fees, Conversion/PIK Schedule and Default Interest.

 

(a) Certain ABL Fees and Amortization. Subject to the satisfaction of the conditions precedent set forth in Section 6 of this Waiver:

 

(i) Notwithstanding anything to the contrary in the February 2023 Limited Waiver, the May 2023 Limited Waiver, the October 2023 Limited Waiver, the A&R Agreement or Section 12(g) of the Notes, the Updated Deferred ABL Fees (as defined in the October 2023 Limited Waiver) and any fee payable pursuant to Section 12(g) of the Notes between November 28, 2023 and June 10, 2024, shall become due and payable in cash on June 10, 2024. The Company and the Holders acknowledge and agree that a complete listing of all fees payable pursuant to Section 12(g) of the Notes as of the date hereof is set forth on Annex B hereto.

 

(ii) Notwithstanding anything to the contrary in Section 2(b) of the Notes, (i) the Holders agree to rescind their election to receive monthly Amortization Payments otherwise due and payable during the period from December 1, 2023 until June 30, 2024 (the “Foregone Amortization Payments”), (ii) the applicable portion of the aggregate Principal Amounts included in the Foregone Amortization Payments shall remain part of the aggregate Principal Amount of the applicable Note outstanding and shall become due and owing in accordance with the terms of such Notes and (iii) Interest shall continue to accrue on such Principal Amounts without interruption (which interest, in the case of all periods from, and including, December 1, 2023 shall include Default Interest (as defined below) as contemplated by Section 2(a) of the Notes and Section 4(c) of this Waiver). The Company and Holders hereby acknowledge and agree that Amortization Payments shall resume on July 1, 2024. The Company and Holders hereby acknowledge and agree that the updated amortization schedule is, as of the date hereof, true and accurate as set forth on Annex C hereto. For the avoidance of doubt, such updated amortization schedule has been calculated without consideration of any Default Interest paid or payable after the date hereof as contemplated by Section 2(a) of the Notes and Section 4(c) of this Waiver.

 

(b) Conversion/PIK Schedule. The Company and Holders hereby acknowledge and agree that the Conversion/PIK Schedule in respect of each of the Original Notes is, as of the date hereof, true and accurate as set forth on Annex D hereto.

 

(c) Default Interest. Regardless whether any of the conditions set forth in Section 6 of this Waiver have been satisfied, the Company acknowledges and agrees that, consistent with the A&R Agreement, all outstanding Obligations under the Notes continue to bear interest, payable whenever Interest is otherwise payable pursuant to the notes, at the rate otherwise applicable thereto plus 2.00% per annum (“Default Interest”), and that such Default Interest is payable notwithstanding the absence of any Defaults or Events of Default as a result of the waivers provided pursuant to this Waiver. The parties acknowledge and agree that (i) through May 9, 2024, cash Default Interest totaling $48,797.58 was accrued and unpaid with respect to the Original Notes and (ii) through April 30, 2024, cash Default Interest totaling $33,750.21 was accrued and unpaid with respect to the Option Notes.

 

 3 

 

 

5. Releases.

 

(a) The Company, on behalf of itself and each of the Note Parties (and on behalf of each Affiliate thereof) and for itself and for its successors in title and assignees and, to the extent the same is claimed by right of, through or under any of the Note Parties, for its past, present and future employees, agents, representatives (other than legal representatives), officers, directors, shareholders, and trustees (each, a “Releasing Party” and collectively, the “Releasing Parties”), does hereby remise, release and discharge, and shall be deemed to have forever remised, released and discharged, the Agent, and each of the Holders in their respective capacities as such under the Note Documents, and the Agent’s and each Holder’s respective successors-in-title, legal representatives and assignees, past, present and future officers, directors, affiliates, shareholders, trustees, agents, employees, consultants, experts, advisors, attorneys and other professionals and all other persons and entities to whom the Agent and each of the Holders or any of their respective successors-in-title, legal representatives and assignees, past, present and future officers, directors, affiliates, shareholders, trustees, agents, employees, consultants, experts, advisors, attorneys and other professionals would be liable if such persons or entities were found to be liable to any Releasing Party or any of them (collectively, hereinafter the “Releasees”), from any and all manner of action and actions, cause and causes of action, claims, charges, demands, counterclaims, crossclaims, suits, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts, rights of setoff and recoupment, controversies, damages, judgments, expenses, executions, liens, claims of liens, claims of costs, penalties, attorneys’ fees, or any other compensation, recovery or relief on account of any liability, obligation, demand or cause of action of whatever nature, whether in law, equity or otherwise, whether known or unknown, fixed or contingent, joint and/or several, secured or unsecured, due or not due, primary or secondary, liquidated or unliquidated, contractual or tortious, direct, indirect, or derivative, asserted or unasserted, foreseen or unforeseen, suspected or unsuspected, now existing, heretofore existing or which may heretofore accrue against any of the Releasees, and which are, in each case, based on any act, fact, event or omission or other matter, cause or thing occurring at any time prior to or on the date hereof in any way, directly or indirectly arising out of, connected with or relating to the Notes or any other Note Document and the transactions contemplated thereby, and all other agreements, certificates, instruments and other documents and statements (whether written or oral) related to any of the foregoing (each, a “Claim” and collectively, the “Claims”); provided, that, no Releasing Party shall have any obligation with respect to Claims to the extent such Claims are determined by a court of competent jurisdiction by final and non-appealable judgment to have resulted from the gross negligence or willful misconduct of any Releasee. Each Releasing Party further stipulates and agrees with respect to all Claims, that it hereby waives, to the fullest extent permitted by applicable law, any and all provisions, rights, and benefits conferred by any applicable U.S. federal or state law, or any principle of common law, that would otherwise limit a release or discharge of any unknown Claims pursuant to this Section 5.

 

(b) The Company, on behalf of each Note Party, itself and its successors, assigns, and other legal representatives, hereby absolutely, unconditionally and irrevocably, covenants and agrees with and in favor of each Releasee that it will not sue (at law, in equity, in any regulatory proceeding or otherwise) any Releasee on the basis of any Claim released, remised and discharged by any Note Party pursuant to Section 5(a) of this Waiver. If any Note Party or any of its successors, assigns or other legal representatives violates the foregoing covenant, the Note Parties, each for itself and its successors, assigns and legal representatives, agrees to pay, in addition to such other damages as any Releasee may sustain as a result of such violation, all attorneys’ fees and costs incurred by any Releasee as a result of such violation.

 

6. Conditions to Effectiveness. This Waiver shall not be effective until each of the following conditions precedent has been fulfilled to the satisfaction of the Agent (at the direction of all Holders):

 

(a) This Waiver shall have been duly executed and delivered by the Company, the Agent, and the Majority Holders, and the Agent shall have received evidence thereof.

 

(b) After giving effect to this Waiver, no Default or Event of Default shall have occurred and be continuing.

 

(c) The Company shall have paid (i) all accrued and unpaid Interest (other than Default Interest) as of April 30, 2024 on the Option Notes, totaling $39,781.33, (ii) all outstanding fees and expenses of King & Spalding LLP, counsel to the Holders, and (iii) all outstanding fees and expenses of Chapman and Cutler LLP, counsel to the Agent.

 

 4 

 

 

7. Binding Effect. The terms and provisions hereof shall be binding upon and inure to the benefit of the parties hereto and their heirs, representatives, successors and assigns.

 

8. Reaffirmation of Obligations. The Company hereby ratifies the Note Documents and acknowledges and reaffirms (a) that it is bound by all terms of the Note Documents applicable to it and (b) that it is responsible for the observance and full performance of its respective Obligations.

 

9. Note Document. This Waiver shall constitute a Note Document under the terms of each Note.

 

10. Multiple Counterparts. This Waiver may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Waiver by telecopy, pdf or other electronic transmission shall be as effective as delivery of a manually executed counterpart of this Waiver.

 

11. Governing Law. THIS WAIVER AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION, WHETHER IN LAW OR EQUITY, WHETHER IN CONTRACT OR IN TORT OR OTHERWISE BASED UPON, ARISING OUT OF OR RELATING TO THIS WAIVER AND THE TRANSACTIONS CONTEMPLATED HEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

 

12. Consent to Jurisdiction; Service of Process; Agreement of Jury Trial. The jurisdiction, service of process and waiver of jury trial provisions set forth in subsections 13(h) and 13(i) of the Notes are hereby incorporated by reference.

 

13. Agent Authorization. Each of the undersigned Holders hereby authorizes and directs Agent to execute and deliver this Waiver on its behalf and, by its execution below, each of the undersigned Holders agrees to be bound by the terms and conditions of this Waiver. In executing this Waiver, the Agent shall be entitled to all of the rights, benefits, protections, indemnities and immunities afforded to it pursuant to the Note Documents.

 

[Signature page follows]

 

 5 

 

 

IN WITNESS WHEREOF, this Limited Waiver and Deferral Agreement has been duly executed and delivered by each of the parties hereto as of the date first above written.

 

COMPANY:   HOLDER REPRESENTATIVE:
     
Reed’s, Inc.   Wilmington Savings Fund Society, FSB, solely in its capacity as the Holder Representative
         
By: /s/ Norman E. Snyder, Jr.   By: /s/ Raye Goldsborough
Name: Norman E. Snyder, Jr   Name: Raye Goldsborough
Title: CEO   Title: Vice President
         
HOLDERS:   COLLATERAL AGENT:
       
Whitebox Multi-Strategy Partners, LP   Wilmington Savings Fund Society, FSB, solely in its capacity as the Collateral Agent
     
By: /s/ Andrew Thau   By: /s/ Raye Goldsborough
Name: Andrew Thau   Name: Raye Goldsborough
Title: Authorized Signatory   Title: Vice President
     
Whitebox Relative Value Partners, LP      
         
By: /s/ Andrew Thau      
Name: Andrew Thau      
Title: Authorized Signatory      
         
Pandora Select Partners, LP      
         
By: /s/ Andrew Thau      
Name: Andrew Thau      
Title: Authorized Signatory      
         
Whitebox GT Fund, LP      
         
By: /s/ Andrew Thau      
Name: Andrew Thau      
Title: Authorized Signatory      

 

[Signature Page to Limited Waiver]

 

 

 

 

Annex A to

Limited Waiver and Deferral Agreement

 

Specified Events of Default

 

  1. The Company’s failure to comply with Section 4(f) of the Notes on or prior to the date hereof.
     
  2. The Company’s failure to comply with Section 7(w) of the Notes on or prior to the date hereof by maintaining Indebtedness in favor of the ABL Lenders arising under the ABL Debt Documents that exceeds the amount permitted by clause (n) of the definition of Permitted Indebtedness in the Notes.
     
  3. The Company’s failure to comply with Section 7(kk) of the Notes on or prior to the date hereof.
     
  4. The Company’s failure to timely pay on or prior to the date hereof (a) the Principal Amount as required by Section 2(a) of each Option Note at their maturity, (b) any Cash Interest (including Default Interest) as required by Section 2(d) of each Option Note, (c) the Principal Amount of any amortization payment pursuant to Section 2(b) of each Original Note and (d) any Cash Interest or PIK Interest (including Default Interest) as required by Section 2(d) of each Original Note.
     
  5. The Company’s failure to timely pay (a) on or prior to the date hereof the Amortization Payments due on December 1, 2023, January 1, 2024, February 1, 2024, March 1, 2024, April 1, 2024 and May 1, 2024 as required by Section 2(b) of the Notes, or (b) on or prior to the date hereof the Excess ABL Fee as required under Section 12(g) of the Notes.

 

 

 

 

Annex B to

Limited Waiver and Deferral Agreement

 

ABL Fees

 

Fees payable pursuant to Section 12(g) with respect to Indebtedness in favor of the ABL Lenders arising under the ABL Debt Documents for the month ending as of each date listed below:

 

Date   Excess ABL Fee

 

[OMITTED]

 

 

 

 

Annex C to

Limited Waiver and Deferral Agreement

 

Updated Amortization Schedule

 

(Calculated without giving effect to Default Interest occurring after the date hereof)

 

See Attached

 

[OMITTED]

 

 

 

 

Annex D to

Limited Waiver and Deferral Agreement

 

Conversion / PIK Schedules

 

See attached.

 

[OMITTED]

 

 

 

EX-31 3 ex31.htm

 

EXHIBIT 31

 

Certification of Principal Executive Officer

 

I, Norman E. Snyder, Jr., certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Reed’s, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s first fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 20, 2024

 

  /s/ Norman E. Snyder, Jr.
  Name: Norman E. Snyder, Jr.
 

Title: Chief Executive Officer

(Principal Executive Officer)

 

 
 

 

Certification of Principal Financial Officer

 

I, Joann Tinnelly, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Reed’s, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s first fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 20, 2024

 

  /s/ Joann Tinnelly
  Name: Joann Tinnelly
 

Title: Chief Financial Officer

(Principal Financial Officer)

 

 

 

EX-32 4 ex32.htm

 

EXHIBIT 32

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Norman E. Snyder, Jr., the Chief Executive Officer of Reed’s, Inc. (the “Company”), hereby certify, that, to my knowledge:

 

1. The Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 (the “Report”) of the Company fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 20, 2024

 

  /s/ Norman E. Snyder, Jr.
  Name: Norman E. Snyder, Jr.
 

Title: Chief Executive Officer

(Principal Executive Officer)

 

 
 

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Joann Tinnelly, the Chief Financial Officer of Reed’s, Inc. (the “Company”), hereby certify, that, to my knowledge:

 

1. The Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024 (the “Report”) of the Company fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 20, 2024

 

  /s/ Joann Tinnelly
  Name: Joann Tinnelly
 

Title: Chief Financial Officer

(Principal Financial Officer)

 

 

 

 

EX-101.SCH 5 reed-20240331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Statements of Changes in Stockholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Line of Credit link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Secured Convertible Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Leases Liabilities link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Simple Agreements for Future Equity (“SAFE”) Investments link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stock Warrants link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Transactions with California Custom Beverage, LLC, former related party link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Line of Credit (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Secured Convertible Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stock Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Schedule of Potentially Dilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Summary of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Schedule of Amount Outstanding Under Credit Facilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Line of Credit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Schedule of Secured Convertible Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Schedule of Secured Convertible Notes Payable (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Secured Convertible Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Leases Liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Simple Agreements for Future Equity (“SAFE”) Investments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Stock-Based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Schedule of Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Stock Warrants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Schedule of Related Parties (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Schedule of Related Parties (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 reed-20240331_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 reed-20240331_def.xml XBRL DEFINITION FILE EX-101.LAB 8 reed-20240331_lab.xml XBRL LABEL FILE Related and Nonrelated Parties [Axis] Related Party [Member] Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Customer [Axis] Customer One [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Product Concentration Risk [Member] Customer Two [Member] Accounts Receivable [Member] Customer Concentration Risk [Member] Customer Three [Member] Vendor One [Member] Accounts Payable [Member] Vendor Two [Member] Antidilutive Securities [Axis] Warrant [Member] Equity Option [Member] Convertible Notes Payable [Member] Unvested Restricted Common Stock [Member] Common Stock Equivalent of Series A Convertible Preferred Stock [Member] Long-Lived Tangible Asset [Axis] Right of Use Assets Under Operating Leases [Member] Computer Hardware And Software [Member] Machinery and Equipment [Member] Construction in Progress [Member] Lender Name [Axis] Alterna Capital Solutions [Member] Debt Instrument [Axis] Notes Payable A [Member] Notes Payable B [Member] Secured Convertible Notes Payable [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Note Purchase Agreement [Member] Legal Entity [Axis] Whitebox Advisors, LLC [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Additional Option Notes [Member] Limited Waiver, Deferral, and Amendment and Restatement Agreement [Member] Simple Agreements For Future Equity Investments [Member] Stockholders [Member] Award Type [Axis] Share-Based Payment Arrangement, Option [Member] Securities Purchase Agreement [Member] Title and Position [Axis] Christopher J. Reed [Member] California Custom Beverage, LLC [Member] Related Party Transaction [Axis] Chris Reed [Member] Short-Term Debt, Type [Axis] Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current assets: Cash Accounts receivable, net of allowance of $258 and $860, respectively Inventory Receivable from former related party Prepaid expenses and other current assets Total current assets Property and equipment, net of accumulated depreciation of $1,136 and $1,068, respectively Intangible assets Total assets LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities: Accounts payable Accrued expenses Revolving line of credit, net of capitalized financing costs of $161 and $201, respectively Payable to former related party Current portion of convertible notes payable, net of debt discount of $509 and $424, respectively Current portion of lease liabilities Total current liabilities SAFE agreements Convertible note payable, net of debt discount of $45 and $148, respectively, less current portion Total liabilities Stockholders’ deficit: Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding Common stock, $.0001 par value, 180,000,000 shares authorized; 4,187,291 and 4,187,291 shares issued and outstanding, respectively Additional paid in capital Accumulated deficit Total stockholders’ deficit Total liabilities and stockholders’ deficit Statement of Financial Position [Abstract] Accounts receivable, net of allowance Property and equipment, accumulated depreciation Capitalized financing costs Debt discount current Debt discount, noncurrent Series A convertible preferred stock, par value Series A convertible preferred stock, shares authorized Series A convertible preferred stock, shares issued Series A convertible preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Net Sales Cost of goods sold Gross profit Operating expenses: Delivery and handling expense Selling and marketing expense General and administrative expense Total operating expenses Loss from operations Interest expense Net loss Net loss per share - basic Net loss per share - diluted Weighted average number of shares outstanding - basic Weighted average number of shares outstanding - diluted Statement [Table] Statement [Line Items] Balance Balance, shares Fair value of vested options Stock Issued During Period, Value, New Issues Net loss Fair value of vested restricted shares granted to officers Fair value of vested restricted shares granted to officers, shares Repurchase of common stock Repurchase of common stock, shares Common shares issued for financing costs Common shares issued for financing costs, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation Amortization of debt discount Fair value of vested options Fair value of vested restricted shares granted to officers Change in allowance for doubtful accounts Inventory write-downs Accrued interest Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other assets Decrease in right of use assets Accounts payable Accrued expenses Lease liabilities Net cash provided by (used in) operating activities Cash flows from investing activities: Trademark costs Purchase of property and equipment Net cash used in investing activities Cash flows from financing activities: Proceeds from line of credit Payments on line of credit Proceeds from convertible note payable, net of expenses Proceeds from SAFE agreement Payment of cost recorded as debt discount Repurchase of common stock Amounts from former related party, net Net cash provided by (used in) financing activities Net increase (decrease) in cash Cash at beginning of period Cash at end of period Supplemental disclosures of cash flow information: Cash paid for interest Non-cash investing and financing activities: Reclass of prepaid expenses and accounts payable Accounting Policies [Abstract] Summary of Significant Accounting Policies Inventory Disclosure [Abstract] Inventory Property, Plant and Equipment [Abstract] Property and Equipment Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Line Of Credit Line of Credit Debt Disclosure [Abstract] Secured Convertible Notes Payable Leases [Abstract] Leases Liabilities Equity [Abstract] Simple Agreements for Future Equity (“SAFE”) Investments Share-Based Payment Arrangement [Abstract] Stock-Based Compensation Stock Warrants Stock Warrants Related Party Transactions [Abstract] Transactions with California Custom Beverage, LLC, former related party Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Basis of Presentation Liquidity Recent Trends - Market Conditions Use of Estimates Revenue Recognition Loss per Common Share Stock Compensation Expense Advertising Costs Concentrations Fair Value of Financial Instruments Reclassifications Recent Accounting Pronouncements Schedule of Potentially Dilutive Securities Schedule of Inventory Schedule of Property and Equipment Summary of Intangible Assets Schedule of Amount Outstanding Under Credit Facilities Schedule of Secured Convertible Notes Payable Schedule of Stock Option Activity Schedule of Warrant Activity Schedule of Related Parties Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Additional cash received Shipping and handling costs Advertising costs Concentration risk, percentage Collection from customers Raw materials and packaging Finished products Total Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Total cost Accumulated depreciation and amortization Net book value Operating Lease, Right-of-Use Asset, Periodic Reduction Brand names Trademarks Total Line of Credit Facility [Table] Line of Credit Facility [Line Items] Total Capitalized financing costs Debt Instrument, Term Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Amount Outstanding During Period Line of Credit Facility, Remaining Borrowing Capacity Line of Credit Facility, Interest Rate Description Long-Term Line of Credit [custom:LineOfCreditMonitoringFee-0] Direct Operating Costs [custom:AmortizationOfLineOfCreditPeriod] Debt Instrument, Unamortized Discount Amortization of Debt Discount (Premium) Short-Term Debt [Table] Short-Term Debt [Line Items] Secured Convertible “Option”” Notes Payable Accrued interest Accrued interest on excess debt borrowing Capitalized financing costs Total Secured convertible promissory notes Debt Instrument, Interest Rate Terms Convertiable notes payable maturity date Fee percentage Credit exceeds Debt Issuance Costs, Line of Credit Arrangements, Net Principal balance Principal payment Weighted average interest Debt conversion percentage Debt conversion price Payment for fees Share price Convertiable notes payable Debt conversion trading days Future minimum equity financing Conversion of SAFE investments into equity Interest on convertible notes Interest expenses Excess of asset base loan fees Unamortized debt discount amount Incurred costs for aforementioned waivers Lease cost Operating leases liability Payments of operating lease liability Weighted average remaining lease term for operating lease Weighted average discount rate for operating lease Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Proceeds from Related Party Debt Shares Outstanding, Beginning balance Weighted-Average Exercise Price, Outstanding Weighted-Average Remaining Contractual Terms (Years), Outstanding Aggregate Intrinsic Value, Shares Outstanding Shares, Granted Weighted-Average Exercise Price, Granted Shares, Exercised Weighted-Average Exercise Price, Exercised Shares, Unvested forfeited Weighted-Average Exercise Price, Unvested forfeited Shares, Vested forfeited Weighted-Average Exercise Price, Vested forfeited Shares Outstanding, Ending balance Weighted-Average Exercise Price, Outstanding Aggregate Intrinsic Value, Shares Outstanding Shares, Exercisable Weighted-Average Exercise Price, Exercisable Weighted-Average Remaining Contractual Terms (Years), Exercisable Aggregate Intrinsic Value Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair value of vested stock option Aggregate value of unvested compensation Stock price Shares outstanding, Beginning balance Weighted average exercise price, outstanding Weighted average remaining contractual terms (years), outstanding Aggregate intrinsic value shares outstanding beginning Shares, granted Weighted average exercise price, granted Shares, exercised Weighted average exercise price, exercised Shares, forfeited Weighted average exercise price, forfeited Shares outstanding, Ending balance Weighted average exercise price, outstanding ending balance Aggregate intrinsic value shares outstanding Shares exercisable Weighted average exercise price, exercisable Weighted average remaining contractual terms (years), exercisable Aggregate intrinsic value shares exercisable Warrants exerice price Accounts receivable, net of provision of $1,123 and $1,123 at March 31, 2024 and December 31, 2023, respectively Accounts payable Net (payable) receivable Related Party Transaction [Table] Related Party Transaction [Line Items] Net of provision Royalty percentage Due to related party Loss Contingencies [Table] Loss Contingencies [Line Items] Fees Deposit of security with lessor Number of common stock value placed Escrow deposits Subsequent Event [Table] Subsequent Event [Line Items] Minimum of conversion amount Conversion amount Interest payable Product quality hold write down. Delivery and handling expense. Adjustments to additional paid in capital share based compensation stock options vested. Fair value of vested options. Fair value of vested restricted shares granted to officers. Fair value of common shares issued as financing costs. Product quality hold write downs. Accrual of interest on convertible note. Amortization of right of use of asset. Secured Convertible Notes Payable [Member] Note Purchase Agreement [Member] Whitebox Advisors, LLC [Member] Going Concern [Policies Text Block] Covid Nineteen Consideration [Policy Text Block] Repurchase price percentage. Simple Agreements For Future Equity Investments [Member] Stockholders [Member] Option Notes [Member] Annum Payable Option Notes [Member] Share based compensation arrangement by share based payment award options vested forfeitures and expirations in period. Share based compensation arrangement by share based payment award options vested forfeiture and expirations in period, weighted average grant date fair value. Carrying cost property and exploration rights. Schedule of non option equity instruments roll forward table text block. Share based compensation arrangement by share based payment award non option equity instruments exercisable number. Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments exercises in period weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments forfeitures and expirations in period weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average remaining contractual terms. Share based compensation arrangement by share based payment award non option equity instruments outstanding aggregate intrinsic value. Share based compensation arrangement by share based payment award non option equity instruments exercisable aggregate intrinsic value. Securities Purchase Agreement [Member] Customer One [Member] Customer Two [Member] Royalty percentage Christopher J. Reed [Member] California Custom Beverage, LLC [Member] Royalty receivable. Related party transaction due from related party. Provision for receivable with former related party. Customer Three [Member] Chris Reed [Member] Vendor One [Member] Vendor Two [Member] Original Notes [Member] Line of Credit [Text Block] Alterna Capital Solutions [Member] Monitoring fee. Amortization of line of credit period. Stock Warrants [Text Block] Unvested Restricted Common Stock [Member] Common Stock Equivalent of Series A Convertible Preferred Stock [Member] Right of Use Assets Under Operating Leases [Member] Computer Hardware And Software [Member] Limited Waiver, Deferral, and Amendment and Restatement Agreement [Member] Incurred costs for Aforementioned waivers. Future minimum equity financing. Conversion of investments into equity. Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Shares, Outstanding Stock Repurchased During Period, Value Stock Repurchased During Period, Shares FairValueOfVestedOptions FairValueOfVestedRestrictedSharesGrantedToOfficers Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets IncreaseDecreaseInAmortizationOfRightOfUseAssets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Intangible Assets Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Lines of Credit Repayments of Short-Term Debt Payments for Repurchase of Common Stock Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Inventory Disclosure [Text Block] Stock Warrants [Text Block] Indefinite-Lived Intangible Assets (Excluding Goodwill) Interest Payable AccruedInterestOnExcessDebtBorrowing Debt Issuance Costs, Net Convertible Debt Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue Repayments of Related Party Debt Related Party Transaction, Amounts of Transaction EX-101.PRE 9 reed-20240331_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 10, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2024  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --12-31  
Entity File Number 001-32501  
Entity Registrant Name REED’S, INC.  
Entity Central Index Key 0001140215  
Entity Tax Identification Number 35-2177773  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 201 Merritt 7  
Entity Address, City or Town Norwalk  
Entity Address, State or Province CT  
Entity Address, Postal Zip Code 06851  
City Area Code (800)  
Local Phone Number 997-3337  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   4,187,291
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 314 $ 603
Accounts receivable, net of allowance of $258 and $860, respectively 3,251 3,571
Inventory 12,017 11,300
Prepaid expenses and other current assets 2,332 2,028
Total current assets 18,178 17,761
Property and equipment, net of accumulated depreciation of $1,136 and $1,068, respectively 441 493
Intangible assets 631 629
Total assets 19,250 18,883
Current liabilities:    
Accounts payable 8,484 9,133
Accrued expenses 872 1,096
Revolving line of credit, net of capitalized financing costs of $161 and $201, respectively 7,844 9,758
Current portion of convertible notes payable, net of debt discount of $509 and $424, respectively 7,339 6,737
Current portion of lease liabilities 155 207
Total current liabilities 25,025 27,190
SAFE agreements 4,097
Convertible note payable, net of debt discount of $45 and $148, respectively, less current portion 10,853 10,874
Total liabilities 39,975 38,064
Stockholders’ deficit:    
Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding 94 94
Common stock, $.0001 par value, 180,000,000 shares authorized; 4,187,291 and 4,187,291 shares issued and outstanding, respectively
Additional paid in capital 119,581 119,452
Accumulated deficit (140,400) (138,727)
Total stockholders’ deficit (20,725) (19,181)
Total liabilities and stockholders’ deficit 19,250 18,883
Related Party [Member]    
Current assets:    
Receivable from former related party 264 259
Current liabilities:    
Payable to former related party $ 331 $ 259
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Accounts receivable, net of allowance $ 258 $ 860
Property and equipment, accumulated depreciation 1,136 1,068
Capitalized financing costs 161 201
Debt discount current 509 424
Debt discount, noncurrent $ 45 $ 148
Series A convertible preferred stock, par value $ 10 $ 10
Series A convertible preferred stock, shares authorized 500,000 500,000
Series A convertible preferred stock, shares issued 9,411 9,411
Series A convertible preferred stock, shares outstanding 9,411 9,411
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 180,000,000 180,000,000
Common stock, shares issued 4,187,291 4,187,291
Common stock, shares outstanding 4,187,291 4,187,291
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net Sales $ 9,595 $ 11,157
Cost of goods sold 6,182 8,459
Gross profit 3,413 2,698
Operating expenses:    
Delivery and handling expense 1,502 2,120
Selling and marketing expense 1,093 1,447
General and administrative expense 1,468 1,709
Total operating expenses 4,063 5,276
Loss from operations (650) (2,578)
Interest expense (1,023) (1,779)
Net loss $ (1,673) $ (4,357)
Net loss per share - basic $ (0.40) $ (1.70)
Net loss per share - diluted $ (0.40) $ (1.70)
Weighted average number of shares outstanding - basic 4,187,291 2,559,855
Weighted average number of shares outstanding - diluted 4,187,291 2,559,855
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2022 $ 94 $ 114,635 $ (123,199) $ (8,470)
Balance, shares at Dec. 31, 2022 2,519,485 9,411      
Fair value of vested options     229   229
Net loss (4,357) (4,357)
Fair value of vested restricted shares granted to officers     4   4
Fair value of vested restricted shares granted to officers, shares 750        
Repurchase of common stock     (1)   (1)
Repurchase of common stock, shares (274)        
Common shares issued for financing costs     273   273
Common shares issued for financing costs, shares 82,438        
Balance at Mar. 31, 2023 $ 94 115,140 (127,556) (12,322)
Balance, shares at Mar. 31, 2023 2,602,399 9,411      
Balance at Dec. 31, 2023 $ 94 119,452 (138,727) (19,181)
Balance, shares at Dec. 31, 2023 4,187,291 9,411      
Fair value of vested options 129 129
Stock Issued During Period, Value, New Issues
Net loss (1,673) (1,673)
Balance at Mar. 31, 2024 $ 94 $ 119,581 $ (140,400) $ (20,725)
Balance, shares at Mar. 31, 2024 4,187,291 9,411      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (1,673) $ (4,357)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation 29 47
Amortization of debt discount 144 281
Fair value of vested options 129 229
Fair value of vested restricted shares granted to officers 4
Change in allowance for doubtful accounts (601) (39)
Inventory write-downs (783) (228)
Accrued interest 564 1,113
Changes in operating assets and liabilities:    
Accounts receivable 922 1,044
Inventory 66 1,102
Prepaid expenses and other assets (1,305) 338
Decrease in right of use assets 39 32
Accounts payable 351 1,360
Accrued expenses (225) 235
Lease liabilities (52) (44)
Net cash provided by (used in) operating activities (2,395) 1,117
Cash flows from investing activities:    
Trademark costs (2)
Purchase of property and equipment (16)
Net cash used in investing activities (18)
Cash flows from financing activities:    
Proceeds from line of credit 8,285 8,699
Payments on line of credit (10,239) (12,120)
Proceeds from convertible note payable, net of expenses 2,405
Proceeds from SAFE agreement 4,097
Payment of cost recorded as debt discount (86)  
Repurchase of common stock (1)
Amounts from former related party, net 67 (166)
Net cash provided by (used in) financing activities 2,124 (1,183)
Net increase (decrease) in cash (289) (66)
Cash at beginning of period 603 533
Cash at end of period 314 467
Supplemental disclosures of cash flow information:    
Cash paid for interest 318 390
Non-cash investing and financing activities:    
Reclass of prepaid expenses and accounts payable $ 1,000 $ 0
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

1. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 1, 2024. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2024, and the results of its operations and its cash flows for the three months ended March 31, 2024 and 2023. The balance sheet as of December 31, 2023 is derived from the Company’s audited financial statements.

 

The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.

 

Liquidity

 

For the three months ended March 31, 2024, the Company recorded a net loss of $1,673 and used cash in operations of $2,395. In accordance with Accounting Standards Codification (“ASC”) 205-40, Going Concern, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. As of the issuance date of these financial statements, management expects that the Company’s existing cash of $314, which includes $4,100 of additional cash received during the three months ended March 31, 2024, from investments with significant stockholders plus expected cash from operations, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners, strategic transactions or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

 

We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.

 

Recent Trends - Market Conditions

 

Although the U.S. economy continued to grow throughout 2023 and into Q1 2024, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations.

 

During the three months ended March 31, 2024, the Company experienced moderation from the elevated freight costs experienced in 2023. The average cost of shipping and handling for the three months ended March 31, 2024, was $3.01 per case, as compared to $3.46 per case for the three months ended March 31, 2023. Although the Company has experienced decreases in freight costs over the last four quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. The Company has been negatively impacted by supply chain challenges affecting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins. The Company has experienced moderation in inflation and anticipates this to continue throughout 2024.

 

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in the determination of the Company’s liquidity.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.

 

The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.

 

Loss per Common Share

 

Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.

 

For the periods ended March 31, 2024 and 2023, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:

   March 31,
2024
   March 31,
2023
 
Warrants   549,292    235,946 
Options   141,869    174,460 
Convertible note payable   1,557,066    1,257,491 
Unvested restricted common stock   -    710 
Common stock equivalent of Series A Convertible Preferred stock   753    753 
Total   2,248,980    1,669,360 

 

Stock Compensation Expense

 

The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

 

The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

 

Advertising Costs

 

Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $17 and $55 for the three months ended March 31, 2024 and 2023, respectively.

 

Concentrations

 

Net sales. During the three months ended March 31, 2024, the Company’s two largest customers accounted for 17% and 16% of net sales, respectively. During the three months ended March 31, 2023, the Company’s two largest customers accounted for 18% and 12% of net sales, respectively. No other customers exceeded 10% of net sales in either period.

 

Accounts receivable. As of March 31, 2024, the Company had accounts receivable from one customer which comprised 29% of its gross accounts receivable. As of December 31, 2023, the Company had accounts receivable from three customers which comprised 24%, 15% and 11% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.

 

The Company utilizes co-packers to produce 100% of its products. During the three months ended March 31, 2024 and the year ended December 31, 2023, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company has long-standing relationships with two different co-packers, and a third co-packing agreement with California Custom Beverage LLC (“CCB”), a former related party (see Note 11). Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.

 

Purchases from vendors. During the three months ended March 31, 2024, the Company’s largest vendor accounted for approximately 10% of all purchases. During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately 11% of all purchases. No other vendors exceeded 10% of all purchases in either period.

 

Accounts payable. As of March 31, 2024, one vendor accounted for 11% of total accounts payable. As of December 31, 2023, two vendors accounted for 10% and 10% of total accounts payable, respectively. No other vendors exceeded 10% of accounts payable in either period.

 

Fair Value of Financial Instruments

 

The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

 

Reclassifications

 

Certain prior year amounts have been reclassified for consistency with the current period presentation. Collection from customers amounting to $1,217 that was previously presented as a deduction from prepaid expenses have been reclassed as an offset against accounts receivable. These reclassifications had no effect on the reported results of operations or cash flows.

 

Recent Accounting Pronouncements

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure, which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the chief operating decision maker and included in each reported measure of a segment’s profit or loss. The update also requires all annual disclosures about a reportable segment’s profit or loss and assets to be provided in interim periods and for entities with a single reportable segment to provide all the disclosures required by ASC 280, Segment Reporting, including the significant segment expense disclosures. This standard will be effective for the Company on January 1, 2024 and interim periods beginning in fiscal year 2025, with early adoption permitted. The updates required by this standard should be applied retrospectively to all periods presented in the financial statements. The Company does not expect this standard to have a material impact on its results of operations, financial position or cash flows.

 

 

In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The ASU requires buyers to disclose information about their supplier finance programs. Interim and annual requirements include the disclosure of outstanding amounts under the obligations as of the end of the reporting period, and annual requirements include a roll-forward of those obligations for the annual reporting period, as well as a description of payment and other key terms of the programs. This update is effective for annual periods beginning after December 15, 2022, and interim periods within those fiscal years, except for the requirement to disclose roll-forward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted ASU 2022-04 on January 1, 2023, and there was no material impact on our financial statements.

 

Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventory
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Inventory

2. Inventory

 

Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Raw materials and packaging  $6,766   $6,445 
Finished products   5,251    4,855 
Total  $12,017   $11,300 

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property and Equipment

3. Property and Equipment

 

Property and equipment are comprised of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Right-of-use assets under operating leases  $724   $724 
Computer hardware and software   400    400 
Machinery and equipment   352    352 
Construction in progress   101    85 
Total cost   1,577    1,561 
Accumulated depreciation and amortization   (1,136)   (1,068)
Net book value  $441   $493 

 

 

Depreciation expense for the three months ended March 31, 2024 and 2023 was $29 and $47, respectively, and amortization of right-of-use assets for the three months ended March 31, 2024 and 2023 was $39 and $32, respectively.

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets

4. Intangible Assets

 

Intangible assets consist of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Brand names  $576   $576 
Trademarks   55    53 
Total  $631   $629 

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Line of Credit
3 Months Ended
Mar. 31, 2024
Line Of Credit  
Line of Credit

5. Line of Credit

 

The Company’s credit facility consisted of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Line of credit – Alterna Capital Solutions  $8,005   $9,959 
Less: capitalized financing costs   (161)   (201)
Total  $7,844   $9,758 

 

In March, 2022, the Company entered into a financing agreement for a line of credit with Alterna Capital Solutions (“ACS”) The ACS line of credit is for a term of 3 years, provides for borrowings of up to $13,000, and is secured by eligible accounts receivable and inventory, and are subject to a collateral sharing agreement with Whitebox, another secured lender (see Note 6). An over advance rider provides for up to $400 of additional borrowing above the collateralized base (the “Over Advance”) up to a total borrowing of $13,000. As of March 31, 2024, there was no remaining availability under the line of credit, and $4,995 of borrowing capacity available.

 

Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (13.25% at March 31, 2024 and 13.25% at December 31, 2023). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.90% at March 31, 2024 and 13.90% at December 31, 2023). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2024 and 18.00% at December 31, 2023). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility. A loan balance of less than $1,500 will bear interest at a rate in line with account receivables advances plus the monthly monitoring fee of $1.

 

The Company incurred $483 of direct costs of the transaction, consisting primarily of broker, bank and legal fees. These costs have been capitalized and are being amortized over the 3-year life of the ACS agreement. The unamortized debt discount balance was $201 at December 31, 2023. For the three months ended March 31, 2024, amortization of debt discount was $40, and as of March 31, 2024, the remaining unamortized debt discount balance is $161.

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Secured Convertible Notes Payable
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Secured Convertible Notes Payable

6. Secured Convertible Notes Payable

 

Amounts outstanding under the Company’s convertible notes payable are as follows (amounts in 000’s except share amounts):

  

March 31,

2024

  

December 31,

2023

 
Secured Convertible “Original” Notes Payable (A)  $10,250   $10,250 
Secured Convertible “Option”” Notes Payable (B)   4,050    4,050 
Accrued interest   1,457    1,059 
           
Accrued interest on excess debt borrowing   2,989    2,824 
Capitalized financing costs   (554)   (572)
Total  $18,192   $17,611 

 

Secured Convertible Notes

 

(A)In May 2022, the Company issued $11,250 of convertible notes payable (the “Original Notes”) to entities affiliated with Whitebox Advisors, LLC (collectively, “Whitebox”). The Original Notes bear interest at 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the notes), are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with Alterna Capital (ACS), the Company’s existing secured lender. The Original Notes mature the earlier of March 31, 2025 or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. The Original Notes together with the Option Notes are collectively referred to as the “Notes”. Upon conversion or early payment, holders of the Notes are entitled to receive an interest make-whole payment, as defined, equal to the sum of the remaining scheduled payments of interest on the Notes that would be due at maturity, payable, at the Company’s option, in cash or in shares of common stock. Effective August 11, 2022, the Notes were amended to add a 10% fee for the amount that the Company’s line of credit with ACS exceeds $6,000, as defined (the “Excess ABL Amount”). Effective June 30, 2023, the Excess ABL Amount was amended to $7,500. At March 31,2024 and December 31, 2023, the principal balance of the Original Notes was $10,250.

 

The Original Notes have an amortization feature which requires the Company to make monthly payments of principal of $200 plus accrued interest, payable in cash or in shares of the Company’s common stock at the option of the Company, based on 90% of the average prices of the Company’s common stock, as defined During 2023, Whitebox waived the requirement for the Company to pay the December 2022 to October 2023 monthly amortization payments on the Original Notes. The November 2023 amortization payment of $200 principal was paid, and the amortization payment for December 2023 to May 2024 was waived. The parties agreed that amortization period shall resume on June 1, 2024.

 

The terms of the Original Notes contained conversion terms that are expected to be amended, subject to satisfaction of certain conditions. Under the revised terms, the conversion price of the Original Notes will be between 125% and 145% of the effective price of the company’s subsequent equity offering, with the premium set based on the aggregate gross proceeds realized by the company in the offering and the conversion price subject to a cap of $7.50 per share.

 

In addition on February 12, 2024, subject to the satisfaction of certain conditions, the parties agreed that a portion of the outstanding ABL accrued fees will be satisfied through payment of $132 in cash and the issuance of shares of the Company’s common stock (up to the beneficial ownership limitation applicable to each holder) at a value per share equal to the lesser of $1.50 or the per share price of securities issued in the Company’s subsequent equity offering. The remaining balance of any outstanding accrued ABL fees will be added to the principal amount of the Notes. The $132 has not been paid nor any shares issued as of the date of these financial statements.

 

 

(B)In February 2023 and May 2023, the Company issued an aggregate of $4,050 of additional Option Notes to Whitebox that substantially have the same terms as the Original Notes, except the Option Notes issued in 2023 do not require any amortization payments, initially were to bear interest at 10% payable in cash, and were initially due four months after issuance. On February 12, 2024, the parties agreed to change the terms so that the Option Notes shall bear interest at a rate of 10% per annum, with 5% per annum payable in cash and 5% per annum payable (“in kind” by adding such PIK interest to the unpaid principal amount. In addition, the parties agreed, subject to certain outstanding conditions, to amend the maturity date to the earlier of March 31, 2025 or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. Once they are amended, the Company shall have the right at any time prior to the date that is the 180th day from the effective date to prepay the amended and restated Option Notes, in whole or in part, at a price equal to 102% of the principal amount plus all accrued and unpaid interest thereon to the date of prepayment. At March 31, 2024 and December 31, 2023, the principal balance of the Option Notes was $4,050.

The terms of the Original Notes contained conversion terms that are expected to be amended , subject to the satisfaction of certain conditions by the Company. Under the revised terms, the conversion price of the Option Notes will be 120% of the arithmetic average of the Daily VWAP for the five (5) VWAP Trading Days beginning on, and including, the VWAP Trading Day immediately following the consummation of an equity offering undertaken for purposes of satisfying the terms and conditions of the Waiver and Amendment

 

Waiver of Default

 

On February 12, 2024, the Company entered into a Limited Waiver, Deferral, and Amendment and Restatement Agreement (the “Waiver and Amendment”) with each holder (each an entity affiliated with Whitebox Advisors, LLC) of the Original and Option Notes payable to Whitebox (the “Notes”). Subject to the Waiver and Amendment, the holders agreed to temporarily waive certain events of default under the Notes, including the failure to pay Excess ABL Amounts and the failure to pay amortization payments due December 1, 2023 to April 30, 2024. Subject to satisfaction of certain conditions by March 31, 2024, the parties further agreed to amend and restate the Notes, to extend the maturity date of the Option Notes originally due November 28, 2023, to March 31, 2025 and to equitize certain interest and fees owing on the Notes.

 

The conversion rate under the amended and restated notes is to be based on the pricing and size of the Company’s proposed equity financing of a minimum of $3 million (which will include conversion of approximately $4.1 million of previously funded SAFE investments into equity of the Company). Delays related to the Company’s evaluation of long term financing options have delayed the proposed financing. On April 1, 2024 the parties executed the Amended Limited Waiver, Deferral, and Amendment and Restatement Agreement (“Amended Waiver”). Subject to certain terms and conditions set forth in the Amended Waiver, the holders temporarily waived certain specified events of default under the Notes to April 30, 2024 and extended the waiver of monthly amortization payments to April 30, 2024. In addition, Reed’s remitted a partial interest payment of $100 to the holders.

 

Accrued Interest

 

At December 31, 2023, the balance of accrued interest was $3,883. During the period ended March 31, 2024, the Company recorded interest of $563, made up of $398 of interest on the convertible notes, and $165 related to the excess ABL fees. At March 31, 2024, the balance of accrued interest was $4,446.

 

Debt Discount

 

At December 31, 2023, the unamortized debt discount was $572. During the period ended March 31, 2024, the Company incurred $86 of costs for the aforementioned waivers. These costs have been capitalized and are being amortized over the term of the convertible notes or waiver period. For the three months ended March 31, 2024, amortization of debt discount was $104, and as of March 31, 2024, the remaining unamortized debt discount balance is $554.

 

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases Liabilities
3 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Leases Liabilities

7. Leases Liabilities

 

During the three months ended March 31, 2024 and 2023, lease costs totaled $39 and $32, respectively.

 

As of December 31, 2023, operating lease liabilities totaled $207. During the three months ended March 31, 2024, the Company made payments of $52 towards its operating lease liability. As of March 31, 2024, operating lease liabilities totaled $155.

 

As of March 31, 2024, the weighted average remaining lease terms for an operating lease are 0.75 years. As of March 31, 2024, the weighted average discount rate on the operating lease is 12.60%.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Simple Agreements for Future Equity (“SAFE”) Investments
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Simple Agreements for Future Equity (“SAFE”) Investments

8. Simple Agreements for Future Equity (“SAFE”) Investments

 

During the first quarter of 2024, the Company received $4.1 million in gross proceeds from three significant stockholders of the Company, D&D Source of Life Holding LTD (“D&D”) and Union Square Park Partners LP, and John J. Bello, the Company’s Chairman, pursuant to Simple Agreements for Future Equity (“SAFE”) agreements. The SAFE investments will convert into the next equity financing of Reed’s on the same terms and conditions as investors in Reed’s next equity financing at the lesser of $1.50 per share or the per share price in the financing. Until such time as the SAFE investments convert to equity the approximately $4.1 million received is recorded as a liability. D&D was given the right to designate a second independent director nominee to the board of directors of Reed’s and the company agreed to limit the size of its board of directors to nine (9) for so long as D&D owns 25% or more of the equity securities of the Company.

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

9. Stock-Based Compensation

 

Stock Options

 

The following table summarizes stock option activity during the three months ended March 31, 2024:

 

   Shares   Weighted-
Average
Exercise Price
   Weighted-
Average
Remaining
Contractual
Terms
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2023   145,012   $45.09    6.75   $- 
Granted   -   $-           
Exercised   -   $-           
Unvested forfeited   -   $-           
Vested forfeited   (3,143)  $45.05                   
Outstanding at March 31, 2024   141,869   $44.03    6.50   $- 
Exercisable at March 31, 2024   111,583   $51.09    6.07   $- 

 

During the three months ended March 31, 2024 and 2023, the Company recognized $129 and $229 of compensation expense relating to vested stock options. As of March 31, 2024, the aggregate amount of unvested compensation related to stock options was approximately $314 which will be recognized as an expense as the options vest in future periods through March 28, 2027.

 

As of March 31, 2024, the outstanding and exercisable options have no intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2024, which was $1.63, and the exercise price of the outstanding stock options.

 

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock Warrants
3 Months Ended
Mar. 31, 2024
Stock Warrants  
Stock Warrants

10. Stock Warrants

 

The Company’s warrant activity during the three months ended March 31, 2024 is as follows:

 

   Shares   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
Terms
(Years)
   Aggregate
Intrinsic
Value
 
                 
Outstanding at December 31, 2023   549,292   $8.77    2.84   $- 
Granted   -    -    -      
Exercised   -    -    -      
Forfeited   -    -    -                   
Outstanding at March 31, 2024   549,292   $8.77    2.59   $- 
Exercisable at March 31, 2024   549,292   $8.77    2.59   $- 

 

As of March 31, 2024, the outstanding and exercisable warrants have no aggregate intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2024, which was $1.63, and the exercise price of the Company’s warrants to purchase common stock.

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Transactions with California Custom Beverage, LLC, former related party
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Transactions with California Custom Beverage, LLC, former related party

11. Transactions with California Custom Beverage, LLC, former related party

 

In December 2018, the Company signed a co-packing agreement with California Custom Beverage, LLC’s (“CCB”), an entity owned by Christopher J. Reed, a former related party, pursuant to which CCB agreed to produce certain products for the Company for agreed fees. The co-packing agreement, as amended, includes certain provisions for product inputs, shrinkage, and quality assurance. Also beginning in 2019, CCB agreed to pay the Company a 5% royalty through 2021 on certain private label sales made by CCB.

 

At March 31, 2024 and 2023, accounts receivable due from and accounts payable due to CCB were as follows:

 

   March 31,
2024
   December 31,
2023
 
Accounts receivable, net of provision of $1,123 and $1,123 at March 31, 2024 and December 31, 2023, respectively   264    259 
Accounts payable   (331)   (259)
Net (payable) receivable   (67)    - 

 

In addition, on April 19, 2023, the Company received a letter from CCB demanding payment of various amounts, including the $452] and $452 outstanding at March 31, 2024 and December 31, 2023, respectively. The Company has determined that the probability of realizing any loss on the demand from CCB is remote and therefore has not recorded any additional accruals related to the demand.

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

12. Commitments and Contingencies

 

During 2023, the firm engaged an investment bank to explore financing options for the Company. We have a maximum obligation of $1.2M in fees so far in this engagement. These fees will be recognized on a success basis and will be paid out only if a transaction is finalized.

 

In 2018, CCB assumed the monthly payments on our lease obligation for a Los Angeles manufacturing plant for payments through September 2024, and our release from the obligation by the lessor, however, is dependent upon CCB’s deposit of $1,200 of security with the lessor. As of March 31, 2024, $800 has been deposited with the lessor and Chris J. Reed has placed approximately 7,260 shares of the Company’s common stock valued at $12 that remain in escrow with the lessor.

 

From time to time, we are a party to claims and legal proceedings arising in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and provides for potential losses on such litigation if the amount of the loss is estimable and the loss is probable.

 

We believe that there are no material litigation matters at the current time. Although the result of such litigation matters and claims cannot be predicted with certainty, we believe that the final outcome of such claims and proceedings will not have a material adverse impact on our financial position, liquidity, or results of operations.

 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events
3 Months Ended
Mar. 31, 2024
Subsequent Events [Abstract]  
Subsequent Events

13. Subsequent Events

 

Secured Convertible Notes Payable

 

The Company has not yet satisfied conditions required for issuance of the amended and restated Notes and equitization of certain interest and fees owing on the Notes. The conversion rate under the amended and restated Notes is to be based on the pricing and size of the Company’s proposed equity financing of a minimum of $3 million (which will include conversion of approximately $4.1 million of previously funded SAFE investments into equity of the Company). Delays related to the Company’s evaluation of long term financing options have delayed the proposed financing. On May 17, 2024, Reed’s entered into a Limited Waiver, Deferral, and Amendment and Restatement Agreement (the “Waiver and Amendment”) with each holder. The holders agreed to temporarily waive certain specified events of default and the payment of Excess ABL Fees through June 10, 2024. Further, the holders agreed to waive the payment of monthly amortization payments through June 30, 2024. Amortization payments are scheduled to resume on July 1, 2024. The Company further remitted $40 representing all interest (including default interest) to the holders and reimbursed the holders for certain fees and expenses.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 1, 2024. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2024, and the results of its operations and its cash flows for the three months ended March 31, 2024 and 2023. The balance sheet as of December 31, 2023 is derived from the Company’s audited financial statements.

 

The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.

 

Liquidity

Liquidity

 

For the three months ended March 31, 2024, the Company recorded a net loss of $1,673 and used cash in operations of $2,395. In accordance with Accounting Standards Codification (“ASC”) 205-40, Going Concern, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. As of the issuance date of these financial statements, management expects that the Company’s existing cash of $314, which includes $4,100 of additional cash received during the three months ended March 31, 2024, from investments with significant stockholders plus expected cash from operations, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners, strategic transactions or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

 

We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.

 

Recent Trends - Market Conditions

Recent Trends - Market Conditions

 

Although the U.S. economy continued to grow throughout 2023 and into Q1 2024, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations.

 

During the three months ended March 31, 2024, the Company experienced moderation from the elevated freight costs experienced in 2023. The average cost of shipping and handling for the three months ended March 31, 2024, was $3.01 per case, as compared to $3.46 per case for the three months ended March 31, 2023. Although the Company has experienced decreases in freight costs over the last four quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. The Company has been negatively impacted by supply chain challenges affecting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins. The Company has experienced moderation in inflation and anticipates this to continue throughout 2024.

 

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in the determination of the Company’s liquidity.

 

Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.

 

The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.

 

Loss per Common Share

Loss per Common Share

 

Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.

 

For the periods ended March 31, 2024 and 2023, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:

   March 31,
2024
   March 31,
2023
 
Warrants   549,292    235,946 
Options   141,869    174,460 
Convertible note payable   1,557,066    1,257,491 
Unvested restricted common stock   -    710 
Common stock equivalent of Series A Convertible Preferred stock   753    753 
Total   2,248,980    1,669,360 

 

Stock Compensation Expense

Stock Compensation Expense

 

The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

 

The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

 

Advertising Costs

Advertising Costs

 

Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $17 and $55 for the three months ended March 31, 2024 and 2023, respectively.

 

Concentrations

Concentrations

 

Net sales. During the three months ended March 31, 2024, the Company’s two largest customers accounted for 17% and 16% of net sales, respectively. During the three months ended March 31, 2023, the Company’s two largest customers accounted for 18% and 12% of net sales, respectively. No other customers exceeded 10% of net sales in either period.

 

Accounts receivable. As of March 31, 2024, the Company had accounts receivable from one customer which comprised 29% of its gross accounts receivable. As of December 31, 2023, the Company had accounts receivable from three customers which comprised 24%, 15% and 11% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.

 

The Company utilizes co-packers to produce 100% of its products. During the three months ended March 31, 2024 and the year ended December 31, 2023, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company has long-standing relationships with two different co-packers, and a third co-packing agreement with California Custom Beverage LLC (“CCB”), a former related party (see Note 11). Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.

 

Purchases from vendors. During the three months ended March 31, 2024, the Company’s largest vendor accounted for approximately 10% of all purchases. During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately 11% of all purchases. No other vendors exceeded 10% of all purchases in either period.

 

Accounts payable. As of March 31, 2024, one vendor accounted for 11% of total accounts payable. As of December 31, 2023, two vendors accounted for 10% and 10% of total accounts payable, respectively. No other vendors exceeded 10% of accounts payable in either period.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

 

Reclassifications

Reclassifications

 

Certain prior year amounts have been reclassified for consistency with the current period presentation. Collection from customers amounting to $1,217 that was previously presented as a deduction from prepaid expenses have been reclassed as an offset against accounts receivable. These reclassifications had no effect on the reported results of operations or cash flows.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure, which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the chief operating decision maker and included in each reported measure of a segment’s profit or loss. The update also requires all annual disclosures about a reportable segment’s profit or loss and assets to be provided in interim periods and for entities with a single reportable segment to provide all the disclosures required by ASC 280, Segment Reporting, including the significant segment expense disclosures. This standard will be effective for the Company on January 1, 2024 and interim periods beginning in fiscal year 2025, with early adoption permitted. The updates required by this standard should be applied retrospectively to all periods presented in the financial statements. The Company does not expect this standard to have a material impact on its results of operations, financial position or cash flows.

 

 

In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. The ASU requires buyers to disclose information about their supplier finance programs. Interim and annual requirements include the disclosure of outstanding amounts under the obligations as of the end of the reporting period, and annual requirements include a roll-forward of those obligations for the annual reporting period, as well as a description of payment and other key terms of the programs. This update is effective for annual periods beginning after December 15, 2022, and interim periods within those fiscal years, except for the requirement to disclose roll-forward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted ASU 2022-04 on January 1, 2023, and there was no material impact on our financial statements.

 

Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Securities

   March 31,
2024
   March 31,
2023
 
Warrants   549,292    235,946 
Options   141,869    174,460 
Convertible note payable   1,557,066    1,257,491 
Unvested restricted common stock   -    710 
Common stock equivalent of Series A Convertible Preferred stock   753    753 
Total   2,248,980    1,669,360 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventory (Tables)
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventory

Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Raw materials and packaging  $6,766   $6,445 
Finished products   5,251    4,855 
Total  $12,017   $11,300 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment (Tables)
3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

Property and equipment are comprised of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Right-of-use assets under operating leases  $724   $724 
Computer hardware and software   400    400 
Machinery and equipment   352    352 
Construction in progress   101    85 
Total cost   1,577    1,561 
Accumulated depreciation and amortization   (1,136)   (1,068)
Net book value  $441   $493 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets (Tables)
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Intangible Assets

Intangible assets consist of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Brand names  $576   $576 
Trademarks   55    53 
Total  $631   $629 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Line of Credit (Tables)
3 Months Ended
Mar. 31, 2024
Line Of Credit  
Schedule of Amount Outstanding Under Credit Facilities

The Company’s credit facility consisted of the following (in thousands):

 

   March 31,
2024
   December 31,
2023
 
Line of credit – Alterna Capital Solutions  $8,005   $9,959 
Less: capitalized financing costs   (161)   (201)
Total  $7,844   $9,758 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Secured Convertible Notes Payable (Tables)
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Secured Convertible Notes Payable

Amounts outstanding under the Company’s convertible notes payable are as follows (amounts in 000’s except share amounts):

  

March 31,

2024

  

December 31,

2023

 
Secured Convertible “Original” Notes Payable (A)  $10,250   $10,250 
Secured Convertible “Option”” Notes Payable (B)   4,050    4,050 
Accrued interest   1,457    1,059 
           
Accrued interest on excess debt borrowing   2,989    2,824 
Capitalized financing costs   (554)   (572)
Total  $18,192   $17,611 

 

Secured Convertible Notes

 

(A)In May 2022, the Company issued $11,250 of convertible notes payable (the “Original Notes”) to entities affiliated with Whitebox Advisors, LLC (collectively, “Whitebox”). The Original Notes bear interest at 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the notes), are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with Alterna Capital (ACS), the Company’s existing secured lender. The Original Notes mature the earlier of March 31, 2025 or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. The Original Notes together with the Option Notes are collectively referred to as the “Notes”. Upon conversion or early payment, holders of the Notes are entitled to receive an interest make-whole payment, as defined, equal to the sum of the remaining scheduled payments of interest on the Notes that would be due at maturity, payable, at the Company’s option, in cash or in shares of common stock. Effective August 11, 2022, the Notes were amended to add a 10% fee for the amount that the Company’s line of credit with ACS exceeds $6,000, as defined (the “Excess ABL Amount”). Effective June 30, 2023, the Excess ABL Amount was amended to $7,500. At March 31,2024 and December 31, 2023, the principal balance of the Original Notes was $10,250.

 

The Original Notes have an amortization feature which requires the Company to make monthly payments of principal of $200 plus accrued interest, payable in cash or in shares of the Company’s common stock at the option of the Company, based on 90% of the average prices of the Company’s common stock, as defined During 2023, Whitebox waived the requirement for the Company to pay the December 2022 to October 2023 monthly amortization payments on the Original Notes. The November 2023 amortization payment of $200 principal was paid, and the amortization payment for December 2023 to May 2024 was waived. The parties agreed that amortization period shall resume on June 1, 2024.

 

The terms of the Original Notes contained conversion terms that are expected to be amended, subject to satisfaction of certain conditions. Under the revised terms, the conversion price of the Original Notes will be between 125% and 145% of the effective price of the company’s subsequent equity offering, with the premium set based on the aggregate gross proceeds realized by the company in the offering and the conversion price subject to a cap of $7.50 per share.

 

In addition on February 12, 2024, subject to the satisfaction of certain conditions, the parties agreed that a portion of the outstanding ABL accrued fees will be satisfied through payment of $132 in cash and the issuance of shares of the Company’s common stock (up to the beneficial ownership limitation applicable to each holder) at a value per share equal to the lesser of $1.50 or the per share price of securities issued in the Company’s subsequent equity offering. The remaining balance of any outstanding accrued ABL fees will be added to the principal amount of the Notes. The $132 has not been paid nor any shares issued as of the date of these financial statements.

 

 

(B)In February 2023 and May 2023, the Company issued an aggregate of $4,050 of additional Option Notes to Whitebox that substantially have the same terms as the Original Notes, except the Option Notes issued in 2023 do not require any amortization payments, initially were to bear interest at 10% payable in cash, and were initially due four months after issuance. On February 12, 2024, the parties agreed to change the terms so that the Option Notes shall bear interest at a rate of 10% per annum, with 5% per annum payable in cash and 5% per annum payable (“in kind” by adding such PIK interest to the unpaid principal amount. In addition, the parties agreed, subject to certain outstanding conditions, to amend the maturity date to the earlier of March 31, 2025 or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. Once they are amended, the Company shall have the right at any time prior to the date that is the 180th day from the effective date to prepay the amended and restated Option Notes, in whole or in part, at a price equal to 102% of the principal amount plus all accrued and unpaid interest thereon to the date of prepayment. At March 31, 2024 and December 31, 2023, the principal balance of the Option Notes was $4,050.

The terms of the Original Notes contained conversion terms that are expected to be amended , subject to the satisfaction of certain conditions by the Company. Under the revised terms, the conversion price of the Option Notes will be 120% of the arithmetic average of the Daily VWAP for the five (5) VWAP Trading Days beginning on, and including, the VWAP Trading Day immediately following the consummation of an equity offering undertaken for purposes of satisfying the terms and conditions of the Waiver and Amendment

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

The following table summarizes stock option activity during the three months ended March 31, 2024:

 

   Shares   Weighted-
Average
Exercise Price
   Weighted-
Average
Remaining
Contractual
Terms
(Years)
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2023   145,012   $45.09    6.75   $- 
Granted   -   $-           
Exercised   -   $-           
Unvested forfeited   -   $-           
Vested forfeited   (3,143)  $45.05                   
Outstanding at March 31, 2024   141,869   $44.03    6.50   $- 
Exercisable at March 31, 2024   111,583   $51.09    6.07   $- 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock Warrants (Tables)
3 Months Ended
Mar. 31, 2024
Stock Warrants  
Schedule of Warrant Activity

The Company’s warrant activity during the three months ended March 31, 2024 is as follows:

 

   Shares   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
Terms
(Years)
   Aggregate
Intrinsic
Value
 
                 
Outstanding at December 31, 2023   549,292   $8.77    2.84   $- 
Granted   -    -    -      
Exercised   -    -    -      
Forfeited   -    -    -                   
Outstanding at March 31, 2024   549,292   $8.77    2.59   $- 
Exercisable at March 31, 2024   549,292   $8.77    2.59   $- 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Transactions with California Custom Beverage, LLC, former related party (Tables)
3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Schedule of Related Parties

At March 31, 2024 and 2023, accounts receivable due from and accounts payable due to CCB were as follows:

 

   March 31,
2024
   December 31,
2023
 
Accounts receivable, net of provision of $1,123 and $1,123 at March 31, 2024 and December 31, 2023, respectively   264    259 
Accounts payable   (331)   (259)
Net (payable) receivable   (67)    - 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Potentially Dilutive Securities (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 2,248,980 1,669,360
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 549,292 235,946
Equity Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 141,869 174,460
Convertible Notes Payable [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 1,557,066 1,257,491
Unvested Restricted Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 710
Common Stock Equivalent of Series A Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 753 753
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Details Narrative)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Product Information [Line Items]      
Cash $ 314   $ 603
Additional cash received $ 4,100    
Shipping and handling costs 3.01 3.46  
Advertising costs $ 17 $ 55  
Collection from customers $ 1,217    
Customer One [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 17.00% 18.00%  
Customer One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 29.00% 24.00%  
Customer Two [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 16.00% 12.00%  
Customer Two [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage   15.00%  
Customer Three [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage   11.00%  
Vendor One [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 10.00% 11.00%  
Vendor One [Member] | Accounts Payable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 11.00% 10.00%  
Vendor Two [Member] | Accounts Payable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage   10.00%  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Inventory (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials and packaging $ 6,766 $ 6,445
Finished products 5,251 4,855
Total $ 12,017 $ 11,300
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Property and Equipment (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]    
Total cost $ 1,577 $ 1,561
Accumulated depreciation and amortization (1,136) (1,068)
Net book value 441 493
Right of Use Assets Under Operating Leases [Member]    
Property, Plant and Equipment [Line Items]    
Total cost 724 724
Computer Hardware And Software [Member]    
Property, Plant and Equipment [Line Items]    
Total cost 400 400
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total cost 352 352
Construction in Progress [Member]    
Property, Plant and Equipment [Line Items]    
Total cost $ 101 $ 85
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Property, Plant and Equipment [Abstract]    
Depreciation $ 29 $ 47
Operating Lease, Right-of-Use Asset, Periodic Reduction $ 39 $ 32
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Intangible Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]    
Brand names $ 576 $ 576
Trademarks 55 53
Total $ 631 $ 629
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Amount Outstanding Under Credit Facilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Line of Credit Facility [Line Items]    
Total $ 7,844 $ 9,758
Capitalized financing costs (161) (201)
Alterna Capital Solutions [Member]    
Line of Credit Facility [Line Items]    
Total $ 8,005 $ 9,959
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Line of Credit (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Mar. 31, 2022
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Line of Credit Facility [Line Items]        
Amortization of Debt Discount (Premium)   $ 144 $ 281  
Alterna Capital Solutions [Member]        
Line of Credit Facility [Line Items]        
Debt Instrument, Term 3 years      
Line of Credit Facility, Maximum Borrowing Capacity $ 13,000 4,995    
Line of Credit Facility, Maximum Amount Outstanding During Period $ 400      
Line of Credit Facility, Remaining Borrowing Capacity   0    
Line of Credit Facility, Interest Rate Description Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (13.25% at March 31, 2024 and 13.25% at December 31, 2023). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.90% at March 31, 2024 and 13.90% at December 31, 2023). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2024 and 18.00% at December 31, 2023). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility.      
Long-Term Line of Credit $ 1,500      
[custom:LineOfCreditMonitoringFee-0] 1      
Direct Operating Costs $ 483      
[custom:AmortizationOfLineOfCreditPeriod] 3 years      
Debt Instrument, Unamortized Discount   161   $ 201
Amortization of Debt Discount (Premium)   $ 40    
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Secured Convertible Notes Payable (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Notes Payable A [Member]    
Short-Term Debt [Line Items]    
Secured Convertible “Option”” Notes Payable $ 10,250 $ 10,250
Notes Payable B [Member]    
Short-Term Debt [Line Items]    
Secured Convertible “Option”” Notes Payable 4,050 4,050
Secured Convertible Notes Payable [Member]    
Short-Term Debt [Line Items]    
Accrued interest 1,457 1,059
Accrued interest on excess debt borrowing 2,989 2,824
Capitalized financing costs (554) (572)
Total $ 18,192 $ 17,611
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Secured Convertible Notes Payable (Details) (Parenthetical)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 4 Months Ended
Feb. 12, 2024
USD ($)
$ / shares
Aug. 11, 2022
USD ($)
Nov. 30, 2023
USD ($)
Integer
$ / shares
Aug. 31, 2022
USD ($)
May 31, 2022
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
May 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Jun. 30, 2023
USD ($)
Feb. 28, 2023
USD ($)
Short-Term Debt [Line Items]                      
Fee percentage   10.00%                  
Credit exceeds   $ 6,000       $ 8,285 $ 8,699        
Debt Issuance Costs, Line of Credit Arrangements, Net                   $ 7,500  
Principal balance           10,250     $ 10,250    
Convertiable notes payable           7,339     6,737    
Whitebox Advisors, LLC [Member] | Convertible Notes Payable [Member]                      
Short-Term Debt [Line Items]                      
Principal payment     $ 200                
Debt conversion price | $ / shares     $ 7.50                
Payment for fees $ 132         132          
Share price | $ / shares $ 1.50                    
Whitebox Advisors, LLC [Member] | Convertible Notes Payable [Member] | Minimum [Member]                      
Short-Term Debt [Line Items]                      
Debt conversion percentage     1.25                
Whitebox Advisors, LLC [Member] | Convertible Notes Payable [Member] | Maximum [Member]                      
Short-Term Debt [Line Items]                      
Debt conversion percentage     1.45                
Whitebox Advisors, LLC [Member] | Additional Option Notes [Member]                      
Short-Term Debt [Line Items]                      
Convertiable notes payable maturity date               Mar. 31, 2025      
Principal balance           $ 4,050     $ 4,050    
Debt conversion percentage     1.20                
Convertiable notes payable               $ 4,050     $ 4,050
Debt conversion trading days | Integer     5                
Note Purchase Agreement [Member]                      
Short-Term Debt [Line Items]                      
Secured convertible promissory notes         $ 11,250            
Debt Instrument, Interest Rate Terms         The Original Notes bear interest at 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the notes), are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with Alterna Capital (ACS), the Company’s existing secured lender.            
Convertiable notes payable maturity date         Mar. 31, 2025            
Principal payment       $ 200              
Weighted average interest       90.00%              
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Secured Convertible Notes Payable (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Feb. 12, 2024
Dec. 31, 2023
Short-Term Debt [Line Items]        
Interest on convertible notes $ 1,023 $ 1,779    
Amortization of debt discount 144 $ 281    
Whitebox Advisors, LLC [Member] | Convertible Notes Payable [Member]        
Short-Term Debt [Line Items]        
Accrued interest 4,446     $ 3,883
Interest on convertible notes 563      
Interest expenses 398      
Excess of asset base loan fees 165      
Unamortized debt discount amount 554     $ 572
Incurred costs for aforementioned waivers 86      
Amortization of debt discount $ 104      
Limited Waiver, Deferral, and Amendment and Restatement Agreement [Member]        
Short-Term Debt [Line Items]        
Future minimum equity financing     $ 3,000  
Conversion of SAFE investments into equity     4,100  
Accrued interest     $ 100  
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Leases Liabilities (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Leases [Abstract]      
Lease cost $ 39 $ 32  
Operating leases liability 155   $ 207
Payments of operating lease liability $ 52    
Weighted average remaining lease term for operating lease 9 months    
Weighted average discount rate for operating lease 12.60%    
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Simple Agreements for Future Equity (“SAFE”) Investments (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Proceeds from Related Party Debt $ 264 $ 259
Simple Agreements For Future Equity Investments [Member] | Stockholders [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Proceeds from Related Party Debt $ 4,100  
Share price $ 1.50  
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Stock Option Activity (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]    
Shares Outstanding, Beginning balance 145,012  
Weighted-Average Exercise Price, Outstanding $ 45.09  
Weighted-Average Remaining Contractual Terms (Years), Outstanding 6 years 6 months 6 years 9 months
Aggregate Intrinsic Value, Shares Outstanding  
Shares, Granted  
Weighted-Average Exercise Price, Granted  
Shares, Exercised  
Weighted-Average Exercise Price, Exercised  
Shares, Unvested forfeited  
Weighted-Average Exercise Price, Unvested forfeited  
Shares, Vested forfeited (3,143)  
Weighted-Average Exercise Price, Vested forfeited $ 45.05  
Shares Outstanding, Ending balance 141,869 145,012
Weighted-Average Exercise Price, Outstanding $ 44.03 $ 45.09
Aggregate Intrinsic Value, Shares Outstanding
Shares, Exercisable 111,583  
Weighted-Average Exercise Price, Exercisable $ 51.09  
Weighted-Average Remaining Contractual Terms (Years), Exercisable 6 years 25 days  
Aggregate Intrinsic Value  
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Details Narrative) - Share-Based Payment Arrangement, Option [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Fair value of vested stock option $ 129 $ 229
Aggregate value of unvested compensation $ 314  
Stock price $ 1.63  
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Warrant Activity (Details) - Warrant [Member] - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Shares outstanding, Beginning balance 549,292  
Weighted average exercise price, outstanding $ 8.77  
Weighted average remaining contractual terms (years), outstanding 2 years 7 months 2 days 2 years 10 months 2 days
Aggregate intrinsic value shares outstanding beginning  
Shares, granted  
Weighted average exercise price, granted  
Shares, exercised  
Weighted average exercise price, exercised  
Shares, forfeited  
Weighted average exercise price, forfeited  
Shares outstanding, Ending balance 549,292 549,292
Weighted average exercise price, outstanding ending balance $ 8.77 $ 8.77
Aggregate intrinsic value shares outstanding
Shares exercisable 549,292  
Weighted average exercise price, exercisable $ 8.77  
Weighted average remaining contractual terms (years), exercisable 2 years 7 months 2 days  
Aggregate intrinsic value shares exercisable  
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock Warrants (Details Narrative)
Mar. 31, 2024
$ / shares
Securities Purchase Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Warrants exerice price $ 1.63
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Related Parties (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Related Party Transactions [Abstract]    
Accounts receivable, net of provision of $1,123 and $1,123 at March 31, 2024 and December 31, 2023, respectively $ 264 $ 259
Accounts payable (331) (259)
Net (payable) receivable $ (67)
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Schedule of Related Parties (Details) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Related Party [Member]    
Related Party Transaction [Line Items]    
Net of provision $ 1,123 $ 1,123
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Transactions with California Custom Beverage, LLC, former related party (Details Narrative) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2018
California Custom Beverage, LLC [Member]      
Related Party Transaction [Line Items]      
Due to related party $ 452 $ 452  
Christopher J. Reed [Member] | California Custom Beverage, LLC [Member]      
Related Party Transaction [Line Items]      
Royalty percentage     5.00%
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2018
Chris Reed [Member] | California Custom Beverage, LLC [Member]      
Loss Contingencies [Line Items]      
Deposit of security with lessor $ 800   $ 1,200
Escrow deposits $ 12    
Chris Reed [Member] | California Custom Beverage, LLC [Member] | Common Stock [Member]      
Loss Contingencies [Line Items]      
Number of common stock value placed 7,260    
Maximum [Member]      
Loss Contingencies [Line Items]      
Fees   $ 1,200  
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Subsequent Events (Details Narrative) - Secured Convertible Notes Payable [Member] - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Jul. 01, 2024
Subsequent Event [Line Items]    
Minimum of conversion amount $ 3,000  
Conversion amount $ 4,100  
Subsequent Event [Member]    
Subsequent Event [Line Items]    
Interest payable   $ 40
EXCEL 62 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ^ M%@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " /@+18K'2TJ^X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M3L,P#(9?!>7>.LT8AZC+98@32$A, G&+'&^+:-HH,6KW]K1EZX3@ 3C&_O/Y ML^0:H\8NT7/J(B7VE&^&T+198]R((W/4 !F/%&PNQT0[-O=="I;'9SI M/AA M#P1*RCL(Q-99MC !B[@0A:D=:DQDN4MGO,,%'S]3,\,< C44J.4,55F!,-/$ M>!J:&JZ "<:40OXND%N(<_5/[-P!<4X.V2^ION_+?C7GQATJ>'MZ?)G7+7R; MV;9(XZ_L-9\B;<1E\NMJ>[][$$9)=5O(=:'D3DDMI:[6[Y/K#[^K<.B621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M ^ M%AQ*<^M1 4 /T; 8 >&PO=V]R:W-H965T&UL MM9G_;^(V&,9_O[_"XJ33)I42.U!HKR"UN79#N_;:TFVZ3?O!30Q$36)F&VC_ M^[U.(*&5>6'1T1]*OCT/_N2UG8?X?"G5LYX*822OE<=88G.?'[M3@7,Y-$F?B3A$] M3U.N7B]%(I?]!FVL#SS$DZFQ!UJ#\QF?B)$PO\_N%.RU2I17_!&+I=[8)A;E2NU_G\ #SQ+4(9/)G')EIO]%KD$B,^3PQ#W+YJU@!=:Q?*!.= M_R?+XMIVNT'"N38R78FA!6F<%9_\974C-@2,;1&PE8"]$U!_B\!?"?P0JBT3T5M^"MI0-8NL&73+4\(:K8^+3(\(\UG:T M)]@E?R74BWX!Q MIH5:B,;@TT=ZXGUVT?T@LS>P[1*VC;D/OLAP#B/4D,?7F7"1XG+J->]=2*BJ M)E*G1.J@;;H GBAGND[XQ,6$Z\<\T:Y;$:"RFE G)=3)?G6ZGW-EA$I>R8.8 M265R5@;S_ .Z%B M&=FID\#D[1QRN%,Y66Z=+5%]3<[3DO-T/\[K6(<\6>->PV'GDP9WNZ"# MF,0VSD!-;WGJKB%N]'!U]>73QQZCW<^CHP_#V^#827N(+$.K,$/Q.+*B#:#O M*NBW0\BG+^0W\>KDQ:T\J"IM>XQVG)R'"#BT2C@4CR@KSD?^0H81P,;C..3Y M0Q/IQ+BEWVE";>'/=_(>(OO0*OQ0/+*L>(=9*!6$@ASUB(P,3$=$*A+(.10< MZBXC=]?>D:VNG,B'R$.T"D043S$KY(LH G=]M-X@7^$Z\BUS<^*6S*,?;H12 ML3&DZT0^1$*B542B>+)YCQS8/2COHUQF3ES<[E:J)4^>G:"'B$BTRD@4CS7O M0/,>]$YJ _/R7_%LZUC=X>B=]#K. MYRRNJTM:)2:V(S'EG$KP[6"XP4\]S_O9"7:(A,2JA,3PTP M.3WM-GW?=TXZN+0N7Q60V%X!:9UXBQ^=<3;)!Z4[T^]P_.Y\IQ;@JKJ<531B M>T6C86:$*MZCVC3/U^!.3MQQ&^\0D8=5 MD8?M%7D +(5?*2,CPV?(/?D"!/DV-Q +L@CJZR3^01EF=1\*MT[N9A>\%H,V M[779*:2*Q29B:V.!Q?:^?-U)D]#^UBC66LJCY=K61;ZBTZHN+Q;&;KCMO)HD M8@Q2[[@+WZZ*M:9BQ\A9OESS)(V1:;XY%3P2REX Y\=2FO6._8)RQ6_P'U!+ M P04 " /@+18;'Y>#F & #Q&P & 'AL+W=O^))(U,WJ/',X;4I=/4GW32\X-^E'DI;Z:+(U97(E/%E(53 #M^IQIE>*LZQR*O(9Q3B<%4R4D_EE]=NMFE_*MM0V7QI^!/>N<:62H/4GZS-Y^RJPFVB'C.4V-#,/BWX3<\ MSVTDP/%]&W32O-,Z[EZ_1/]0D01; M0H&-E\I<5W_1T]863U"ZUD866V= 4(BR_L]^; =BQX'X PYTZT"/=?"V#EY% MM$96T7K/#)M?*OF$E+6&:/:B&IO*&]B(TD[CO5'P5("?F=_(,H-)X1EZQW)6 MIAS=VU@:O4%?[]^CW\Y^1V=(E.C+4JXU*S-].3/P6NL\2[>O>%>_@@Z\XC-3 MY\@C4T0Q]1WN-^/N[WG:N'O[[C,@VS"F#6-:Q?.&&*^5XJ5!3&O@>>'B4P?P MW0'LPKK0*Y;RJPFL',W5AD_FKU^1$+]UL3M1L#VN7L/5&XL^OV%ZZ2)8>X65 MEUWHF[E'8&HVN[C[-B'V&IL].'X#QQ^%/[OHU&\-=NG0@'3X.(R"B+@)!0VA M8)30IW(#J225$U70>R&AF$0=6 XKXF'LQA4VN,)17+>*KYC($/^QLHM;5V,I MS9(KJ"F[Z>_"'?804<^C'=@.(TQC-^JH01V-HOXB#"56IE!6L/ 163(,;.N^-_$)#7 'F\LLCN.!H2,[>DJ.DI=1"R.X6V.V M84XD,J>*MD^ZE50RJF)M85^Q9UO5G81I;\!C/^ZJCL,J(=[0K+0Z2,:%$ "J M-6\+HA.@UP<8=>N>PXC@)!S UPHC&5?&.[Z1^4:4C\@^L>4B53P3;65)V4I MWHM_@<1"E""4UCB5&@:]*BXAJ4L+2,SAPD+Z8AC%?F\N^E9)% P4>=)J)AD7 MS9<5LI+JI3:F$H04[FS)*:7A32(U_#/^8% F=)5G%>, )S5CG_I',.[K;.1Y M29=QWRJ,O&B <:O&9%R.'8QS#GN/W2+A!-U761($7$/Q!X5YU:,W0@=,HF3;B\V_AYW%45C M!;157#(NN3>=!7!$_OO!MI?P.YW$%))+ZV;NMDGG')6^0!,^> M-]HJ.3U&R0_D%NWKM)= &>I@=)G%.!S"V,HY'9?S>R/3;TN99USIUZ]B2J*W M]I1 I,*XMXXGE?531=LGO[-3'I?U>ZY@5M UVDU/V%LL.*16AK0=FRED((9T M56C#\C4D;(#Q%&.,])(IN_-8FZ545K>F*)GZA+P\$%I;1:YV)FNCH>7,0-*< M8^KH";I:-6ZSS[_M&NB![;,L"BC7+SS/@1;9I4KBBJJ;[EOD3TD<36E2*W-[ M-SH AZ5L'/1156H[9K\>:']@VW:''C@(R*"W@:($R[_:IXKRI<%Q$N[W(80D M0=S=;KCM_( .Y$';L=#QCN5Z;UM7+7XGSG[W\(;XV,?=O8?3T(-FKAH.7'W.X@WT$+T]-ME1Q(2#^RI:=MLT&.:C1TAJ!;%S[)P;/@= M^SZ7V?"^C[9-"!UO0NYXG1^WS!X/_/V9%P]<_>,$^C^ZC!&).%&T?=IMXT*3 M7SY-'6U]?IKOB:+MGZ>V/8LWWK/<-2>7:*%D@>R'%*Z@9M>SO[*S[SQQ[?\= M:3F,^E,TV_D>8S^&?6;J490:^O(%>.'S"&98U=^7ZALC5]4GF@=IC"RJRR5G M4/BL 3Q?2-@3;&_L5Y_F*]_\/U!+ P04 " /@+18BAYHB8Z(4*26I.S=_OH.)46V+%KV(3G$^I@9/N]P MR*'F!ZE>=4:I0=]S+O3"RXPI'GQ?)QG-B;Z7!17P9B=53@SSGA EO.:^>K=5R+DO#F:!KA729YT3]>*)<'A8>]MX>?&$OF;$/_.6\ M("]T0\W78JW@SF^CI"RG0C,ID**[A?>('U9X;!TJB[\8/>B3:V2E;*5\M3>_ MIPLOL$24T\38$ 1^]G1%.;>1@.-;$]1KQ[2.I]=OT3]7XD',EFBZDOQOEIIL MX4T]E-(=*;GY(@^_T490!9A(KJO_Z%#;QK&'DE(;F3?.0) S4?^2[TTB3AQP M=,$A;!S"6QU&C<.H$EJ35;*>B2'+N9('I*PU1+,756XJ;U##A)W&C5'PEH&? M6:ZD2&%2:(J>"":M.ZCKKL/XML, MA&T&PBK>Z$*\C2&&0F$:)'?H,Q.0!$8X6DO-JD+[YW&KC8)R^]+3%.UI][RYY]P'/SJ$OY.P3II&+5I& U%7SXFB2P%3+RB"65[ MLN7T#@E:985P6.VV.%P9J,/&55B[:>R7X7@Z]_>GPOHVTSAH;3J\4?P#O:%I,Q+#G.:PG*&1,%LVGETH=NN''+?QX$'Y%"F8(9_\!Y*XN.?&"$JF-% 9N1LAN"BR_NC3T.9F=\?9O(KGX7WZ3EF]S.!\4JQ0#CI%>" MT?@,L6^"HPL3/6T1IX.(&ZH8U>@1YE;LH5P9+"L$1;FC )HBV-Z3USM4$(7V MA)?.]37M4P5GX(,F'>Y9RSU[!VZ=08_0B)0FD\H6LXM_YB@.^W>FX:I91P<. MCOTM>#\E3.O2K:(9Y91O%N'S17C-JJOAI$?C]], 9S5M8%.$'<4I!-\DY(I5 M5\BQU>+!%@:GC3R'EGI+V3>1)B<$P3W40X_TJEV7]=@/\7!#[++>5.I-Q,Y& M/0T"5[G?9-HE/W9&/-P:G>0#I=WO3L)9+]77#;O$QW:(K_1#%_&U0NYW MO O8UPUK;/_D&&V_8>"@^L*$1ISNP#.XGT (57\6U#=&%M7)>BL-G-.KRPP^ MI:BR!O!^)Z5YN[&']?;C;/D_4$L#!!0 ( ^ M%B1>7FG.@0 %8/ 8 M >&PO=V]R:W-H965T&ULK9=M;]LV$,>_"J$50PLLEJAG M9;: Q-E#@74+ZF9],>P%8]&6$$ET22I.O_V.DBS9$J5V0-[8>K@[_HZD[L]; M'AE_$BFE$KT4>2E61BKEX=HTQ3:E!1$+=J EO-DQ7A )MWQOB@.G)*F=BMRT M+,DJF6=(5$5!^-=;FK/CRL#&Z<'';)]*]<",EP>R MIQLJ'P[W'.[,+DJ2%;04&2L1I[N5<8.OUSA4#K7%WQD]BK-KI%)Y9.Q)W;Q/ M5H:EB&A.MU*%(/#W3-&-A!'U@I4X%^ 8#DTM^$)+I, M[%,FM_9LP ^$+Y"#?T*V9;L:GO7WNSLS.$XWL4X=SYF(][[1%WM)\/JL]8(I!@>:+C:V)X9T/[.+0'?&.CT/4B/9[?X?FS>+]Q)@0Z<+;+I [,'XWI MN-@9@(V-;#\*]6!!!Q;,;N.V#I1[1%\.JE"(:QU?\)K;]Y6"7>0;=OF&LPMQ M1W.0%?X5055#*?SD9[GK,@]'DXX]:[AEQD8VMBW]RD0=:31+N@'I4VP*%!3X MBM.?'O8ZD7&FM_>M(1ME->L) $9RU0I5 (^!]P&O83Q MPP&QSBJP)KY'?*:+>!;Y$Y, S$;;7PN*1PBNY0^G5F/EV8$_ 6KWH/8LZ!^J MQZ.^.Q<:W& MEX@ZLR"86O%>N/"WE2N'R=2BC47I"OO!"$UCYCI3VH5[\<+SZG5"0[#"2*2$ M4SB)P>DUVVIAFV#A.86U<(>L&BN\F$+MA0S/*YD6-2VL_UVP&JMI MV%[<\*R6Q)_K4SX=-Y-(+%YY7KO^;R]R:C/5J(AN-L&FS,<\ZE(+R?=VX";1E M52F;(W[WM&L.;^J6:/#\5C6-=>?3AVDZ3CC [S-H5W*Z@Y#6(@ JWC1QS8UD MA[H/>F02NJKZ,H7&EW)E .]WC,G3C1J@:Z7C_P!02P,$% @ #X"T6$L' M*.>C!0 F"( !@ !X;"]W;W)KM/>S81@^152PLP%X^E]N)M,T)?V!IC#G[F6<%N!VO.-S>C$8O7.$?LFFQP(9XL"I06^IX!M\QS1?^]P1O:W M SAX_>$A7:VY_&$TFV[0"C]B_K2YI^)N5*,D:8X+EI("4+R\'7R&-Y%M2852 MXD>*]^SD&LBA/!/R(F^^)+<#2WJ$,QQS"8'$UP[/<99)).''/Q7HH+8I%4^O M7]&C)"GQ>$;_:P"<:)@VV<4[$K!;BMX9Q2<2L%I*3C^&06W4G#;%H(S M"EZEX+44H'-&P:\4_#+VAV"5D0X11[,I)7M I;1 DQG\U)D8@\P0EXY(ACD3.< ;($\S4J5IB!M! /2/RR)EF"*?L-A'B9QBD' M'Y\*M$U2CI-/8 B>'D/P\<,G\$$J?%^3+4-%PJ8C+ER4AD9QY<[=P1W[K#MY M3BJ3X*^O.'_&]&\%S%P/$+T31VP/3MQQ:V#SKMS$A; 5)*U[:CY^_07ZUN^JU#4)%AD":]#B MUK2X6EHBE%*P0]D6RP5MAYE8JP#9R-FL7)FT:#T'/C<)%KK=9+%;F;TP:3#2 M&VRPX=5L>%HVOHE34D:8,O):S1[KB2&@Z7M!:DRY)-<+MU^'V M^R>_\);3-):7U5*UHJB0MYP(,;&QBRU>19#65M^I81(L]#O!:^T@"Y/F(IVY M!D]!S5/P/_'TNMVH^ HZ;@:>U=I9M'[UI<$DV,(D6&0(K$'NN"9WK"7W 6^V M-%Z+PD>2&Q_.MDR>2%6D:;'Z3C*38.&XNT*UCB +D_8BK;T&$Y.:B&^D38)MC )%AD":[ 'K6.5:FGYJ^K":C5,&=N*Q7!)*%BF MA3A[BQI*D,JXNN+40O>=6$;1P@JM<=(*G-;<,FHRNF"R2=!)&P$:(4@WW2H3 MIYZ-;=<9MR:#)A$6QA%BTRA-3D]=@3@FUL"7Q&MZUE'R9VIG@!\0U.@ MDCE-% @]Z%KMB=.5&T([\#R_=017"SJR=%=.BV-G /9N#5P.I:(WX O9=C-C MKA!4- ?T'O9.<*/M 5-H37:.#0*H[Q"ESJ4W8K7A<+I"6PG>%=0E>#O M*-K@^26X(*(3=BAMV>E^FK$47K#59.);X M4%_C'_Z#^'(X$X5;*@]#]YBF)+D"/R0Y5^ ;WA\$U+2\HXA5TV((*#0%M# % M%!D :M)[+/*AOLK7=3;UJGV8,P04F@):0%65[K>+E^BB6#/JQX(>ZBOZ,X=3 M5\G".XI7-0N3-^S=71FQ=WOC=L=$(3<41UC7LMH15 C:5F![ZA#:QZ+:UA?5 M%PZGRE#:W>I1O7)PP\FF_-O^F7!.\O)RC5&"J100SY>$\-<;^29 _3+*[#]02P,$ M% @ #X"T6 @8BKMK!P -2( !@ !X;"]W;W)K OB20?C\^]\)XCI:L'J;[I-><&?2^+2E\/UL9L+D$5_+*4JF0&;M5JI#>*L]P-*HL129+)J&2B&LROW+,[-;^26U.(BM\I MI+=ER=3C.U[(A^L!'CP]^"Q6:V,?C.97&[;B]]Q\W=PIN!OMM>2BY)46LD** M+Z\'-_CR-G4#G,1?@C_H@VMD35E(^_)%?#Q*+B!<\,U8%@W\[?LN+PFH" M'/\V2@?[.>W P^LG[1^<\6#,@FE^*XN_16[6UX/I .5\R;:%^2P??N>-06.K M+Y.%=G_10R.;#%"VU4:6S6! 4(JJ_L^^-XXX& !ZP@-(,X!T!Z0] V@S@#I# M:V3.K/?,L/F5D@](66G09B^<;]QHL$94-HSW1L&O L:9^:VL<@@*S]&]889# M@(Q&H->(5&A+VNYU:S*]=7( M !BKO3X(%1DUHFF+Y+VA/)B#^HB"NJFE,J(_QPH6[1ROC H%SJ3 MV\J$4%YX$'":=F#Z,F2*PSBG>YS3*,X/3"BT8\666Y0[KJ&60@Y9V,'5,?5A M>M[T9ZC6#.[12K+*WL$SD$Y? AG4*/G:/J+:;>^AJ0( MF?:@)"U*$E^66::VKE(:;M,G")!X4X\GW:48$,(8TQY\+3/C'U"S"[^V\3\H MY%IS8 1H9E AV$(4_44=GY6BSZ7MV!DM2>,X2]\TJ6Z)D(L=6Q0\:'/JA6)& M2#=>OA!.TK[EVA(VCC);F_5!8&-OSLFDB\N7P3@A/;A:2L1Q3KQ3?,-$COCW MC6VAZ^219LU5DTU!O#X-#C%-QEW(OABE?2NSY4L<)\SW/(.]GG:E3]D-CBWT MT-7$\/I\2+M<%)+I\V[+F3A.FOO$W+#'WJST69".O5(HA_$YY,7%%@OUKX4H>,P/M*2'(F3W)\NT >U+ 20!&AJW%W6(:&^54U: M+B-Q+OMT>HL=M"#$8736]7% #*BDI_\D+=41\6@33[=P2ZV:U1TYA<8U=(FB=/F?H$U:RJ8G$&[ M?+HMN:6HH(-_SIJ+TOG):^Y,VHZ]T%(YB5/YG9(9 MYWGC _NK35Z@]UR$D]7GZ"F9>F4R(#69]>Q;2,OE),[E=^RQ.5FLG@/5)^PA MM&M>VQ&4(YCT4#MIJ9W$J?W8MYF$=:.,6-@S(FGX4T/RBSLE DMB'4!\IA.V MP230)*1)3Y= VRZ!QKN$8U/O;S[\AMA*<=Y7\ZC?"Z3)[*(3F?BDIQ<'VG85 M--Y5-)GF$@RXR!WO*=M<,/WCXR$:Z"6FW8(>!_#"=4_;CH/&-]>?^>: K#)9 MEK"FM)'9MZ!%+V@,@NE'_:WXL.=4C!X@/S[6CO2M(38*6N W#U"ZNB<@ :DA MQM.>(Q#:]@;TQ[V!J)K-X.N\V1:^L5V"M2T(.- 5D&FW)H>D>GW>4CZ-[[0= MY3.#%GPEJLHZUS9J7 F9!Z'ZF^=)TCW\"@B-:9]C6UJF<5I^0LKM44 48V#/ MC+WP^T+II&?30ELVIM-H W6_W6P*5^%9X>IA(?76GNS:@O+47$$JU"^)A:S" M[ZFBE'_RBZHS:3MV2> \<.+JG/P]1KCD-"LYZV)&VY.DVB M""QE?LN02.'H'Z#O7^Z__;AQKWQ[SQ_AR]O MZR\86C7U!Q4?F8+:IU'!EZ R>7L!R:7J;Q3J&R,W[C7_0AHC2W>YYK O5U8 M?E]*Z%V;&SO!_DN1^?]02P,$% @ #X"T6+_B6O"S$0 4"X !@ !X M;"]W;W)KRYY^V-@'L HDT2H6Z+I(EK]^S\E$72A36O?.@V6R""3RGB<3 M]?PF5%?UVKG&?-T49?WB8-TTVV='1W6V=AM;3\+6E?AE&:J-;?"U6AW5V\K9 M7#9MBJ/Y='IVM+&^/'CY7)Y]J%X^#VU3^-)]J$S=;C:VNGWEBG#SXF!VT#WX MZ%?KA@^.7C[?VI6[=,WG[8<*WXYZ*KG?N++VH3256[XXN)@]>W7"];+@W][= MU*//AI(L0KCBE_?YBX,I&7*%RQI2L/COVKUV14%"8.-+I'G0'\F-X\\=]7EDH:OEK;G3MR?&!R=JZ M"9NX&1QL?*G_VZ]1#Z,-Y]-[-LSCAKGPK0<)EV]L8U\^K\*-J;@:U/A!1)7= M8,Z7-,IE4^%7CWW-RTLUA@E+<^E7I5_ZS):-N=QUE$7:KY3V_![:Q^;74#;KVKPM M.[-PKC00>FLK,.5+V20HE %QM706_F4>3A\^1RDOSMXN)#QXFQ92Y;[78+;=I%X4S5\A3^ M4+E56X@VA1K77;JLK7SCXXJW7[.U+5?.0#<;7TO"'*OL\NWK_BA0LU5.87S9 M@*]-,M@!2@@5!9V8UZYJD-*Q2!._9% <58;&F=S761'J%H;& _Q,-4 S19L/ M:MAKWK&>J=DZH%D.UC.PR>$NH3(!-J-EM6]4MW; )*";9>K^N)N9W M$BF\ [%F;1OA:LPZB%/&GN7:#>]D'Z\;F[DN+)SQ]8Z^A+?)D 4_ ONB7?[2E%C-QS'NU?%YS<)524R]QRF.+?!# MSP4#5?Y L10Z:71%GJC>"14B7BH^V%E70K"Z9GZ#+:/9S-+Z"NZ\3VT#U]M0 M>XT)27DH3'##KC*E?3R#)-"!A*WG?UND# UDKN"CS-9KLP0TJGO--^O*.;/1 MTJD6V*4OFVD'5?'"%@RB1$&^UCIR5 MC 0:"?,G.(>)&0Z=YKTDCAPYC^"L2V_[3X&-$ WNZQ: C@$:#UVV,/\280UV M.Z>EI>^J [YB__2^IR)_=V/ M+4:%8XZ8YZIY>OST=(**=C?UC>LIRD:9(T/7.#27>BM^UM6.B\L^E2?SZ>GA MR30U?PO<^#J 7%6"\Q-SDLZF4_-W#_C(RH/TG"8W3O.J&I<9M:UVU+NN0KM: M([LN4(-$&(3S-3-=;0NM9(AEZ I>$;(KA%G--)R)V1 ]2UM\*M!)IK64MQT MGCW(!)\-S [NVDO"[O.N5Q+)D$P8'\P1^ B7=->V0(ZG6J_AI*$%*ZVZE2W M<"GNJ@QO[*VIG;NB?U;6UZP0>@ XYJY!M5(I1DI#(8$S@@WW[9LM(3&KG&BH M[@M\VN^V5<4BK[E2W(9 M7$K6 M%M8$2L'IXA@]E;;/H?U5/)RR8-24?JZX? MT/+$7-3T'!%P)%<-Y\G4)^+&U"U\PC+%>I=G1>7]"K!ZB M49I*]0T&M[[!0B#;*P==PO1UN_@#:440!?!"13)07:AVJHEN2(04W AX)!N[ MDT04G$^@ *66) _?9Q@:%A:IN"5X2"5=;U,$T MP!DEY,A\S32I1N56O]E6@8D3>\'=RI<[##,W KRWC=B+3W1AV5*ZME),&YB+ MQ7. $Z"-C%?^$F$.,'#+Q0KO,8U&AYJ)HUG391& UX:&J_5;.\F6+ MPZ&$%1NIZ-V05>N=ZAZ__FLV2N1K-.F.:EXJ2M2G79 LM.R_<[EXP$=MA'@$ MW L"U:.-X@45[ &)F']6MU$P1A6S3>VK4*I? MK#T"Y,:CGG7R\6QW'8IKU^<:J!W\4J/)HJV9)LE61QCNYT.NX%?\A_6R\DXR M?MVBOX#RUHP8_$5F1$+9\1A\ OLL8H2KAA[+5(N$XXBR1AI@[%?V!CF4;03< M-$467Z'D^$P] "$M7E'#(W(5)4:Z!B]D9++R9?08V@8^#N_,)[WI<6X$]01E M*"J^$:*LQVQ_6&6AB;%D:5>(Q[E:9?=(D5 S8FF ?ES<9Z#TCHY&+&:2KC(K MA-E'5.U6]!!9^#XG03NFUPZD0/:IU&.'"'3C2%,]V!P)",$"UI9+IZ;>*6IO M)*:2/X]?=IQA$_)(<@"$#J4R%E(99R5JO?$VR#5 3\M4N7)B9/I#O?;;K51) MVA-_).#WP<-D/[,W\+"?S/%D.L.?DS/SN7;$UV_A51MIIPE"M8GLG7!O+[&G MC]_3L>]O[:.EZE&OT3=[KN-$XI\%;K/M\!,KE%I,02SS)@_9\ RIE5COHI4+ MKPXC)7[^YJ5#ID&.4.FV,UHRA*AE[ MV"3:D;2"L(3/2C^E %UC C 5V"^)7A3JD9;H)CL/S%VUQ;'!: 7=I4.!!-AQ M'J4_1(OQ:>: 3B5F1_02 >"P/A&<)C0(21BL6B-L1X(K_#=!%UP% LRIOE)# MDQ%6+.HGHOTBE*M#P:D YROBV*Z\]%_%3!IL$3N&,H&SA1M! DL!=A$A-_9K MOP'R5"W3 U=L0T.0 7O>,=871N;N[%X K''@%H )B-8($=US9*4?J?U3DL* MCRB:+_N VM<:%EWKQ+HM;I.@?H=5Z?LQ7Y=D*GW^32))ENZ9]OQ(RX->Y[$Y MFYZEW9&:J%[W.$,(O98A.1/[F(D\R&Q*,"/0 ;51.>1;XB/WE>&O-K$;1'@^ M)& I#AI:_,6$3+H"KG"'@%-+7U#-2,*[.SOJ4G23]:CSTD$6+#3,3R?FE=-" M(MKVT7%JZN'0PMN GJT6A^5.?4A[H$C_J6OQ6'9?(] 9T+ZMM%1(CAJU 8)0 MNHPLD$P:NQZXI:RV>1"]#MN-(93VP,,D^=U%;N7( M792H6<;6 .X((\$R462L0V*HM7GAV5]:]#B.*&#!23.Z>22'!)++U!-++M>< M+G ,G27.5H2QM7G$%/*8"D)QXN_L\^ C+7,A\%[NKWW>Y3LF!^0C>%.W;S20 M1048M[7K4.1TNH@9;Z1>,K_&DEBV,C*3HFBK[]MG0>4T. \?Y5R.,,1%(R ; M=K?22;@(K3V'(#L4)ZJ!F-K[)?);(J+?F=!2C]E]G(_YC61'#/>(@0"1'VX- MF4-8^$)4>Z\!DA\TP'^J^0?Y3[9P+3VQ7SSJ('?W26'79G483(^5X9M.<+9>*/^WT3I/F M<59R*V>LD#Y :F(^W",5%ZF[CD>+:F)-Y%U.]95QBH\\H[_QG<8FG,<)GHWM MR\-C3\V62*[9^%Y$O9EK.C4(>A@BG_\DS=H-C:@)>+!5QTPRS%[&5J?Q;"EL M'_:65G$4"_>4BMO!%4:TV$MXB=\.L 66)JC^F;G,UBYO"\%R'T9TWG1TA@N? M1)0BH_C^4_*[S(:04T]/GJ;SIW,S/SY-GYZ<);_%>C\[F:7G9T_-[,E)>G(V M19D<1G)RI;.UMQ)KL_3T]$DZ/3O#ISD^G3R=)9]CXDGN23SHW9_,2)./$GU$ M" V,$NO3I1/\=6%&Y_*>, (BW?+D])C_DD^!PYEY.C\Y3Y^>3\'(V=G3]/AL M"J# 5,82#ZBJOO568>M.[5\[KELO74/QY:L8:.=RC)"J'UQH*=^^#>+LJ0HAVD)S-=)>H7A4V MNSJ$OP8@A\-?84O05R^#015=L+,LTCC.:-E3Q$E(,H:@E2N$-L>FOKXZ7+(Y ME#M)G&LXQ!2HIM-^%7_;2['(O<&_7OHJ==$R22-7AW&FRH[RN M"Z+T/?I7?;?;4/;PWGU_E_+#BA$VA&:B;Z6PH1HZ[-A8WX/5?_P4;&17*]Y:TY(_(8.9TU.][""05!7]TS6)8-D)?Y\A>9V;V;SK M,>ID:!8G9O[4H);,3LULMI,U6KK7-TG4AUMHF1!#K@4)O9$8I]/_ZN[Q.CB. MHM@B!<.6M99/G822BRG)]^?'[#KA0_XT->\0CLF_NW!\U_?N[T>=W YW#*/N M+L*7J*V2BKK>K0O/W2@GK\-8X+Y1 LT@Z$.P#J](XDJ!W?W5:1)A][N[!(=+ ML69\OI6K@,:MT A]4ZQ'#@NT*J!]9_XL1GYA=N26:2&><__ZL-\M:!3G=]]R99 M?WW E,UDTK#B]+JKQDJ>1)+S2/*]')2:P!L3 DR-[B\/GY3&&1/[P@7KBU1L MYX5([F$'MFM!;A'BM^[@XWCPYW*T,RJXKR=[KX2'1*0WP!F@AESFCP9)_Y>/ MI5K2;+SN[B_N!I"@DY#O)SOU.E2-CEX6MKS2>\(TZ=?&P$KEO93^JW;)HI;X MA/2W"-NO4M#,71^J>SS851.>R^Q)U'4;G[(N#.$Y23X)"HWJB'0(L2,T*#A' M'[?"JI9^EC0 @ITU/\3F;IU,0O?^R@ZER@VVW5:.,^[A%NL.";F.*6"^?OY2 M]^\ P1_A5'*WWAE]:(2J?EL<.G4XM\QT[BJX/DX38E7IWK60,DN07F_A1.V=T;C=]!JT(9>-^B>?-]F?PS7.OE_] OO+NX?-7!J8O+ MS_++X?1)"G"ZDCG*QW[:^>A3V**7F)]/'S\S[_6:2TF##5TF;M;M?-./;_<0 M S>7G#9W[,PC.WW,[)V$O0KXSSPBTX][KOJNW2!K*C7K+8R_$MTI>/]DZRNVB)E3W<47ZDJI MEKRJ%C;IKN*&R0=]A2'JR^X,PG_@U;GZ#5 M7\^5R;YTVKUDQ'Y <=;^=VWVO2YZ-'K+EPJ2=YEE!E\V^L)O_[1_7?I"WQ(> MENN[UK_J53%2U!);IY,GIP< X?+^LGZ!/\@[PXO0(!3EX]I9@%XNP._+@'P; MO_" _B7RE_\+4$L#!!0 ( ^ M%@0EC!2MP( ,X% 8 >&PO=V]R M:W-H965T&ULA53;;MLP#'WW5Q#>,+2 %U_BI$66!.AEQ?I0 MH&AW>1CVH-AT+%26/$F.VWW]*#MQ,R#-7BQ2XCD\M$3.6Z6?3(EHX;D2TBS\ MTMIZ%H8F*[%B9J1JE'12*%TQ2ZY>AZ;6R/(.5(DPB:)I6#$N_>6\V[O7R[EJ MK. 2[S68IJJ8?KE$H=J%'_N[C0>^+JW;")?SFJWQ$>VW^EZ3%PXL.:]0&JXD M:"P6_D4\NTQ=?!?PG6-K]FQPE:R4>G+.;;[P(R<(!6;6,3!:-GB%0C@BDO%[ MR^D/*1UPW]ZQWW2U4RTK9O!*B1\\M^7"/_6Z-QFF&VAESTT>0,ZACLE;6G@ ML\PQ_Q@3C.( D2M(C?..AMG''-_Y?;7#-32:4:33" MSXN5L9H>PZ]#%?>$Z6%"UR S4[,,%SYU@$&]07_YX5T\C3X=D9L.O MXBCTL+!DY+W^@<'RN($-$PWFP"S8$H'Z$C6H C)E+)P47!O[DHLZ^124 M!DD3@MI>\#]L);#G"+I=@K::6X15V69H-@X M":+XS!EQ,(XB.'29X5Z/5:C7W21Q13;2]NTV[ [#ZJ+OT=?P?M)17236@,"" MH-'H;.*#[J='[UA5=QV[4I;ZOS-+&KBH70"=%TK9G>,2#"-\^1=02P,$% M @ #X"T6(']=LTR P 1 < !@ !X;"]W;W)K5>F_>V1B1X:E1K5V%-U-U$D2UJ;(2=Z@Y; M/JFT:00Q:7:1[0R*TBLU*DKC>!XU0K;A>NEY&[->ZIZ4;'%CP/9-(\S'.U1Z MOPJ3\,AX(W)C=WN9/W F\E M[NW)'EPD6ZW?.^*W[H_HO_C8 M.9:ML'BOU3M94KT*KT,HL1*]HC=Z_RL>XIDYO$(KZU?8#[(Y6RQZ2[HY*#/= MR';XBZ=#'DX4KN.O**0'A=3[/1CR7KX4)-9+H_=@G#2CN8T/U6NS<[)U17D@ MPZ>2]6B],5Q?0Q]!M"6\^M#+CC-.RX@8VTE$Q0'G;L!)OX*3P6O=4FWA55MB M^;E^Q#Z-CJ5'Q^[2BX"OA9E"EDP@C=/\ EXV!IIYO.P;@4Y@HT1+G\<+?]UN M+1F^(G^?"WU SL\CN[:YL9THV, B%;CHC+9:@*Z :H=**>UNV.W@F6^;HWK*6O;J! M!YXA9:_029XW%'"=BSIPA7Z)!39;-(X(_'1XKJOGO<5 6(MDH>>K9<"A"'+6 M%'([6O@1%FD^K,$]^]838]3"E'OGK;-F=46>R./8?6RTJ#D_YLOPLEGJ/H9I M^3KT?G $'%-G](Z39B&)$[B>!7]H$BHHM"5()K/%PJWS)+@MBK[IE2 L@Q(Y MS844P^QA*Z+1AN0_ ^-9,DFR.5RY33R_AJO@=Z3 #2]X%*I'#B?/$[>^R#@Q MGZ "?.)Y;%W2C4\^U081FJ'YT#4?^)2.O>.-\R:#O7#)2E_XH!EZ 9. H^K0 M3T;%K?$?/[ENYJ02<*C$_S:>'8UGZ1?&IW"N6:*3R=:@V?GY;?D*]BT-0V[D MCD_$[3 9/XD/[PL[MI.MY5M3L6H\7NW];\S*%Q GQ> M:4U'PAD8'\[UOU!+ P04 " /@+189ZR3P&\" !X!0 &0 'AL+W=O MS(#!9A34S([5%22>%TC6S9.HR,%N-+.^2:A%$83@-:L:EG\X[WUJG M<]58P26N-9BFKIG^LT*AVH4_]O>.&UY6UCF"=+YE)=ZB_;9=:[*" 27G-4K# ME02-Q<)?CF>KB8OO KYS;,W!'EPG&Z7NG7&5+_S0$4*!F74(C#X/>(%".""B M\7N'Z0\E7>+A?H_^N>N=>MDP@Q=*_."YK1;^N0\Y%JP1]D:U7W'73^+P,B5, MMT+;QR:Q#UECK*IWR<2@YK+_LL?=/1PDG(<\FQZ)2V3)=\(A*4Q:,T\L 3K#H-L!['J(:(7 M(&*X5M)6!C[)'/-_\P.B,W"*]IQ6T4G :Z9'$(_?0Q1&DQ-X\=!CW.'%+^!] M42ION1# 9 [/&H9+;C*A3*,1?BXWQFKZ4WX=NX:^RN1X%:>>F=FR#!<^R<.@ M?D _??-J/ T_GNAA,O0P.87^?^]T$N(XPWXC3QZ/]9Y,D0R-!56 K1 * M)4C-7);PEDORJ,;0W9IW,[CMQ>U1X#-88;U![0QOI2G9DZQ& M Z\A.9OVJW>G64XCB,83) DDL7>G+!-T.(W';HT^P+&;#0[44*,N.\V[%AII M>V$,WF&L+'LU/87W,XD(EUP:$%A0:C@Z2WS0O6[XESA5P MTBVV0+LMFG;[3$ECBQN*=$G*;O;K=X:493MPW7TQQT*(H@5*G^,$W/^Y60NG-W M$]8^V;L;4WLE-7ZRX.JJ$O;Y'I59WW8&GH+\-MI,MF7#X8-0W6?CRMC/M0(%S42O_V:S_ MQ,:>">/E1KGP"^MXEI8AKYTW52-,#"JIXRA^-'[8$9BF/Q$8-@+#P#LJ"BS? M""_N;JQ9@^73A,8?P=0@3>2DYJ \>DN[DN3\W7N:@YG#@\5"^IN^)TS>Z>>- M_'V4'_Y$?@0?C/:E@S]T@<6^?)^XM(2&&T+WPZ. 'X3MP6C0A6$Z'!_!&[4& MC@+>Z)B!'X\9&.7'A^6Y**[<4N1XVZ&L=VA7V+G[[=7@/+T^PF[MN_A8>^=IFX]_I52P&]5O M([Y$EU!H\S+AV+[!'*L,+4\"5T9J" 6"@VN8*8]6"W@02^F%@D>C:BYD!R

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 64 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 66 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 116 247 1 false 46 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://drinkreeds.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Balance Sheets Sheet http://drinkreeds.com/role/BalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://drinkreeds.com/role/BalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://drinkreeds.com/role/StatementsOfOperations Condensed Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit Condensed Statements of Changes in Stockholders' Deficit (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://drinkreeds.com/role/StatementsOfCashFlows Condensed Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Summary of Significant Accounting Policies Sheet http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Inventory Sheet http://drinkreeds.com/role/Inventory Inventory Notes 8 false false R9.htm 00000009 - Disclosure - Property and Equipment Sheet http://drinkreeds.com/role/PropertyAndEquipment Property and Equipment Notes 9 false false R10.htm 00000010 - Disclosure - Intangible Assets Sheet http://drinkreeds.com/role/IntangibleAssets Intangible Assets Notes 10 false false R11.htm 00000011 - Disclosure - Line of Credit Sheet http://drinkreeds.com/role/LineOfCredit Line of Credit Notes 11 false false R12.htm 00000012 - Disclosure - Secured Convertible Notes Payable Notes http://drinkreeds.com/role/SecuredConvertibleNotesPayable Secured Convertible Notes Payable Notes 12 false false R13.htm 00000013 - Disclosure - Leases Liabilities Sheet http://drinkreeds.com/role/LeasesLiabilities Leases Liabilities Notes 13 false false R14.htm 00000014 - Disclosure - Simple Agreements for Future Equity (???SAFE???) Investments Sheet http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestments Simple Agreements for Future Equity (???SAFE???) Investments Notes 14 false false R15.htm 00000015 - Disclosure - Stock-Based Compensation Sheet http://drinkreeds.com/role/Stock-basedCompensation Stock-Based Compensation Notes 15 false false R16.htm 00000016 - Disclosure - Stock Warrants Sheet http://drinkreeds.com/role/StockWarrants Stock Warrants Notes 16 false false R17.htm 00000017 - Disclosure - Transactions with California Custom Beverage, LLC, former related party Sheet http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty Transactions with California Custom Beverage, LLC, former related party Notes 17 false false R18.htm 00000018 - Disclosure - Commitments and Contingencies Sheet http://drinkreeds.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 00000019 - Disclosure - Subsequent Events Sheet http://drinkreeds.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Inventory (Tables) Sheet http://drinkreeds.com/role/InventoryTables Inventory (Tables) Tables http://drinkreeds.com/role/Inventory 22 false false R23.htm 00000023 - Disclosure - Property and Equipment (Tables) Sheet http://drinkreeds.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://drinkreeds.com/role/PropertyAndEquipment 23 false false R24.htm 00000024 - Disclosure - Intangible Assets (Tables) Sheet http://drinkreeds.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://drinkreeds.com/role/IntangibleAssets 24 false false R25.htm 00000025 - Disclosure - Line of Credit (Tables) Sheet http://drinkreeds.com/role/LineOfCreditTables Line of Credit (Tables) Tables http://drinkreeds.com/role/LineOfCredit 25 false false R26.htm 00000026 - Disclosure - Secured Convertible Notes Payable (Tables) Notes http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables Secured Convertible Notes Payable (Tables) Tables http://drinkreeds.com/role/SecuredConvertibleNotesPayable 26 false false R27.htm 00000027 - Disclosure - Stock-Based Compensation (Tables) Sheet http://drinkreeds.com/role/Stock-basedCompensationTables Stock-Based Compensation (Tables) Tables http://drinkreeds.com/role/Stock-basedCompensation 27 false false R28.htm 00000028 - Disclosure - Stock Warrants (Tables) Sheet http://drinkreeds.com/role/StockWarrantsTables Stock Warrants (Tables) Tables http://drinkreeds.com/role/StockWarrants 28 false false R29.htm 00000029 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Tables) Sheet http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables Transactions with California Custom Beverage, LLC, former related party (Tables) Tables http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty 29 false false R30.htm 00000030 - Disclosure - Schedule of Potentially Dilutive Securities (Details) Sheet http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails Schedule of Potentially Dilutive Securities (Details) Details 30 false false R31.htm 00000031 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables 31 false false R32.htm 00000032 - Disclosure - Schedule of Inventory (Details) Sheet http://drinkreeds.com/role/ScheduleOfInventoryDetails Schedule of Inventory (Details) Details 32 false false R33.htm 00000033 - Disclosure - Schedule of Property and Equipment (Details) Sheet http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails Schedule of Property and Equipment (Details) Details 33 false false R34.htm 00000034 - Disclosure - Property and Equipment (Details Narrative) Sheet http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://drinkreeds.com/role/PropertyAndEquipmentTables 34 false false R35.htm 00000035 - Disclosure - Summary of Intangible Assets (Details) Sheet http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails Summary of Intangible Assets (Details) Details 35 false false R36.htm 00000036 - Disclosure - Schedule of Amount Outstanding Under Credit Facilities (Details) Sheet http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails Schedule of Amount Outstanding Under Credit Facilities (Details) Details 36 false false R37.htm 00000037 - Disclosure - Line of Credit (Details Narrative) Sheet http://drinkreeds.com/role/LineOfCreditDetailsNarrative Line of Credit (Details Narrative) Details http://drinkreeds.com/role/LineOfCreditTables 37 false false R38.htm 00000038 - Disclosure - Schedule of Secured Convertible Notes Payable (Details) Notes http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails Schedule of Secured Convertible Notes Payable (Details) Details 38 false false R39.htm 00000039 - Disclosure - Schedule of Secured Convertible Notes Payable (Details) (Parenthetical) Notes http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical Schedule of Secured Convertible Notes Payable (Details) (Parenthetical) Details 39 false false R40.htm 00000040 - Disclosure - Secured Convertible Notes Payable (Details Narrative) Notes http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative Secured Convertible Notes Payable (Details Narrative) Details http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables 40 false false R41.htm 00000041 - Disclosure - Leases Liabilities (Details Narrative) Sheet http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative Leases Liabilities (Details Narrative) Details http://drinkreeds.com/role/LeasesLiabilities 41 false false R42.htm 00000042 - Disclosure - Simple Agreements for Future Equity (???SAFE???) Investments (Details Narrative) Sheet http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative Simple Agreements for Future Equity (???SAFE???) Investments (Details Narrative) Details http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestments 42 false false R43.htm 00000043 - Disclosure - Schedule of Stock Option Activity (Details) Sheet http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails Schedule of Stock Option Activity (Details) Details 43 false false R44.htm 00000044 - Disclosure - Stock-Based Compensation (Details Narrative) Sheet http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative Stock-Based Compensation (Details Narrative) Details http://drinkreeds.com/role/Stock-basedCompensationTables 44 false false R45.htm 00000045 - Disclosure - Schedule of Warrant Activity (Details) Sheet http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails Schedule of Warrant Activity (Details) Details 45 false false R46.htm 00000046 - Disclosure - Stock Warrants (Details Narrative) Sheet http://drinkreeds.com/role/StockWarrantsDetailsNarrative Stock Warrants (Details Narrative) Details http://drinkreeds.com/role/StockWarrantsTables 46 false false R47.htm 00000047 - Disclosure - Schedule of Related Parties (Details) Sheet http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails Schedule of Related Parties (Details) Details 47 false false R48.htm 00000048 - Disclosure - Schedule of Related Parties (Details) (Parenthetical) Sheet http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical Schedule of Related Parties (Details) (Parenthetical) Details 48 false false R49.htm 00000049 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Details Narrative) Sheet http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative Transactions with California Custom Beverage, LLC, former related party (Details Narrative) Details http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables 49 false false R50.htm 00000050 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://drinkreeds.com/role/CommitmentsAndContingencies 50 false false R51.htm 00000051 - Disclosure - Subsequent Events (Details Narrative) Sheet http://drinkreeds.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://drinkreeds.com/role/SubsequentEvents 51 false false All Reports Book All Reports form10-q.htm reed-20240331.xsd reed-20240331_cal.xml reed-20240331_def.xml reed-20240331_lab.xml reed-20240331_pre.xml http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 true true JSON 68 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-q.htm": { "nsprefix": "REED", "nsuri": "http://drinkreeds.com/20240331", "dts": { "inline": { "local": [ "form10-q.htm" ] }, "schema": { "local": [ "reed-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "reed-20240331_cal.xml" ] }, "definitionLink": { "local": [ "reed-20240331_def.xml" ] }, "labelLink": { "local": [ "reed-20240331_lab.xml" ] }, "presentationLink": { "local": [ "reed-20240331_pre.xml" ] } }, "keyStandard": 213, "keyCustom": 34, "axisStandard": 17, "axisCustom": 0, "memberStandard": 19, "memberCustom": 23, "hidden": { "total": 54, "http://fasb.org/us-gaap/2024": 39, "http://drinkreeds.com/20240331": 11, "http://xbrl.sec.gov/dei/2024": 4 }, "contextCount": 116, "entityCount": 1, "segmentCount": 46, "elementCount": 410, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 426, "http://xbrl.sec.gov/dei/2024": 27 }, "report": { "R1": { "role": "http://drinkreeds.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R2": { "role": "http://drinkreeds.com/role/BalanceSheets", "longName": "00000002 - Statement - Condensed Balance Sheets", "shortName": "Condensed Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R3": { "role": "http://drinkreeds.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Condensed Balance Sheets (Parenthetical)", "shortName": "Condensed Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R4": { "role": "http://drinkreeds.com/role/StatementsOfOperations", "longName": "00000004 - Statement - Condensed Statements of Operations (Unaudited)", "shortName": "Condensed Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R5": { "role": "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit", "longName": "00000005 - Statement - Condensed Statements of Changes in Stockholders' Deficit (Unaudited)", "shortName": "Condensed Statements of Changes in Stockholders' Deficit (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_PreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_PreferredStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R6": { "role": "http://drinkreeds.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)", "shortName": "Condensed Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "REED:FairValueOfVestedOptions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R7": { "role": "http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies", "longName": "00000007 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R8": { "role": "http://drinkreeds.com/role/Inventory", "longName": "00000008 - Disclosure - Inventory", "shortName": "Inventory", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R9": { "role": "http://drinkreeds.com/role/PropertyAndEquipment", "longName": "00000009 - Disclosure - Property and Equipment", "shortName": "Property and Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R10": { "role": "http://drinkreeds.com/role/IntangibleAssets", "longName": "00000010 - Disclosure - Intangible Assets", "shortName": "Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R11": { "role": "http://drinkreeds.com/role/LineOfCredit", "longName": "00000011 - Disclosure - Line of Credit", "shortName": "Line of Credit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "REED:LineOfCreditDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "REED:LineOfCreditDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R12": { "role": "http://drinkreeds.com/role/SecuredConvertibleNotesPayable", "longName": "00000012 - Disclosure - Secured Convertible Notes Payable", "shortName": "Secured Convertible Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R13": { "role": "http://drinkreeds.com/role/LeasesLiabilities", "longName": "00000013 - Disclosure - Leases Liabilities", "shortName": "Leases Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R14": { "role": "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestments", "longName": "00000014 - Disclosure - Simple Agreements for Future Equity (\u201cSAFE\u201d) Investments", "shortName": "Simple Agreements for Future Equity (\u201cSAFE\u201d) Investments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R15": { "role": "http://drinkreeds.com/role/Stock-basedCompensation", "longName": "00000015 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R16": { "role": "http://drinkreeds.com/role/StockWarrants", "longName": "00000016 - Disclosure - Stock Warrants", "shortName": "Stock Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "REED:StockWarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "REED:StockWarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R17": { "role": "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty", "longName": "00000017 - Disclosure - Transactions with California Custom Beverage, LLC, former related party", "shortName": "Transactions with California Custom Beverage, LLC, former related party", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R18": { "role": "http://drinkreeds.com/role/CommitmentsAndContingencies", "longName": "00000018 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R19": { "role": "http://drinkreeds.com/role/SubsequentEvents", "longName": "00000019 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R20": { "role": "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "20", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R21": { "role": "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R22": { "role": "http://drinkreeds.com/role/InventoryTables", "longName": "00000022 - Disclosure - Inventory (Tables)", "shortName": "Inventory (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R23": { "role": "http://drinkreeds.com/role/PropertyAndEquipmentTables", "longName": "00000023 - Disclosure - Property and Equipment (Tables)", "shortName": "Property and Equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R24": { "role": "http://drinkreeds.com/role/IntangibleAssetsTables", "longName": "00000024 - Disclosure - Intangible Assets (Tables)", "shortName": "Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R25": { "role": "http://drinkreeds.com/role/LineOfCreditTables", "longName": "00000025 - Disclosure - Line of Credit (Tables)", "shortName": "Line of Credit (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "REED:LineOfCreditDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "REED:LineOfCreditDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R26": { "role": "http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables", "longName": "00000026 - Disclosure - Secured Convertible Notes Payable (Tables)", "shortName": "Secured Convertible Notes Payable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R27": { "role": "http://drinkreeds.com/role/Stock-basedCompensationTables", "longName": "00000027 - Disclosure - Stock-Based Compensation (Tables)", "shortName": "Stock-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R28": { "role": "http://drinkreeds.com/role/StockWarrantsTables", "longName": "00000028 - Disclosure - Stock Warrants (Tables)", "shortName": "Stock Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "REED:ScheduleOfNonOptionEquityInstrumentsRollForwardTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "REED:StockWarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "REED:ScheduleOfNonOptionEquityInstrumentsRollForwardTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "REED:StockWarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R29": { "role": "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables", "longName": "00000029 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Tables)", "shortName": "Transactions with California Custom Beverage, LLC, former related party (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R30": { "role": "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "longName": "00000030 - Disclosure - Schedule of Potentially Dilutive Securities (Details)", "shortName": "Schedule of Potentially Dilutive Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R31": { "role": "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000031 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "REED:AdditionalCashReceived", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "REED:LiquidityPoliciesTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R32": { "role": "http://drinkreeds.com/role/ScheduleOfInventoryDetails", "longName": "00000032 - Disclosure - Schedule of Inventory (Details)", "shortName": "Schedule of Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R33": { "role": "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails", "longName": "00000033 - Disclosure - Schedule of Property and Equipment (Details)", "shortName": "Schedule of Property and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R34": { "role": "http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative", "longName": "00000034 - Disclosure - Property and Equipment (Details Narrative)", "shortName": "Property and Equipment (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R35": { "role": "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails", "longName": "00000035 - Disclosure - Summary of Intangible Assets (Details)", "shortName": "Summary of Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:IndefiniteLivedTradeNames", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:IndefiniteLivedTradeNames", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R36": { "role": "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails", "longName": "00000036 - Disclosure - Schedule of Amount Outstanding Under Credit Facilities (Details)", "shortName": "Schedule of Amount Outstanding Under Credit Facilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2024-03-31", "name": "us-gaap:LinesOfCreditCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_AlternaCapitalSolutionsMember", "name": "us-gaap:LinesOfCreditCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "REED:LineOfCreditDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R37": { "role": "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "longName": "00000037 - Disclosure - Line of Credit (Details Narrative)", "shortName": "Line of Credit (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:AmortizationOfDebtDiscountPremium", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-03-012022-03-31_custom_AlternaCapitalSolutionsMember", "name": "us-gaap:DebtInstrumentTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "REED:LineOfCreditDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R38": { "role": "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails", "longName": "00000038 - Disclosure - Schedule of Secured Convertible Notes Payable (Details)", "shortName": "Schedule of Secured Convertible Notes Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2024-03-31_custom_NotesPayableAMember", "name": "us-gaap:SecuredDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_NotesPayableAMember", "name": "us-gaap:SecuredDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R39": { "role": "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "longName": "00000039 - Disclosure - Schedule of Secured Convertible Notes Payable (Details) (Parenthetical)", "shortName": "Schedule of Secured Convertible Notes Payable (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "From2022-08-112022-08-11", "name": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-08-112022-08-11", "name": "us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R40": { "role": "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "longName": "00000040 - Disclosure - Secured Convertible Notes Payable (Details Narrative)", "shortName": "Secured Convertible Notes Payable (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:InterestExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_WhiteboxAdvisorsLLCMember_us-gaap_ConvertibleNotesPayableMember", "name": "us-gaap:InterestPayableCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R41": { "role": "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative", "longName": "00000041 - Disclosure - Leases Liabilities (Details Narrative)", "shortName": "Leases Liabilities (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:LeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R42": { "role": "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative", "longName": "00000042 - Disclosure - Simple Agreements for Future Equity (\u201cSAFE\u201d) Investments (Details Narrative)", "shortName": "Simple Agreements for Future Equity (\u201cSAFE\u201d) Investments (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ProceedsFromRelatedPartyDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_SimpleAgreementsForFutureEquityInvestmentsMember_custom_StockholdersMember", "name": "us-gaap:ProceedsFromRelatedPartyDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R43": { "role": "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails", "longName": "00000043 - Disclosure - Schedule of Stock Option Activity (Details)", "shortName": "Schedule of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R44": { "role": "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "longName": "00000044 - Disclosure - Stock-Based Compensation (Details Narrative)", "shortName": "Stock-Based Compensation (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_EmployeeStockOptionMember", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_EmployeeStockOptionMember", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R45": { "role": "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails", "longName": "00000045 - Disclosure - Schedule of Warrant Activity (Details)", "shortName": "Schedule of Warrant Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_WarrantMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "REED:ScheduleOfNonOptionEquityInstrumentsRollForwardTableTextBlock", "REED:StockWarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_WarrantMember54186484", "name": "REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "REED:ScheduleOfNonOptionEquityInstrumentsRollForwardTableTextBlock", "REED:StockWarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R46": { "role": "http://drinkreeds.com/role/StockWarrantsDetailsNarrative", "longName": "00000046 - Disclosure - Stock Warrants (Details Narrative)", "shortName": "Stock Warrants (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "AsOf2024-03-31_custom_SecuritiesPurchaseAgreementMember", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "REED:StockWarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_SecuritiesPurchaseAgreementMember", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "REED:StockWarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R47": { "role": "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails", "longName": "00000047 - Disclosure - Schedule of Related Parties (Details)", "shortName": "Schedule of Related Parties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:ProceedsFromRelatedPartyDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-01-01to2024-03-31", "name": "us-gaap:RepaymentsOfRelatedPartyDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "unique": true } }, "R48": { "role": "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical", "longName": "00000048 - Disclosure - Schedule of Related Parties (Details) (Parenthetical)", "shortName": "Schedule of Related Parties (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_RelatedPartyMember", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_us-gaap_RelatedPartyMember", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R49": { "role": "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative", "longName": "00000049 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Details Narrative)", "shortName": "Transactions with California Custom Beverage, LLC, former related party (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "AsOf2024-03-31_custom_CaliforniaCustomBeverageLLCMember", "name": "us-gaap:OtherLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_CaliforniaCustomBeverageLLCMember", "name": "us-gaap:OtherLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R50": { "role": "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "00000050 - Disclosure - Commitments and Contingencies (Details Narrative)", "shortName": "Commitments and Contingencies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "AsOf2024-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember", "name": "us-gaap:SecurityDeposit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember", "name": "us-gaap:SecurityDeposit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } }, "R51": { "role": "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative", "longName": "00000051 - Disclosure - Subsequent Events (Details Narrative)", "shortName": "Subsequent Events (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "From2024-01-012024-03-31_custom_SecuredConvertibleNotesPayableMember", "name": "us-gaap:DebtConversionOriginalDebtAmount1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_custom_SecuredConvertibleNotesPayableMember", "name": "us-gaap:DebtConversionOriginalDebtAmount1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-q.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r39", "r524" ] }, "us-gaap_AccountsPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableMember", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Payable [Member]", "documentation": "Obligations incurred and payable to vendors for goods and services received." } } }, "auth_ref": [ "r41" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableMember", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r491" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net of allowance of $258 and $860, respectively", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r583" ] }, "REED_AccrualOfInterestOnConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "AccrualOfInterestOnConvertibleNote", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accrued interest", "documentation": "Accrual of interest on convertible note." } } }, "auth_ref": [] }, "REED_AccruedInterestOnExcessDebtBorrowing": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "AccruedInterestOnExcessDebtBorrowing", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accrued interest on excess debt borrowing", "label": "AccruedInterestOnExcessDebtBorrowing" } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r42" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical", "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, accumulated depreciation", "negatedLabel": "Accumulated depreciation and amortization", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r27", "r122", "r399" ] }, "REED_AdditionalCashReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "AdditionalCashReceived", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Additional cash received" } } }, "auth_ref": [] }, "REED_AdditionalOptionNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "AdditionalOptionNotesMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Additional Option Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r53", "r524", "r655" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r420", "r573", "r574", "r575", "r576", "r603", "r658" ] }, "REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Fair value of vested options", "documentation": "Adjustments to additional paid in capital share based compensation stock options vested." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising Costs", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r107" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advertising costs", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r325", "r517" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of vested stock option", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r315", "r323" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Net of provision", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r125", "r185", "r189", "r190", "r192", "r624" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net of allowance", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r125", "r185", "r189" ] }, "REED_AlternaCapitalSolutionsMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "AlternaCapitalSolutionsMember", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Alterna Capital Solutions [Member]", "documentation": "Alterna Capital Solutions [Member]" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of debt discount", "verboseLabel": "Amortization of Debt Discount (Premium)", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r4", "r67", "r248", "r609" ] }, "REED_AmortizationOfLineOfCreditPeriod": { "xbrltype": "durationItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "AmortizationOfLineOfCreditPeriod", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "[custom:AmortizationOfLineOfCreditPeriod]", "documentation": "Amortization of line of credit period." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r553" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Total", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r168" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r19" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r19" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative", "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r335" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r95", "r105", "r123", "r143", "r171", "r173", "r179", "r180", "r186", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r336", "r338", "r351", "r390", "r445", "r503", "r504", "r524", "r538", "r597", "r598", "r613" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r119", "r127", "r143", "r186", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r336", "r338", "r351", "r524", "r597", "r598", "r613" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r553" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails", "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r286", "r287", "r288", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r310", "r311", "r312", "r313", "r314" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "REED_CaliforniaCustomBeverageLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "CaliforniaCustomBeverageLLCMember", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "California Custom Beverage, LLC [Member]", "documentation": "California Custom Beverage, LLC [Member]" } } }, "auth_ref": [] }, "REED_CarryingCostPropertyAndExplorationRights": { "xbrltype": "decimalItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "CarryingCostPropertyAndExplorationRights", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shipping and handling costs", "documentation": "Carrying cost property and exploration rights." } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Cash", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r106", "r393", "r421", "r440", "r524", "r538", "r563" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash at beginning of period", "periodEndLabel": "Cash at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r16", "r71", "r139" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r71" ] }, "REED_ChrisReedMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ChrisReedMember", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chris Reed [Member]", "documentation": "Chris Reed [Member]" } } }, "auth_ref": [] }, "REED_ChristopherJReedMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ChristopherJReedMember", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Christopher J. Reed [Member]", "documentation": "Christopher J. Reed [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants exerice price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r267" ] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative", "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r335" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r81", "r207", "r208", "r492", "r587", "r592" ] }, "REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock Equivalent of Series A Convertible Preferred Stock [Member]", "documentation": "Common Stock Equivalent of Series A Convertible Preferred Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r528", "r529", "r530", "r532", "r533", "r534", "r535", "r573", "r574", "r576", "r603", "r653", "r658" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r52" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r52", "r432" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r52" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r52", "r432", "r451", "r658", "r659" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $.0001 par value, 180,000,000 shares authorized; 4,187,291 and 4,187,291 shares issued and outstanding, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r52", "r395", "r524" ] }, "REED_ComputerHardwareAndSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ComputerHardwareAndSoftwareMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Computer Hardware And Software [Member]", "documentation": "Computer Hardware And Software [Member]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r21", "r22", "r34", "r35", "r183", "r491" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r21", "r22", "r34", "r35", "r183", "r412", "r491" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r21", "r22", "r34", "r35", "r183", "r491", "r560" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentrations", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r38", "r110" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration risk, percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r21", "r22", "r34", "r35", "r183" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r21", "r22", "r34", "r35", "r183", "r491" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConstructionInProgressMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Construction in Progress [Member]", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "REED_ConversionOfInvestmentsIntoEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ConversionOfInvestmentsIntoEquity", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion of SAFE investments into equity", "documentation": "Conversion of investments into equity." } } }, "auth_ref": [] }, "us-gaap_ConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleDebt", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Convertible Debt", "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company." } } }, "auth_ref": [ "r13", "r99", "r622" ] }, "us-gaap_ConvertibleLongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleLongTermNotesPayable", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Convertible note payable, net of debt discount of $45 and $148, respectively, less current portion", "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r13" ] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Current portion of convertible notes payable, net of debt discount of $509 and $424, respectively", "verboseLabel": "Convertiable notes payable", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r42" ] }, "us-gaap_ConvertibleNotesPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertibleNotesPayableMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable [Member]", "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r41", "r96" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of goods sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r62", "r63", "r387" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "REED_CovidNineteenConsiderationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "CovidNineteenConsiderationPolicyTextBlock", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Trends - Market Conditions", "documentation": "Covid Nineteen Consideration [Policy Text Block]" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r76", "r183" ] }, "REED_CustomerOneMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "CustomerOneMember", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer One [Member]", "documentation": "Customer One [Member]" } } }, "auth_ref": [] }, "REED_CustomerThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "CustomerThreeMember", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Three [Member]", "documentation": "Customer Three [Member]" } } }, "auth_ref": [] }, "REED_CustomerTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "CustomerTwoMember", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Two [Member]", "documentation": "Customer Two [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentAmount1", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion amount", "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r17", "r18" ] }, "us-gaap_DebtConversionOriginalDebtAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionOriginalDebtAmount1", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum of conversion amount", "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r17", "r18" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayable" ], "lang": { "en-us": { "role": { "label": "Secured Convertible Notes Payable", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r82", "r141", "r202", "r203", "r204", "r205", "r206", "r215", "r216", "r226", "r232", "r233", "r234", "r235", "r236", "r237", "r242", "r249", "r250", "r251", "r360" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r13", "r41", "r42", "r96", "r99", "r146", "r227", "r228", "r229", "r230", "r231", "r233", "r238", "r239", "r240", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r508", "r509", "r510", "r511", "r512", "r522", "r571", "r588", "r589", "r590", "r608", "r610" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Principal balance", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r13", "r99", "r252" ] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt conversion price", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r83", "r229" ] }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleConversionRatio1", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt conversion percentage", "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount." } } }, "auth_ref": [ "r28", "r45", "r85", "r86", "r229" ] }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Weighted average interest", "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleThresholdTradingDays", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt conversion trading days", "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateTerms": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateTerms", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate Terms", "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets." } } }, "auth_ref": [ "r44" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Convertiable notes payable maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r124", "r508", "r604", "r605" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r13", "r146", "r227", "r228", "r229", "r230", "r231", "r233", "r238", "r239", "r240", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r508", "r509", "r510", "r511", "r512", "r522", "r571", "r588", "r589", "r590", "r608", "r610" ] }, "us-gaap_DebtInstrumentPeriodicPaymentInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentPeriodicPaymentInterest", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Excess of asset base loan fees", "documentation": "Amount of the required periodic payments applied to interest." } } }, "auth_ref": [ "r13" ] }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentPeriodicPaymentPrincipal", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Principal payment", "documentation": "Amount of the required periodic payments applied to principal." } } }, "auth_ref": [ "r13" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTerm", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount", "verboseLabel": "Unamortized debt discount amount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r600", "r607", "r608", "r610" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscountCurrent", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt discount current", "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer." } } }, "auth_ref": [ "r607", "r608", "r610" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscountNoncurrent", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt discount, noncurrent", "documentation": "Amount of debt discount to be amortized after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r607", "r608", "r610" ] }, "us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtIssuanceCostsLineOfCreditArrangementsNet", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Line of Credit Arrangements, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r361" ] }, "us-gaap_DeferredFinanceCostsCurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFinanceCostsCurrentNet", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Capitalized financing costs", "negatedLabel": "Capitalized financing costs", "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r607", "r608", "r610" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Capitalized financing costs", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r600", "r607", "r608", "r610" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "REED_DeliveryAndHandlingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "DeliveryAndHandlingExpense", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Delivery and handling expense", "documentation": "Delivery and handling expense." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative", "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r4", "r26" ] }, "us-gaap_DirectOperatingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DirectOperatingCosts", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Direct Operating Costs", "documentation": "The aggregate direct operating costs incurred during the reporting period." } } }, "auth_ref": [ "r64" ] }, "REED_DisclosureLineOfCreditAbstract": { "xbrltype": "stringItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "DisclosureLineOfCreditAbstract", "lang": { "en-us": { "role": { "label": "Line Of Credit" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensation" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r282", "r285", "r316", "r317", "r318", "r516" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "REED_DisclosureStockWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "DisclosureStockWarrantsAbstract", "lang": { "en-us": { "role": { "label": "Stock Warrants" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r552" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r550", "r552", "r553" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r551" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r539" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r552" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r552" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r554" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r542" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per share - basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r133", "r152", "r153", "r154", "r155", "r156", "r157", "r161", "r163", "r165", "r166", "r167", "r170", "r331", "r334", "r348", "r349", "r388", "r403", "r500" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per share - diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r133", "r152", "r153", "r154", "r155", "r156", "r157", "r163", "r165", "r166", "r167", "r170", "r331", "r334", "r348", "r349", "r388", "r403", "r500" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loss per Common Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r19", "r20", "r169" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate value of unvested compensation", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r602" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r545" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r541" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r541" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r558" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r541" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r555" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r553" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r541" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r541" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r541" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r541" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r556" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r117", "r130", "r131", "r132", "r147", "r148", "r149", "r151", "r156", "r158", "r160", "r172", "r187", "r188", "r201", "r268", "r326", "r327", "r328", "r329", "r330", "r332", "r333", "r334", "r340", "r341", "r342", "r343", "r344", "r345", "r347", "r352", "r353", "r354", "r355", "r356", "r357", "r362", "r364", "r372", "r402", "r406", "r407", "r408", "r420", "r475" ] }, "us-gaap_EscrowDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EscrowDeposit", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Escrow deposits", "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy." } } }, "auth_ref": [ "r94", "r493" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r6" ] }, "REED_FairValueOfVestedOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "FairValueOfVestedOptions", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair value of vested options", "documentation": "Fair value of vested options.", "label": "FairValueOfVestedOptions" } } }, "auth_ref": [] }, "REED_FairValueOfVestedRestrictedSharesGrantedToOfficers": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "FairValueOfVestedRestrictedSharesGrantedToOfficers", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Fair value of vested restricted shares granted to officers", "documentation": "Fair value of vested restricted shares granted to officers.", "label": "FairValueOfVestedRestrictedSharesGrantedToOfficers" } } }, "auth_ref": [] }, "REED_FutureMinimumEquityFinancing": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "FutureMinimumEquityFinancing", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Future minimum equity financing", "documentation": "Future minimum equity financing." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and administrative expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r66", "r455" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r61", "r64", "r104", "r143", "r186", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r351", "r502", "r503", "r577", "r578", "r579", "r580", "r581", "r597" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued expenses", "label": "Increase (Decrease) in Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r3" ] }, "REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "IncreaseDecreaseInAmortizationOfRightOfUseAssets", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Decrease in right of use assets", "documentation": "Amortization of right of use of asset.", "label": "IncreaseDecreaseInAmortizationOfRightOfUseAssets" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Lease liabilities", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r561", "r569" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r3" ] }, "REED_IncurredCostsForAforementionedWaivers": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "IncurredCostsForAforementionedWaivers", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Incurred costs for aforementioned waivers", "documentation": "Incurred costs for Aforementioned waivers." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r195", "r198", "r506" ] }, "us-gaap_IndefiniteLivedTradeNames": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedTradeNames", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails": { "parentTag": "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Brand names", "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit." } } }, "auth_ref": [ "r564", "r586" ] }, "us-gaap_IndefiniteLivedTrademarks": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedTrademarks", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails": { "parentTag": "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Trademarks", "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit." } } }, "auth_ref": [ "r564", "r586" ] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://drinkreeds.com/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Intangible Assets", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r196", "r199", "r200", "r496", "r497" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r197", "r585", "r586" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest on convertible notes", "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense." } } }, "auth_ref": [ "r171", "r173", "r176", "r177", "r180", "r359", "r503", "r504" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest expenses", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r67", "r246", "r253", "r511", "r512" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r135", "r137", "r138" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPayableCurrent", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest payable", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r42" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued interest", "label": "Interest Payable", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r97", "r621" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://drinkreeds.com/role/Inventory" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r193" ] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/ScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Finished products", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r566" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://drinkreeds.com/role/ScheduleOfInventoryDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Inventory", "totalLabel": "Total", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r126", "r499", "r524" ] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryRawMaterials", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/ScheduleOfInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/ScheduleOfInventoryDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials and packaging", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r567" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWriteDown", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Inventory write-downs", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r194" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCost", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r367", "r523" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilities" ], "lang": { "en-us": { "role": { "label": "Leases Liabilities", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r363" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r13", "r41", "r42", "r43", "r47", "r48", "r49", "r50", "r143", "r186", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r337", "r338", "r339", "r351", "r431", "r501", "r538", "r597", "r613", "r614" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 deficit", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r57", "r100", "r397", "r524", "r572", "r584", "r606" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r43", "r120", "r143", "r186", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r337", "r338", "r339", "r351", "r524", "r597", "r613", "r614" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "auth_ref": [] }, "REED_LimitedWaiverDeferralAndAmendmentAndRestatementAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "LimitedWaiverDeferralAndAmendmentAndRestatementAgreementMember", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Limited Waiver, Deferral, and Amendment and Restatement Agreement [Member]", "documentation": "Limited Waiver, Deferral, and Amendment and Restatement Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r13", "r99", "r622" ] }, "REED_LineOfCreditDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "LineOfCreditDisclosureTextBlock", "presentation": [ "http://drinkreeds.com/role/LineOfCredit" ], "lang": { "en-us": { "role": { "label": "Line of Credit", "documentation": "Line of Credit [Text Block]" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityAxis", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lender Name [Axis]", "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit." } } }, "auth_ref": [ "r40", "r46", "r571", "r595", "r596" ] }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityInterestRateDescription", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Interest Rate Description", "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate." } } }, "auth_ref": [ "r40", "r46" ] }, "us-gaap_LineOfCreditFacilityLenderDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityLenderDomain", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "auth_ref": [ "r40", "r46", "r571", "r595" ] }, "us-gaap_LineOfCreditFacilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityLineItems", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r216", "r571", "r595" ] }, "us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Maximum Amount Outstanding During Period", "documentation": "Maximum amount borrowed under the credit facility at any time during the period." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r40", "r46" ] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Remaining Borrowing Capacity", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r40", "r46", "r216" ] }, "us-gaap_LineOfCreditFacilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityTable", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Table]", "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement." } } }, "auth_ref": [ "r40", "r46", "r216", "r571", "r595" ] }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Fee percentage", "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility." } } }, "auth_ref": [] }, "REED_LineOfCreditMonitoringFee": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "LineOfCreditMonitoringFee", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "[custom:LineOfCreditMonitoringFee-0]", "documentation": "Monitoring fee." } } }, "auth_ref": [] }, "us-gaap_LinesOfCreditCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LinesOfCreditCurrent", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Revolving line of credit, net of capitalized financing costs of $161 and $201, respectively", "verboseLabel": "Total", "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r41", "r96" ] }, "REED_LiquidityPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "LiquidityPoliciesTextBlock", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Liquidity" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesLineItems", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r209", "r210", "r211", "r214", "r324", "r507", "r593", "r594" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesTable", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Table]", "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation." } } }, "auth_ref": [ "r209", "r210", "r211", "r214", "r324", "r507", "r593", "r594" ] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r183", "r514", "r525", "r527", "r601", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r210", "r211", "r212", "r213", "r281", "r324", "r350", "r386", "r404", "r405", "r411", "r423", "r424", "r483", "r484", "r485", "r486", "r487", "r494", "r495", "r505", "r513", "r515", "r518", "r519", "r520", "r521", "r526", "r599", "r615", "r616", "r617", "r618", "r619", "r620" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r210", "r211", "r212", "r213", "r281", "r324", "r350", "r386", "r404", "r405", "r411", "r423", "r424", "r483", "r484", "r485", "r486", "r487", "r494", "r495", "r505", "r513", "r515", "r518", "r519", "r520", "r526", "r599", "r615", "r616", "r617", "r618", "r619", "r620" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r183", "r514", "r525", "r527", "r601", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r136" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r136" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r71", "r72", "r74" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://drinkreeds.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows", "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit", "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r65", "r74", "r101", "r118", "r128", "r129", "r132", "r143", "r150", "r152", "r153", "r154", "r155", "r156", "r159", "r160", "r164", "r186", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r331", "r334", "r349", "r351", "r401", "r453", "r473", "r474", "r536", "r597" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities:" } } }, "auth_ref": [] }, "REED_NotePurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "NotePurchaseAgreementMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Note Purchase Agreement [Member]", "documentation": "Note Purchase Agreement [Member]" } } }, "auth_ref": [] }, "REED_NotesPayableAMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "NotesPayableAMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Notes Payable A [Member]" } } }, "auth_ref": [] }, "REED_NotesPayableBMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "NotesPayableBMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Notes Payable B [Member]" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r104", "r502", "r577", "r578", "r579", "r580", "r581" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating leases liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r365" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current portion of lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r365" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments of operating lease liability", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r366", "r368" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r570" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average discount rate for operating lease", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r370", "r523" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining lease term for operating lease", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r369", "r523" ] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilities", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Due to related party", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r98", "r391", "r427", "r428", "r538", "r623", "r654" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Payable to former related party", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r42", "r524" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Receivable from former related party", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r552" ] }, "us-gaap_PaymentsForFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForFees", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Payment for fees", "documentation": "Amount of cash outflow for fees classified as other." } } }, "auth_ref": [ "r2" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repurchase of common stock", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r69" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Trademark costs", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r68" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r68" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r546" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r548" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockMember", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r528", "r529", "r532", "r533", "r534", "r535", "r653", "r658" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Series A convertible preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r51", "r255" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Series A convertible preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r51", "r432" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Series A convertible preferred stock, shares issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r51", "r255" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Series A convertible preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r51", "r432", "r451", "r658", "r659" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r51", "r394", "r524" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r568" ] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reclassifications", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r562" ] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from convertible note payable, net of expenses", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ProceedsFromCustomers": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromCustomers", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collection from customers", "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services." } } }, "auth_ref": [ "r73" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from SAFE agreement", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r1", "r414" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from line of credit", "verboseLabel": "Credit exceeds", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r15", "r571" ] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails": { "parentTag": "us-gaap_RelatedPartyTransactionAmountsOfTransaction", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails", "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from Related Party Debt", "verboseLabel": "Accounts receivable, net of provision of $1,123 and $1,123 at March 31, 2024 and December 31, 2023, respectively", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amounts from former related party, net", "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts." } } }, "auth_ref": [] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r77" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductInformationLineItems", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfessionalFees", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r503", "r536", "r656", "r657" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r5", "r371" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://drinkreeds.com/role/PropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r79", "r111", "r114", "r115" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Total cost", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r80", "r121", "r400" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r371" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net of accumulated depreciation of $1,136 and $1,068, respectively", "totalLabel": "Net book value", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r5", "r371", "r389", "r400", "r524" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://drinkreeds.com/role/PropertyAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Property and Equipment", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r80", "r371" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Change in allowance for doubtful accounts", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r134", "r191" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r210", "r211", "r212", "r213", "r279", "r281", "r311", "r312", "r313", "r324", "r350", "r384", "r385", "r386", "r404", "r405", "r411", "r423", "r424", "r483", "r484", "r485", "r486", "r487", "r494", "r495", "r505", "r513", "r515", "r518", "r519", "r520", "r521", "r526", "r530", "r591", "r599", "r604", "r616", "r617", "r618", "r619", "r620" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "auth_ref": [ "r210", "r211", "r212", "r213", "r279", "r281", "r311", "r312", "r313", "r324", "r350", "r384", "r385", "r386", "r404", "r405", "r411", "r423", "r424", "r483", "r484", "r485", "r486", "r487", "r494", "r495", "r505", "r513", "r515", "r518", "r519", "r520", "r521", "r526", "r530", "r591", "r599", "r604", "r616", "r617", "r618", "r619", "r620" ] }, "REED_ReclassOfPrepaidExpensesAndAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ReclassOfPrepaidExpensesAndAccountsPayable", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Reclass of prepaid expenses and accounts payable" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical", "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r184", "r280", "r376", "r377", "r392", "r398", "r426", "r427", "r428", "r429", "r430", "r450", "r452", "r482" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyMember", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r144", "r145", "r376", "r377", "r378", "r379", "r392", "r398", "r426", "r427", "r428", "r429", "r430", "r450", "r452", "r482" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net (payable) receivable", "label": "Related Party Transaction, Amounts of Transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r37", "r376" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r376", "r377", "r612" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r184", "r456", "r457", "r460" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical", "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r184", "r280", "r376", "r377", "r392", "r398", "r426", "r427", "r428", "r429", "r430", "r450", "r452", "r482", "r612" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" ], "lang": { "en-us": { "role": { "label": "Transactions with California Custom Beverage, LLC, former related party", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r373", "r374", "r375", "r377", "r380", "r417", "r418", "r419", "r458", "r459", "r460", "r479", "r481" ] }, "us-gaap_RepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfLinesOfCredit", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on line of credit", "label": "Repayments of Lines of Credit", "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r70", "r571" ] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails": { "parentTag": "us-gaap_RelatedPartyTransactionAmountsOfTransaction", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts payable", "label": "Repayments of Related Party Debt", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r70" ] }, "us-gaap_RepaymentsOfShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfShortTermDebt", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of cost recorded as debt discount", "label": "Repayments of Short-Term Debt", "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r70" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r54", "r87", "r396", "r409", "r410", "r416", "r433", "r524" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r117", "r147", "r148", "r149", "r151", "r156", "r158", "r160", "r187", "r188", "r201", "r326", "r327", "r328", "r329", "r330", "r332", "r333", "r334", "r340", "r342", "r343", "r345", "r347", "r362", "r364", "r406", "r408", "r420", "r658" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Sales", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r102", "r103", "r171", "r174", "r175", "r178", "r180", "r181", "r182", "r183", "r277", "r278", "r387" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r116", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r498" ] }, "REED_RightOfUseAssetsUnderOperatingLeasesMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "RightOfUseAssetsUnderOperatingLeasesMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Right of Use Assets Under Operating Leases [Member]", "documentation": "Right of Use Assets Under Operating Leases [Member]" } } }, "auth_ref": [] }, "REED_RoyaltyPercentage": { "xbrltype": "percentItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "RoyaltyPercentage", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Royalty percentage", "documentation": "Royalty percentage" } } }, "auth_ref": [] }, "REED_SAFEAgreements": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "SAFEAgreements", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "SAFE agreements" } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesRevenueNetMember", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r183", "r559" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Security, Excluded EPS Calculation [Table]", "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS." } } }, "auth_ref": [ "r19" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Potentially Dilutive Securities", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r19" ] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative", "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r335" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Secured Convertible Notes Payable", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan [Table]", "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r7", "r29", "r30", "r31", "r32" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://drinkreeds.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Summary of Intangible Assets", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment." } } }, "auth_ref": [ "r506", "r586" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://drinkreeds.com/role/InventoryTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Inventory", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r14", "r58", "r59", "r60" ] }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "presentation": [ "http://drinkreeds.com/role/LineOfCreditTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Amount Outstanding Under Credit Facilities", "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r40", "r46" ] }, "REED_ScheduleOfNonOptionEquityInstrumentsRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ScheduleOfNonOptionEquityInstrumentsRollForwardTableTextBlock", "presentation": [ "http://drinkreeds.com/role/StockWarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Warrant Activity", "documentation": "Schedule of non option equity instruments roll forward table text block." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nature of Operation, Product Information, Concentration of Risk [Table]", "documentation": "Disclosure of information about concentration risk of product within nature of operation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5", "r371" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r36", "r37", "r456", "r457", "r460" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Parties", "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails", "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r283", "r284", "r286", "r287", "r288", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r310", "r311", "r312", "r313", "r314" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock Option Activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r11", "r12", "r88" ] }, "us-gaap_ScheduleOfShortTermDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShortTermDebtTable", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Table]", "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability." } } }, "auth_ref": [ "r41" ] }, "REED_SecuredConvertibleNotesPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "SecuredConvertibleNotesPayableMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Secured Convertible Notes Payable [Member]", "documentation": "Secured Convertible Notes Payable [Member]" } } }, "auth_ref": [] }, "us-gaap_SecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuredDebt", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Secured Convertible \u201cOption\u201d\u201d Notes Payable", "verboseLabel": "Secured convertible promissory notes", "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower." } } }, "auth_ref": [ "r13", "r99", "r622" ] }, "REED_SecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "SecuritiesPurchaseAgreementMember", "presentation": [ "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement [Member]", "documentation": "Securities Purchase Agreement [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r540" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r544" ] }, "us-gaap_SecurityDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecurityDeposit", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deposit of security with lessor", "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease." } } }, "auth_ref": [ "r565" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r543" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r549" ] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling and marketing expense", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares, Unvested forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r303" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Exercise Price, Unvested forfeited", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r303" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails", "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r283", "r284", "r286", "r287", "r288", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r310", "r311", "r312", "r313", "r314" ] }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Aggregate intrinsic value shares exercisable", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercisable aggregate intrinsic value.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" } } }, "auth_ref": [] }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Shares exercisable", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercisable number.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" } } }, "auth_ref": [] }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted average exercise price, exercisable", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average exercise price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" } } }, "auth_ref": [] }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual terms (years), exercisable", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average remaining contractual terms." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares, exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares, forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations", "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired." } } }, "auth_ref": [ "r91", "r92" ] }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, forfeited", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments forfeitures and expirations in period weighted average exercise price." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "label": "Shares, granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r9" ] }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate intrinsic value shares outstanding beginning", "periodEndLabel": "Aggregate intrinsic value shares outstanding", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments outstanding aggregate intrinsic value.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Shares outstanding, Beginning balance", "periodEndLabel": "Shares outstanding, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r89", "r90" ] }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, outstanding", "periodEndLabel": "Weighted average exercise price, outstanding ending balance", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" } } }, "auth_ref": [] }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual terms (years), outstanding", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Shares, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r292" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted-Average Exercise Price, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r292" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Shares, Granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r294" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Aggregate Intrinsic Value, Shares Outstanding", "periodEndLabel": "Aggregate Intrinsic Value, Shares Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r33" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Shares Outstanding, Beginning balance", "periodEndLabel": "Shares Outstanding, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r290", "r291" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted-Average Exercise Price, Outstanding", "periodEndLabel": "Weighted-Average Exercise Price, Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r290", "r291" ] }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Shares, Vested forfeited", "documentation": "Share based compensation arrangement by share based payment award options vested forfeitures and expirations in period." } } }, "auth_ref": [] }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Exercise Price, Vested forfeited", "documentation": "Share based compensation arrangement by share based payment award options vested forfeiture and expirations in period, weighted average grant date fair value." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails", "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r286", "r287", "r288", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r310", "r311", "r312", "r313", "r314" ] }, "REED_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, exercised", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercises in period weighted average exercise price." } } }, "auth_ref": [] }, "REED_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, granted", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Exercise Price, Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r295" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Exercise Price, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r294" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock Compensation Expense", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r282", "r289", "r308", "r309", "r310", "r311", "r314", "r319", "r320", "r321", "r322" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharePrice", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative", "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share price", "verboseLabel": "Stock price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Aggregate Intrinsic Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r33" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Remaining Contractual Terms (Years), Exercisable", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r33" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-Average Remaining Contractual Terms (Years), Outstanding", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r93" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtLineItems", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetails", "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r41", "r588", "r589", "r590" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r39", "r588", "r589", "r590" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r75", "r140" ] }, "REED_SimpleAgreementsForFutureEquityInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "SimpleAgreementsForFutureEquityInvestmentsMember", "presentation": [ "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Simple Agreements For Future Equity Investments [Member]", "documentation": "Simple Agreements For Future Equity Investments [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r547" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r52", "r55", "r56", "r117", "r130", "r131", "r132", "r147", "r148", "r149", "r151", "r156", "r158", "r160", "r172", "r187", "r188", "r201", "r268", "r326", "r327", "r328", "r329", "r330", "r332", "r333", "r334", "r340", "r341", "r342", "r343", "r344", "r345", "r347", "r352", "r353", "r354", "r355", "r356", "r357", "r362", "r364", "r372", "r402", "r406", "r407", "r408", "r420", "r475" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r147", "r148", "r149", "r172", "r364", "r387", "r413", "r422", "r425", "r426", "r427", "r428", "r429", "r430", "r432", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r443", "r444", "r446", "r447", "r448", "r449", "r450", "r452", "r454", "r455", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r475", "r531" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r147", "r148", "r149", "r172", "r184", "r364", "r387", "r413", "r422", "r425", "r426", "r427", "r428", "r429", "r430", "r432", "r435", "r436", "r437", "r438", "r439", "r441", "r442", "r443", "r444", "r446", "r447", "r448", "r449", "r450", "r452", "r454", "r455", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r475", "r531" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of common stock value placed", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r8", "r51", "r52", "r87", "r414", "r475", "r488" ] }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesOther", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common shares issued for financing costs, shares", "documentation": "Number of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Fair value of vested restricted shares granted to officers, shares", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r8", "r87" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "label": "Shares, Exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r8", "r51", "r52", "r87", "r295" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r8", "r51", "r52", "r87", "r420", "r475", "r488", "r537" ] }, "us-gaap_StockIssuedDuringPeriodValueOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueOther", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common shares issued for financing costs", "documentation": "Value of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "crdr": "credit", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Fair value of vested restricted shares granted to officers", "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period." } } }, "auth_ref": [ "r8", "r51", "r52", "r87" ] }, "us-gaap_StockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockOptionMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Equity Option [Member]", "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)." } } }, "auth_ref": [ "r530" ] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "negatedLabel": "Repurchase of common stock, shares", "label": "Stock Repurchased During Period, Shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r8", "r51", "r52", "r87", "r415", "r475", "r489" ] }, "us-gaap_StockRepurchasedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchasedDuringPeriodValue", "crdr": "debit", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "negatedLabel": "Repurchase of common stock", "label": "Stock Repurchased During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r8", "r51", "r52", "r87", "r420", "r475", "r489", "r537" ] }, "REED_StockWarrantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "StockWarrantsTextBlock", "presentation": [ "http://drinkreeds.com/role/StockWarrants" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock Warrants", "documentation": "Stock Warrants [Text Block]", "label": "Stock Warrants [Text Block]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/StatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 deficit", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r52", "r55", "r56", "r78", "r434", "r451", "r476", "r477", "r524", "r538", "r572", "r584", "r606", "r658" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 deficit:" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestments" ], "lang": { "en-us": { "role": { "label": "Simple Agreements for Future Equity (\u201cSAFE\u201d) Investments", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r84", "r142", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r268", "r346", "r478", "r480", "r490" ] }, "REED_StockholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "StockholdersMember", "presentation": [ "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stockholders [Member]", "documentation": "Stockholders [Member]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventLineItems", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r358", "r382" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventMember", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r358", "r382" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTable", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r358", "r382" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r358", "r382" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r358", "r382" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://drinkreeds.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r381", "r383" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information:" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualAxis", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title and Position [Axis]" } } }, "auth_ref": [ "r582", "r611" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfArrangementAxis", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SimpleAgreementsForFutureEquitySafeInvestmentsDetailsNarrative", "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r335" ] }, "REED_UnvestedRestrictedCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "UnvestedRestrictedCommonStockMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Unvested Restricted Common Stock [Member]", "documentation": "Unvested Restricted Common Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r23", "r24", "r25", "r108", "r109", "r112", "r113" ] }, "REED_VendorOneMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "VendorOneMember", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vendor One [Member]", "documentation": "Vendor One [Member]" } } }, "auth_ref": [] }, "REED_VendorTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "VendorTwoMember", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vendor Two [Member]", "documentation": "Vendor Two [Member]" } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r528", "r529", "r532", "r533", "r534", "r535" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding - diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r162", "r167" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding - basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r161", "r167" ] }, "REED_WhiteboxAdvisorsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://drinkreeds.com/20240331", "localname": "WhiteboxAdvisorsLLCMember", "presentation": [ "http://drinkreeds.com/role/ScheduleOfSecuredConvertibleNotesPayableDetailsParenthetical", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Whitebox Advisors, LLC [Member]", "documentation": "Whitebox Advisors, LLC [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://drinkreeds.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r557" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/330/tableOfContent" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-2" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479359/835-30-S45-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/842-20/tableOfContent" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/985-20/tableOfContent" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r499": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r501": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r502": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r503": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r504": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r505": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r506": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r507": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27" }, "r508": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r509": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r510": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r511": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r512": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r513": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r514": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r515": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r516": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r519": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r520": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r521": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r522": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r523": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r524": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r525": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r526": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r527": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r528": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r530": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r534": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r535": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r536": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r537": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r538": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r539": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r540": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r541": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r543": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r545": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r546": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r547": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r548": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r549": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r550": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r551": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r552": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r553": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r554": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r556": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r557": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r558": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r559": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r560": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r561": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r562": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1" }, "r563": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r564": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r565": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r566": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r567": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r568": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r569": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r572": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r573": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r574": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r575": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r576": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r577": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r578": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r579": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r580": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r581": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r582": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r583": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r584": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r585": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r586": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r587": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r592": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r593": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r595": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 69 0001493152-24-020661-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-020661-xbrl.zip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�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

&UL4$L! M A0#% @ #X"T6%6@Q3:=(P &UL4$L%!@ ) D *0( ,0@ @ $! end XML 71 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001140215 2024-01-01 2024-03-31 0001140215 2024-05-10 0001140215 2024-03-31 0001140215 2023-12-31 0001140215 us-gaap:RelatedPartyMember 2024-03-31 0001140215 us-gaap:RelatedPartyMember 2023-12-31 0001140215 2023-01-01 2023-03-31 0001140215 us-gaap:CommonStockMember 2023-12-31 0001140215 us-gaap:PreferredStockMember 2023-12-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001140215 us-gaap:RetainedEarningsMember 2023-12-31 0001140215 us-gaap:CommonStockMember 2022-12-31 0001140215 us-gaap:PreferredStockMember 2022-12-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001140215 us-gaap:RetainedEarningsMember 2022-12-31 0001140215 2022-12-31 0001140215 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001140215 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001140215 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001140215 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001140215 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001140215 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001140215 us-gaap:CommonStockMember 2024-03-31 0001140215 us-gaap:PreferredStockMember 2024-03-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001140215 us-gaap:RetainedEarningsMember 2024-03-31 0001140215 us-gaap:CommonStockMember 2023-03-31 0001140215 us-gaap:PreferredStockMember 2023-03-31 0001140215 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001140215 us-gaap:RetainedEarningsMember 2023-03-31 0001140215 2023-03-31 0001140215 REED:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001140215 REED:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001140215 REED:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001140215 REED:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:VendorOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001140215 REED:VendorOneMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:VendorOneMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001140215 REED:VendorOneMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 REED:VendorTwoMember us-gaap:AccountsPayableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001140215 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001140215 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001140215 us-gaap:StockOptionMember 2024-01-01 2024-03-31 0001140215 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001140215 us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-03-31 0001140215 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-03-31 0001140215 REED:UnvestedRestrictedCommonStockMember 2024-01-01 2024-03-31 0001140215 REED:UnvestedRestrictedCommonStockMember 2023-01-01 2023-03-31 0001140215 REED:CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001140215 REED:CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember 2023-01-01 2023-03-31 0001140215 REED:RightOfUseAssetsUnderOperatingLeasesMember 2024-03-31 0001140215 REED:RightOfUseAssetsUnderOperatingLeasesMember 2023-12-31 0001140215 REED:ComputerHardwareAndSoftwareMember 2024-03-31 0001140215 REED:ComputerHardwareAndSoftwareMember 2023-12-31 0001140215 us-gaap:MachineryAndEquipmentMember 2024-03-31 0001140215 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001140215 us-gaap:ConstructionInProgressMember 2024-03-31 0001140215 us-gaap:ConstructionInProgressMember 2023-12-31 0001140215 REED:AlternaCapitalSolutionsMember 2024-03-31 0001140215 REED:AlternaCapitalSolutionsMember 2023-12-31 0001140215 REED:AlternaCapitalSolutionsMember 2022-03-01 2022-03-31 0001140215 REED:AlternaCapitalSolutionsMember 2022-03-31 0001140215 REED:AlternaCapitalSolutionsMember 2024-01-01 2024-03-31 0001140215 REED:NotesPayableAMember 2024-03-31 0001140215 REED:NotesPayableAMember 2023-12-31 0001140215 REED:NotesPayableBMember 2024-03-31 0001140215 REED:NotesPayableBMember 2023-12-31 0001140215 REED:SecuredConvertibleNotesPayableMember 2024-03-31 0001140215 REED:SecuredConvertibleNotesPayableMember 2023-12-31 0001140215 REED:NotePurchaseAgreementMember 2022-05-31 0001140215 REED:NotePurchaseAgreementMember 2022-05-01 2022-05-31 0001140215 2022-08-11 2022-08-11 0001140215 2023-06-30 0001140215 REED:NotePurchaseAgreementMember 2022-08-01 2022-08-31 0001140215 us-gaap:ConvertibleNotesPayableMember REED:WhiteboxAdvisorsLLCMember 2023-11-01 2023-11-30 0001140215 srt:MinimumMember us-gaap:ConvertibleNotesPayableMember REED:WhiteboxAdvisorsLLCMember 2023-11-01 2023-11-30 0001140215 srt:MaximumMember us-gaap:ConvertibleNotesPayableMember REED:WhiteboxAdvisorsLLCMember 2023-11-01 2023-11-30 0001140215 us-gaap:ConvertibleNotesPayableMember REED:WhiteboxAdvisorsLLCMember 2023-11-30 0001140215 us-gaap:ConvertibleNotesPayableMember REED:WhiteboxAdvisorsLLCMember 2024-02-12 2024-02-12 0001140215 us-gaap:ConvertibleNotesPayableMember REED:WhiteboxAdvisorsLLCMember 2024-02-12 0001140215 us-gaap:ConvertibleNotesPayableMember REED:WhiteboxAdvisorsLLCMember 2024-01-01 2024-03-31 0001140215 REED:AdditionalOptionNotesMember REED:WhiteboxAdvisorsLLCMember 2023-02-28 0001140215 REED:AdditionalOptionNotesMember REED:WhiteboxAdvisorsLLCMember 2023-05-31 0001140215 REED:AdditionalOptionNotesMember REED:WhiteboxAdvisorsLLCMember 2023-02-01 2023-05-31 0001140215 REED:AdditionalOptionNotesMember REED:WhiteboxAdvisorsLLCMember 2024-03-31 0001140215 REED:AdditionalOptionNotesMember REED:WhiteboxAdvisorsLLCMember 2023-12-31 0001140215 REED:AdditionalOptionNotesMember REED:WhiteboxAdvisorsLLCMember 2023-11-01 2023-11-30 0001140215 REED:LimitedWaiverDeferralAndAmendmentAndRestatementAgreementMember 2024-02-12 0001140215 us-gaap:ConvertibleNotesPayableMember REED:WhiteboxAdvisorsLLCMember 2023-12-31 0001140215 us-gaap:ConvertibleNotesPayableMember REED:WhiteboxAdvisorsLLCMember 2024-03-31 0001140215 REED:StockholdersMember REED:SimpleAgreementsForFutureEquityInvestmentsMember 2024-01-01 2024-03-31 0001140215 REED:StockholdersMember REED:SimpleAgreementsForFutureEquityInvestmentsMember 2024-03-31 0001140215 2023-01-01 2023-12-31 0001140215 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001140215 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001140215 us-gaap:EmployeeStockOptionMember 2024-03-31 0001140215 us-gaap:WarrantMember 2023-12-31 0001140215 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001140215 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001140215 us-gaap:WarrantMember 2024-03-31 0001140215 REED:SecuritiesPurchaseAgreementMember 2024-03-31 0001140215 REED:ChristopherJReedMember REED:CaliforniaCustomBeverageLLCMember 2018-12-31 0001140215 REED:CaliforniaCustomBeverageLLCMember 2024-03-31 0001140215 REED:CaliforniaCustomBeverageLLCMember 2023-12-31 0001140215 srt:MaximumMember 2023-01-01 2023-12-31 0001140215 REED:ChrisReedMember REED:CaliforniaCustomBeverageLLCMember 2018-12-31 0001140215 REED:ChrisReedMember REED:CaliforniaCustomBeverageLLCMember 2024-03-31 0001140215 REED:ChrisReedMember us-gaap:CommonStockMember REED:CaliforniaCustomBeverageLLCMember 2024-01-01 2024-03-31 0001140215 REED:SecuredConvertibleNotesPayableMember 2024-01-01 2024-03-31 0001140215 REED:SecuredConvertibleNotesPayableMember us-gaap:SubsequentEventMember 2024-07-01 iso4217:USD shares iso4217:USD shares pure REED:Integer false Q1 --12-31 0001140215 10-Q true 2024-03-31 2024 false 001-32501 REED’S, INC. DE 35-2177773 201 Merritt 7 Norwalk CT 06851 (800) 997-3337 4187291 Yes Yes Non-accelerated Filer true false false 4187291 314000 603000 258000 860000 3251000 3571000 12017000 11300000 264000 259000 2332000 2028000 18178000 17761000 1136000 1068000 441000 493000 631000 629000 19250000 18883000 8484000 9133000 872000 1096000 161000 201000 7844000 9758000 331000 259000 509000 424000 7339000 6737000 155000 207000 25025000 27190000 4097000 45000 148000 10853000 10874000 39975000 38064000 10 10 500000 500000 9411 9411 9411 9411 94000 94000 0.0001 0.0001 180000000 180000000 4187291 4187291 4187291 4187291 119581000 119452000 -140400000 -138727000 -20725000 -19181000 19250000 18883000 9595000 11157000 6182000 8459000 3413000 2698000 1502000 2120000 1093000 1447000 1468000 1709000 4063000 5276000 -650000 -2578000 1023000 1779000 -1673000 -4357000 -0.40 -0.40 -1.70 -1.70 4187291 4187291 2559855 2559855 4187291 9411 94000 119452000 -138727000 -19181000 129000 129000 -1673000 -1673000 4187291 9411 94000 119581000 -140400000 -20725000 2519485 9411 94000 114635000 -123199000 -8470000 2519485 9411 94000 114635000 -123199000 -8470000 229000 229000 750 4000 4000 274 1000 1000 82438 273000 273000 -4357000 -4357000 2602399 9411 94000 115140000 -127556000 -12322000 2602399 9411 94000 115140000 -127556000 -12322000 -1673000 -4357000 29000 47000 144000 281000 129000 229000 -4000 -601000 -39000 -783000 -228000 564000 1113000 -922000 -1044000 -66000 -1102000 1305000 -338000 -39000 -32000 351000 1360000 -225000 235000 -52000 -44000 -2395000 1117000 2000 16000 -18000 8285000 8699000 10239000 12120000 2405000 4097000 86000 1000 67000 -166000 2124000 -1183000 -289000 -66000 603000 533000 314000 467000 318000 390000 1000000 0 <p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_z8sEYYSPozd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82D_zYjxTExbvaK9">Summary of Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zskPgPfj1nn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zkb4FI08hw58">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 1, 2024. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2024, and the results of its operations and its cash flows for the three months ended March 31, 2024 and 2023. The balance sheet as of December 31, 2023 is derived from the Company’s audited financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--LiquidityPoliciesTextBlock_zegR7s9MY17l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Liquidity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended March 31, 2024, the Company recorded a net loss of $1,673 and used cash in operations of $2,395. In accordance with Accounting Standards Codification (“ASC”) 205-40, <i>Going Concern</i>, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. As of the issuance date of these financial statements, management expects that the Company’s existing cash of $<span id="xdx_90B_eus-gaap--Cash_iI_pn3n3_c20240331_zmduN7yQc3Bj" title="Cash">314</span>, which includes $<span id="xdx_90E_ecustom--AdditionalCashReceived_pn3n3_c20240101__20240331_zvmjHZTQyWE2" title="Additional cash received">4,100</span> of additional cash received during the three months ended March 31, 2024, from investments with significant stockholders plus expected cash from operations, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners, strategic transactions or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--CovidNineteenConsiderationPolicyTextBlock_zctGBYPZoyC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zkIMlDX2bKl9">Recent Trends - Market Conditions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the U.S. economy continued to grow throughout 2023 and into Q1 2024, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2024, the Company experienced moderation from the elevated freight costs experienced in 2023. The average cost of shipping and handling for the three months ended March 31, 2024, was $<span id="xdx_907_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20240101__20240331_z66v6b6iYO29" title="Shipping and handling costs">3.01</span> per case, as compared to $<span id="xdx_90C_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20230101__20230331_zVmycbyoMzW3" title="Shipping and handling costs">3.46</span> per case for the three months ended March 31, 2023. Although the Company has experienced decreases in freight costs over the last four quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. The Company has been negatively impacted by supply chain challenges affecting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins. The Company has experienced moderation in inflation and anticipates this to continue throughout 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--UseOfEstimates_ztkivor19jJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zOnhrrQcrUX8">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zcsXLqnvMQK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zyUXVEnncaGg">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts with Customers</i> (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zwQIpXCBoEBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_86E_zaRvsSdBqF">Loss per Common Share</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the periods ended March 31, 2024 and 2023, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:</span></p> <p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zmH0TfcEwI73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z6R2j1f7UqBb" style="display: none">Schedule of Potentially Dilutive Securities</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_490_20240101__20240331_zTvNfhelfnUg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_490_20230101__20230331_zFyDTM333yE1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zyXPYvBz2NIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">549,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">235,946</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_znG9hBjwb9Ri" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,869</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,460</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zrizxpcJKEOe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,557,066</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,257,491</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedCommonStockMember_zPYJzDiCZt12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unvested restricted common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_zFFcgorMeWLf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock equivalent of Series A Convertible Preferred stock</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">753</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">753</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zkoh59z33zC" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,248,980</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,669,360</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zE8Ig1OFrcGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p id="xdx_84C_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zFWvHyMBqkO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zxIpAyXVWFS">Stock Compensation Expense</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, <i>Compensation-Stock Compensation</i> whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--AdvertisingCostsPolicyTextBlock_zFI92IuHN863" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zhYMwlckrjpf">Advertising Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $<span id="xdx_902_eus-gaap--AdvertisingExpense_pn3n3_c20240101__20240331_zjQvrb94FVci" title="Advertising costs">17</span> and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20230331_zhggCVQDaPS8" title="Advertising costs">55</span> for the three months ended March 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zswVdQmu5Urd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zwTXyRJPpu53">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net sales.</i> During the three months ended March 31, 2024, the Company’s two largest customers accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z8zgCa2p4Pti" title="Concentration risk percentage">17</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z14OHfcuIc4b" title="Concentration risk percentage">16</span>% of net sales, respectively. During the three months ended March 31, 2023, the Company’s two largest customers accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zgRrjTr6hjl7" title="Concentration risk percentage">18</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zhyj2oMUPqL1" title="Concentration risk percentage">12</span>% of net sales, respectively. No other customers exceeded 10% of net sales in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of March 31, 2024, the Company had accounts receivable from one customer which comprised <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6mZd5nQTry6" title="Concentration risk, percentage">29</span>% of its gross accounts receivable. As of December 31, 2023, the Company had accounts receivable from three customers which comprised <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zi0ugSeplv9c" title="Concentration risk, percentage">24</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z7lvzM1EIYg3" title="Concentration risk, percentage">15</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUrFNZe1vIhk" title="Concentration risk, percentage">11</span>% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The Company utilizes co-packers to produce 100% of its products.</i> During the three months ended March 31, 2024 and the year ended December 31, 2023, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company has long-standing relationships with two different co-packers, and a third co-packing agreement with California Custom Beverage LLC (“CCB”), a former related party (see Note 11). Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the three months ended March 31, 2024, the Company’s largest vendor accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zYIHqtySaJO6">10</span>% of all purchases. During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z6ZvABWhdEla">11</span>% of all purchases. No other vendors exceeded 10% of all purchases in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable.</i> As of March 31, 2024, one vendor accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxCT777uxZq9">11</span>% of total accounts payable. As of December 31, 2023, two vendors accounted for <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z91rESf8l7ll">10</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9JO5jZtlb8">10</span>% of total accounts payable, respectively. No other vendors exceeded 10% of accounts payable in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zNqrcrZeA5I9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zgizMTUeaU01">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs based on the Company’s assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z5AvDP1rYfSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Reclassifications</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year amounts have been reclassified for consistency with the current period presentation. Collection from customers amounting to $<span id="xdx_909_eus-gaap--ProceedsFromCustomers_pn3n3_c20240101__20240331_zD4bHVAQlGu3" title="Collection from customers">1,217</span> that was previously presented as a deduction from prepaid expenses have been reclassed as an offset against accounts receivable. These reclassifications had no effect on the reported results of operations or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z9tJtCGzAaV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_znBlCj4aazU6">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued ASU 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure</i>, which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the chief operating decision maker and included in each reported measure of a segment’s profit or loss. The update also requires all annual disclosures about a reportable segment’s profit or loss and assets to be provided in interim periods and for entities with a single reportable segment to provide all the disclosures required by ASC 280, <i>Segment Reporting</i>, including the significant segment expense disclosures. This standard will be effective for the Company on January 1, 2024 and interim periods beginning in fiscal year 2025, with early adoption permitted. The updates required by this standard should be applied retrospectively to all periods presented in the financial statements. The Company does not expect this standard to have a material impact on its results of operations, financial position or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2022-04, <i>Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations</i>. The ASU requires buyers to disclose information about their supplier finance programs. Interim and annual requirements include the disclosure of outstanding amounts under the obligations as of the end of the reporting period, and annual requirements include a roll-forward of those obligations for the annual reporting period, as well as a description of payment and other key terms of the programs. This update is effective for annual periods beginning after December 15, 2022, and interim periods within those fiscal years, except for the requirement to disclose roll-forward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted ASU 2022-04 on January 1, 2023, and there was no material impact on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.</span></p> <p id="xdx_854_zJGF0lGnMfOb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zskPgPfj1nn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zkb4FI08hw58">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 1, 2024. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2024, and the results of its operations and its cash flows for the three months ended March 31, 2024 and 2023. The balance sheet as of December 31, 2023 is derived from the Company’s audited financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--LiquidityPoliciesTextBlock_zegR7s9MY17l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Liquidity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three months ended March 31, 2024, the Company recorded a net loss of $1,673 and used cash in operations of $2,395. In accordance with Accounting Standards Codification (“ASC”) 205-40, <i>Going Concern</i>, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. As of the issuance date of these financial statements, management expects that the Company’s existing cash of $<span id="xdx_90B_eus-gaap--Cash_iI_pn3n3_c20240331_zmduN7yQc3Bj" title="Cash">314</span>, which includes $<span id="xdx_90E_ecustom--AdditionalCashReceived_pn3n3_c20240101__20240331_zvmjHZTQyWE2" title="Additional cash received">4,100</span> of additional cash received during the three months ended March 31, 2024, from investments with significant stockholders plus expected cash from operations, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners, strategic transactions or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 314000 4100000 <p id="xdx_84C_ecustom--CovidNineteenConsiderationPolicyTextBlock_zctGBYPZoyC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zkIMlDX2bKl9">Recent Trends - Market Conditions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the U.S. economy continued to grow throughout 2023 and into Q1 2024, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2024, the Company experienced moderation from the elevated freight costs experienced in 2023. The average cost of shipping and handling for the three months ended March 31, 2024, was $<span id="xdx_907_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20240101__20240331_z66v6b6iYO29" title="Shipping and handling costs">3.01</span> per case, as compared to $<span id="xdx_90C_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20230101__20230331_zVmycbyoMzW3" title="Shipping and handling costs">3.46</span> per case for the three months ended March 31, 2023. Although the Company has experienced decreases in freight costs over the last four quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. The Company has been negatively impacted by supply chain challenges affecting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins. The Company has experienced moderation in inflation and anticipates this to continue throughout 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3.01 3.46 <p id="xdx_846_eus-gaap--UseOfEstimates_ztkivor19jJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zOnhrrQcrUX8">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zcsXLqnvMQK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zyUXVEnncaGg">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts with Customers</i> (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zwQIpXCBoEBb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_86E_zaRvsSdBqF">Loss per Common Share</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the periods ended March 31, 2024 and 2023, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:</span></p> <p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zmH0TfcEwI73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z6R2j1f7UqBb" style="display: none">Schedule of Potentially Dilutive Securities</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_490_20240101__20240331_zTvNfhelfnUg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_490_20230101__20230331_zFyDTM333yE1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zyXPYvBz2NIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">549,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">235,946</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_znG9hBjwb9Ri" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,869</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,460</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zrizxpcJKEOe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,557,066</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,257,491</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedCommonStockMember_zPYJzDiCZt12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unvested restricted common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_zFFcgorMeWLf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock equivalent of Series A Convertible Preferred stock</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">753</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">753</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zkoh59z33zC" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,248,980</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,669,360</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zE8Ig1OFrcGc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zmH0TfcEwI73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z6R2j1f7UqBb" style="display: none">Schedule of Potentially Dilutive Securities</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_490_20240101__20240331_zTvNfhelfnUg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_490_20230101__20230331_zFyDTM333yE1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zyXPYvBz2NIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">549,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">235,946</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_znG9hBjwb9Ri" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,869</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,460</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zrizxpcJKEOe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible note payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,557,066</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,257,491</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedCommonStockMember_zPYJzDiCZt12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unvested restricted common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_zFFcgorMeWLf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock equivalent of Series A Convertible Preferred stock</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">753</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">753</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zkoh59z33zC" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,248,980</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,669,360</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 549292000 235946000 141869000 174460000 1557066000 1257491000 710000 753000 753000 2248980000 1669360000 <p id="xdx_84C_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zFWvHyMBqkO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zxIpAyXVWFS">Stock Compensation Expense</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, <i>Compensation-Stock Compensation</i> whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--AdvertisingCostsPolicyTextBlock_zFI92IuHN863" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zhYMwlckrjpf">Advertising Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $<span id="xdx_902_eus-gaap--AdvertisingExpense_pn3n3_c20240101__20240331_zjQvrb94FVci" title="Advertising costs">17</span> and $<span id="xdx_90B_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20230331_zhggCVQDaPS8" title="Advertising costs">55</span> for the three months ended March 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 17000 55000 <p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zswVdQmu5Urd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zwTXyRJPpu53">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net sales.</i> During the three months ended March 31, 2024, the Company’s two largest customers accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z8zgCa2p4Pti" title="Concentration risk percentage">17</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z14OHfcuIc4b" title="Concentration risk percentage">16</span>% of net sales, respectively. During the three months ended March 31, 2023, the Company’s two largest customers accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zgRrjTr6hjl7" title="Concentration risk percentage">18</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zhyj2oMUPqL1" title="Concentration risk percentage">12</span>% of net sales, respectively. No other customers exceeded 10% of net sales in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of March 31, 2024, the Company had accounts receivable from one customer which comprised <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6mZd5nQTry6" title="Concentration risk, percentage">29</span>% of its gross accounts receivable. As of December 31, 2023, the Company had accounts receivable from three customers which comprised <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zi0ugSeplv9c" title="Concentration risk, percentage">24</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z7lvzM1EIYg3" title="Concentration risk, percentage">15</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUrFNZe1vIhk" title="Concentration risk, percentage">11</span>% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The Company utilizes co-packers to produce 100% of its products.</i> During the three months ended March 31, 2024 and the year ended December 31, 2023, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company has long-standing relationships with two different co-packers, and a third co-packing agreement with California Custom Beverage LLC (“CCB”), a former related party (see Note 11). Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the three months ended March 31, 2024, the Company’s largest vendor accounted for approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zYIHqtySaJO6">10</span>% of all purchases. During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z6ZvABWhdEla">11</span>% of all purchases. No other vendors exceeded 10% of all purchases in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable.</i> As of March 31, 2024, one vendor accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxCT777uxZq9">11</span>% of total accounts payable. As of December 31, 2023, two vendors accounted for <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z91rESf8l7ll">10</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9JO5jZtlb8">10</span>% of total accounts payable, respectively. No other vendors exceeded 10% of accounts payable in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.17 0.16 0.18 0.12 0.29 0.24 0.15 0.11 0.10 0.11 0.11 0.10 0.10 <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zNqrcrZeA5I9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zgizMTUeaU01">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs based on the Company’s assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z5AvDP1rYfSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Reclassifications</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year amounts have been reclassified for consistency with the current period presentation. Collection from customers amounting to $<span id="xdx_909_eus-gaap--ProceedsFromCustomers_pn3n3_c20240101__20240331_zD4bHVAQlGu3" title="Collection from customers">1,217</span> that was previously presented as a deduction from prepaid expenses have been reclassed as an offset against accounts receivable. These reclassifications had no effect on the reported results of operations or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1217000 <p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z9tJtCGzAaV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_znBlCj4aazU6">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2023, the FASB issued ASU 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure</i>, which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the chief operating decision maker and included in each reported measure of a segment’s profit or loss. The update also requires all annual disclosures about a reportable segment’s profit or loss and assets to be provided in interim periods and for entities with a single reportable segment to provide all the disclosures required by ASC 280, <i>Segment Reporting</i>, including the significant segment expense disclosures. This standard will be effective for the Company on January 1, 2024 and interim periods beginning in fiscal year 2025, with early adoption permitted. The updates required by this standard should be applied retrospectively to all periods presented in the financial statements. The Company does not expect this standard to have a material impact on its results of operations, financial position or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2022-04, <i>Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations</i>. The ASU requires buyers to disclose information about their supplier finance programs. Interim and annual requirements include the disclosure of outstanding amounts under the obligations as of the end of the reporting period, and annual requirements include a roll-forward of those obligations for the annual reporting period, as well as a description of payment and other key terms of the programs. This update is effective for annual periods beginning after December 15, 2022, and interim periods within those fiscal years, except for the requirement to disclose roll-forward information, which is effective for fiscal years beginning after December 15, 2023. The Company adopted ASU 2022-04 on January 1, 2023, and there was no material impact on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.</span></p> <p id="xdx_80C_eus-gaap--InventoryDisclosureTextBlock_zqtaGyJz3rfe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span><span id="xdx_827_z3U1c04obKTi">Inventory</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zalJTHPGCcue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_z02pFYsbdMhj" style="display: none">Schedule of Inventory</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_49D_20240331_zeyV5NRqNWLg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_497_20231231_zqnwIjqkaBi3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINz4dt_z5qQpl32lUyj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials and packaging</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,766</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,445</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINz4dt_zzGXEOjQPXEc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished products</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,251</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,855</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pn3n3_mtINz4dt_zTeQatDuH967" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,017</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,300</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zQMk2JHhVSk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zalJTHPGCcue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_z02pFYsbdMhj" style="display: none">Schedule of Inventory</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_49D_20240331_zeyV5NRqNWLg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_497_20231231_zqnwIjqkaBi3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINz4dt_z5qQpl32lUyj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw materials and packaging</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,766</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,445</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINz4dt_zzGXEOjQPXEc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished products</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,251</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,855</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pn3n3_mtINz4dt_zTeQatDuH967" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,017</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,300</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 6766000 6445000 5251000 4855000 12017000 11300000 <p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z71VQgBQGib8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_828_zImQCDyYL9da">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zjysi7W2Ow93" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zrkljcdPiqEe" style="display: none">Schedule of Property and Equipment</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_49B_20240331_zQBsXHvmMBl7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_49A_20231231_zeGsU7OVZw7g" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RightOfUseAssetsUnderOperatingLeasesMember_zmHdZbUOvOEe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets under operating leases</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">724</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">724</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerHardwareAndSoftwareMember_zyimdXNkH5le" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer hardware and software</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z2lk2kMvDNI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zC0VHvUdWFgi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction in progress</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzorg_zOCADulaiF3j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,577</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,561</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzorg_z0Wx9WXPRGHf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,136</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,068</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzorg_zebGAkI1m5Ci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">493</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zPDvi1ZWAi79" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three months ended March 31, 2024 and 2023 was $<span id="xdx_905_eus-gaap--Depreciation_pn3n3_c20240101__20240331_zKXTuaKgRJ83">29 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_906_eus-gaap--Depreciation_pn3n3_c20230101__20230331_z7DyeyC6mHO8">47</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, and amortization of right-of-use assets for the three months ended March 31, 2024 and 2023 was $<span id="xdx_903_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pn3n3_c20240101__20240331_zwtCFVv6UDNh">39 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pn3n3_c20230101__20230331_zlu6bzO46F3l">32</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zjysi7W2Ow93" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zrkljcdPiqEe" style="display: none">Schedule of Property and Equipment</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_49B_20240331_zQBsXHvmMBl7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_49A_20231231_zeGsU7OVZw7g" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RightOfUseAssetsUnderOperatingLeasesMember_zmHdZbUOvOEe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets under operating leases</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">724</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">724</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerHardwareAndSoftwareMember_zyimdXNkH5le" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer hardware and software</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z2lk2kMvDNI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">352</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ConstructionInProgressMember_zC0VHvUdWFgi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction in progress</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzorg_zOCADulaiF3j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,577</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,561</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzorg_z0Wx9WXPRGHf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,136</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,068</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzorg_zebGAkI1m5Ci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">493</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 724000 724000 400000 400000 352000 352000 101000 85000 1577000 1561000 1136000 1068000 441000 493000 29000 47000 39000 32000 <p id="xdx_80A_eus-gaap--IntangibleAssetsDisclosureTextBlock_zrk7zibl9079" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_82B_zuJ4lpk0ltw5">Intangible Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_zPV3pmRnqnD9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B1_zI95gcBvCI7i" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary of Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_491_20240331_zCuaagNZ9581" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_494_20231231_zca0jiQV0hY2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_403_eus-gaap--IndefiniteLivedTradeNames_iI_pn3n3_maILIAEzdvn_zp2Gi4tIwFg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand names</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">576</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">576</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--IndefiniteLivedTrademarks_iI_pn3n3_maILIAEzdvn_zQnoEQfvU6If" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademarks</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iTI_pn3n3_mtILIAEzdvn_z9F30otkxMXf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">631</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">629</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zKGjcZMrmDN5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_zPV3pmRnqnD9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B1_zI95gcBvCI7i" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary of Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_491_20240331_zCuaagNZ9581" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_494_20231231_zca0jiQV0hY2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_403_eus-gaap--IndefiniteLivedTradeNames_iI_pn3n3_maILIAEzdvn_zp2Gi4tIwFg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand names</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">576</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">576</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--IndefiniteLivedTrademarks_iI_pn3n3_maILIAEzdvn_zQnoEQfvU6If" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademarks</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iTI_pn3n3_mtILIAEzdvn_z9F30otkxMXf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">631</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">629</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 576000 576000 55000 53000 631000 629000 <p id="xdx_80A_ecustom--LineOfCreditDisclosureTextBlock_zFOIDUQMN0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_829_zLMaWg408Jej">Line of Credit</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zajEdwlBbyt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s credit facility consisted of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B0_zsZo2YnJL8We" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Amount Outstanding Under Credit Facilities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Line of credit – Alterna Capital Solutions</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20240331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zRebAeB5Xbyd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,005</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20231231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_z08qK69JCMt3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,959</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: capitalized financing costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20240331_zBDaTbFxhj9a" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Capitalized financing costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(161</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20231231_zrouQv5xxVB3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Capitalized financing costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(201</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20240331_zTCqRnLEwR5h" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,844</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20231231_zOVCPZ34uOX2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,758</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_zPdmUF1Zo10l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March, 2022, the Company entered into a financing agreement for a line of credit with Alterna Capital Solutions (“ACS”) The ACS line of credit is for a term of <span id="xdx_905_eus-gaap--DebtInstrumentTerm_dtY_c20220301__20220331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zoATxTrAaDa8">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years, provides for borrowings of up to $<span id="xdx_907_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zDZGhAZKWrJ6">13,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and is secured by eligible accounts receivable and inventory, and are subject to a collateral sharing agreement with Whitebox, another secured lender (see Note 6). An over advance rider provides for up to $<span id="xdx_90E_eus-gaap--LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_pn3n3_c20220301__20220331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zwdabkyNmJF7">400 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of additional borrowing above the collateralized base (the “Over Advance”) up to a total borrowing of $<span id="xdx_90A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zDq9ixGOlxj2">13,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. As of March 31, 2024, there was <span id="xdx_908_eus-gaap--LineOfCreditFacilityRemainingBorrowingCapacity_iI_pn3n3_do_c20240331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_z6ETlCIRNdb6">no </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">remaining availability under the line of credit, and $<span id="xdx_905_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20240331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_z2EYp1nM3O83">4,995 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of borrowing capacity available.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_90E_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20220301__20220331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zIGPOWRjXr74" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (13.25% at March 31, 2024 and 13.25% at December 31, 2023). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.90% at March 31, 2024 and 13.90% at December 31, 2023). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2024 and 18.00% at December 31, 2023). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A loan balance of less than $<span id="xdx_90C_eus-gaap--LineOfCredit_iI_pn3n3_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zDQjuMjO0Mdl">1,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">will bear interest at a rate in line with account receivables advances plus the monthly monitoring fee of $<span id="xdx_905_ecustom--LineOfCreditMonitoringFee_iI_pn3n3_c20220331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_z8KYoA5Oeamf">1</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred $<span id="xdx_908_eus-gaap--DirectOperatingCosts_pn3n3_c20220301__20220331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zNLNefyVSBAg">483 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of direct costs of the transaction, consisting primarily of broker, bank and legal fees. These costs have been capitalized and are being amortized over the <span id="xdx_903_ecustom--AmortizationOfLineOfCreditPeriod_dtY_c20220301__20220331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_z2opeDAxT9C">3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-year life of the ACS agreement. The unamortized debt discount balance was $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20231231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zW1KsQQG44Bi">201 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at December 31, 2023. For the three months ended March 31, 2024, amortization of debt discount was $<span id="xdx_90A_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20240101__20240331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zJVQ0jNBi2Y6">40</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and as of March 31, 2024, the remaining unamortized debt discount balance is $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20240331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zxpOwMqFzfh9">161</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_89F_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zajEdwlBbyt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s credit facility consisted of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B0_zsZo2YnJL8We" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of Amount Outstanding Under Credit Facilities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Line of credit – Alterna Capital Solutions</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20240331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zRebAeB5Xbyd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,005</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20231231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_z08qK69JCMt3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,959</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: capitalized financing costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20240331_zBDaTbFxhj9a" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Capitalized financing costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(161</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20231231_zrouQv5xxVB3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Capitalized financing costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(201</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20240331_zTCqRnLEwR5h" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,844</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20231231_zOVCPZ34uOX2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,758</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 8005000 9959000 161000 201000 7844000 9758000 P3Y 13000000 400000 13000000 0 4995000 Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (13.25% at March 31, 2024 and 13.25% at December 31, 2023). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.90% at March 31, 2024 and 13.90% at December 31, 2023). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2024 and 18.00% at December 31, 2023). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility. 1500000 1000 483000 P3Y 201000 40000 161000 <p id="xdx_80E_eus-gaap--DebtDisclosureTextBlock_z21pggF5ELQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_82C_zWJJyeBxusH7">Secured Convertible Notes Payable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zgiVJ3kI7xu3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under the Company’s convertible notes payable are as follows (amounts in 000’s except share amounts):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zZhHD2wYzpJe" style="display: none">Schedule of Secured Convertible Notes Payable</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20240331__us-gaap--DebtInstrumentAxis__custom--SecuredConvertibleNotesPayableMember_zoLeNo6SZXn7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20231231__us-gaap--DebtInstrumentAxis__custom--SecuredConvertibleNotesPayableMember_zG7T6JHfJsX3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--SecuredDebt_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotesPayableAMember_zrqYDfHTNygk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Secured Convertible “Original” Notes Payable (A)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,250</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SecuredDebt_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotesPayableBMember_zG2crsms7yUi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Secured Convertible “Option”” Notes Payable (B)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,050</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--SecuredDebt_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotesPayableBMember_zEijOEdmfy4i" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Secured Convertible “Option”” Notes Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,050</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_zgQFi9XTN0Ki" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,059</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--AccruedInterestOnExcessDebtBorrowing_iNI_pn3n3_di_zB6PUuxpr29k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued interest on excess debt borrowing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,989</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,824</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredFinanceCostsNet_iNI_pn3n3_di_zM8h4lZs5SZa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(554</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(572</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--ConvertibleDebt_iTI_pn3n3_zKmkrW6tlYfj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,192</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,611</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Secured Convertible Notes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2022, the Company issued $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--SecuredDebt_iI_pn3n3_c20220531__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zgfJa6H5aD68" title="Secured convertible promissory notes">11,250</span> of convertible notes payable (the “Original Notes”) to entities affiliated with Whitebox Advisors, LLC (collectively, “Whitebox”). <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--DebtInstrumentInterestRateTerms_c20220501__20220531__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zCQmFxkAumtb">The Original Notes bear interest at 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the notes), are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with Alterna Capital (ACS), the Company’s existing secured lender.</span> The Original Notes mature the earlier of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20220501__20220531__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z4XuumoFPikg">March 31, 2025</span> or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. The Original Notes together with the Option Notes are collectively referred to as the “Notes”. Upon conversion or early payment, holders of the Notes are entitled to receive an interest make-whole payment, as defined, equal to the sum of the remaining scheduled payments of interest on the Notes that would be due at maturity, payable, at the Company’s option, in cash or in shares of common stock. <span style="background-color: white">Effective August 11, 2022, the Notes were amended to add a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_pid_dp_uPure_c20220811__20220811_z0DVbhSeoB7f" title="Fee percentage">10</span>% fee for the amount that the Company’s line of credit with ACS exceeds $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--ProceedsFromLinesOfCredit_pn3n3_c20220811__20220811_zx7osvbXumYe" title="Credit exceeds">6,000</span>, as defined (the “Excess ABL Amount”). Effective June 30, 2023, the Excess ABL Amount was amended to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--DebtIssuanceCostsLineOfCreditArrangementsNet_iI_pn3n3_c20230630_zuyjNeQYXl8a">7,500</span>. </span> At March 31,2024 and December 31, 2023, the principal balance of the Original Notes was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240331_zzl0hf496zF9" title="Principal balance"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231231_z0we0SDzGwG3" title="Principal balance">10,250</span></span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Original Notes have an amortization feature which requires the Company to make monthly payments of principal of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zBqGjupEHHBe" title="Monthly payment">200</span> plus accrued interest, payable in cash or in shares of the Company’s common stock at the option of the Company, based on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zrvCLcREWbtk" title="Weighted average interest">90</span>% of the average prices of the Company’s common stock, as defined During 2023, Whitebox waived the requirement for the Company to pay the December 2022 to October 2023 monthly amortization payments on the Original Notes. The November 2023 amortization payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20231101__20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zrsEfKgFNlFi" title="Principal payment">200</span> principal was paid, and the amortization payment for December 2023 to May 2024 was waived. The parties agreed that amortization period shall resume on June 1, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The terms of the Original Notes contained conversion terms that are expected to be amended, subject to satisfaction of certain conditions. Under the revised terms, the conversion price of the Original Notes will be between <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionRatio1_pid_dp_uPure_c20231101__20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--RangeAxis__srt--MinimumMember_zkHfiAZK8Qcd" title="Debt conversion percentage">125</span>% and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionRatio1_pid_dp_uPure_c20231101__20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--RangeAxis__srt--MaximumMember_zWkEBobmaGl7" title="Debt conversion percentage">145</span>% of the effective price of the company’s subsequent equity offering, with the premium set based on the aggregate gross proceeds realized by the company in the offering and the conversion price subject to a cap of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_z4kRSs9xUMQg" title="Debt conversion price">7.50</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition on February 12, 2024, subject to the satisfaction of certain conditions, the parties agreed that a portion of the outstanding ABL accrued fees will be satisfied through payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_902_eus-gaap--PaymentsForFees_pn3n3_c20240212__20240212__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zBII7dDdVmQj" title="Payment for fees">132</span> in cash and the issuance of shares of the Company’s common stock (up to the beneficial ownership limitation applicable to each holder) at a value per share equal to the lesser of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--SharePrice_iI_pid_c20240212__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zECWYRFtFEbg" title="Share price">1.50</span> or the per share price of securities issued in the Company’s subsequent equity offering. The remaining balance of any outstanding accrued ABL fees will be added to the principal amount of the Notes. The $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--PaymentsForFees_pn3n3_c20240101__20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zqnqwt38nlo1" title="Payment for fees">132</span> has not been paid nor any shares issued as of the date of these financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 8pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2023 and May 2023, the Company issued an aggregate of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn3n3_c20230228__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zJZKkVMY3tZ5" title="Convertiable notes payable"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn3n3_c20230531__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_ztopDZma10Pc" title="Convertiable notes payable">4,050</span></span> of additional Option Notes to Whitebox that substantially have the same terms as the Original Notes, except the Option Notes issued in 2023 do not require any amortization payments, initially were to bear interest at 10% payable in cash, and were initially due four months after issuance. On February 12, 2024, the parties agreed to change the terms so that the Option Notes shall bear interest at a rate of 10% per annum, with 5% per annum payable in cash and 5% per annum payable (“in kind” by adding such PIK interest to the unpaid principal amount. In addition, the parties agreed, subject to certain outstanding conditions, to amend the maturity date to the earlier of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20230201__20230531__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zzD7MK2gUQ48" title="Convertiable notes payable maturity date">March 31, 2025</span> or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. Once they are amended, the Company shall have the right at any time prior to the date that is the 180th day from the effective date to prepay the amended and restated Option Notes, in whole or in part, at a price equal to 102% of the principal amount plus all accrued and unpaid interest thereon to the date of prepayment. At March 31, 2024 and December 31, 2023, the principal balance of the Option Notes was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zQfDiER1UWv4" title="Principal balance"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231231__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zTUhAqWX4dij" title="Principal balance">4,050</span></span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The terms of the Original Notes contained conversion terms that are expected to be amended , subject to the satisfaction of certain conditions by the Company. Under the revised terms, the conversion price of the Option Notes will be <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionRatio1_pid_dp_uPure_c20231101__20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zPQGv29mnRil" title="Debt conversion percentage">120</span>% of the arithmetic average of the Daily VWAP for the five (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_uInteger_c20231101__20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zPLnAzejAxNb" title="Debt conversion trading days">5</span>) VWAP Trading Days beginning on, and including, the VWAP Trading Day immediately following the consummation of an equity offering undertaken for purposes of satisfying the terms and conditions of the Waiver and Amendment</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p> <p id="xdx_8AB_zjly6Q8wtXNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Waiver of Default</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 12, 2024, the Company entered into a Limited Waiver, Deferral, and Amendment and Restatement Agreement (the “Waiver and Amendment”) with each holder (each an entity affiliated with Whitebox Advisors, LLC) of the Original and Option Notes payable to Whitebox (the “Notes”). Subject to the Waiver and Amendment, the holders agreed to temporarily waive certain events of default under the Notes, including the failure to pay Excess ABL Amounts and the failure to pay amortization payments due December 1, 2023 to April 30, 2024. Subject to satisfaction of certain conditions by March 31, 2024, the parties further agreed to amend and restate the Notes, to extend the maturity date of the Option Notes originally due November 28, 2023, to March 31, 2025 and to equitize certain interest and fees owing on the Notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion rate under the amended and restated notes is to be based on the pricing and size of the Company’s proposed equity financing of a minimum of $<span id="xdx_90A_ecustom--FutureMinimumEquityFinancing_iI_pn6n6_c20240212__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverDeferralAndAmendmentAndRestatementAgreementMember_zk5zBGQkAcB6" title="Future minimum equity financing">3</span> million (which will include conversion of approximately $<span id="xdx_902_ecustom--ConversionOfInvestmentsIntoEquity_iI_pn5n6_c20240212__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverDeferralAndAmendmentAndRestatementAgreementMember_zwLy8amIPkma" title="Conversion of SAFE investments into equity">4.1</span> million of previously funded SAFE investments into equity of the Company). Delays related to the Company’s evaluation of long term financing options have delayed the proposed financing. On April 1, 2024 the parties executed the Amended Limited Waiver, Deferral, and Amendment and Restatement Agreement (“Amended Waiver”). Subject to certain terms and conditions set forth in the Amended Waiver, the holders temporarily waived certain specified events of default under the Notes to April 30, 2024 and extended the waiver of monthly amortization payments to April 30, 2024. In addition, Reed’s remitted a partial interest payment of $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20240212__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverDeferralAndAmendmentAndRestatementAgreementMember_zcmBrgYsuuq4" title="Interest expenses">100</span> to the holders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accrued Interest</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2023, the balance of accrued interest was $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zeuSqftAeOr2" title="Interest expenses">3,883</span>. During the period ended March 31, 2024, the Company recorded interest of $<span id="xdx_901_eus-gaap--InterestExpense_pn3n3_c20240101__20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zhRy2t9Rtgk3" title="Interest on convertible notes">563</span>, made up of $<span id="xdx_900_eus-gaap--InterestExpenseDebt_pn3n3_c20240101__20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zZYI8Zk2is64" title="Interest expenses">398</span> of interest on the convertible notes, and $<span id="xdx_908_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pn3n3_c20240101__20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zaofjHYYA772" title="Excess of asset base loan fees">165</span> related to the excess ABL fees. At March 31, 2024, the balance of accrued interest was $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zUOBJPAncSB9" title="Accrued interest">4,446</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Debt Discount</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2023, the unamortized debt discount was $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20231231__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zCvXzslBj6Wd" title="Unamortized debt discount amount">572</span>. During the period ended March 31, 2024, the Company incurred $<span id="xdx_900_ecustom--IncurredCostsForAforementionedWaivers_iI_pn3n3_c20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zkM774kcf4Yd" title="Incurred costs for aforementioned waivers">86</span> of costs for the aforementioned waivers. These costs have been capitalized and are being amortized over the term of the convertible notes or waiver period. For the three months ended March 31, 2024, amortization of debt discount was $<span id="xdx_907_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20240101__20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_ztIvhZ4b1bsa" title="Amortization of debt discount">104</span>, and as of March 31, 2024, the remaining unamortized debt discount balance is $<span id="xdx_90B_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zfHjlkRs3gt" title="Unamortized debt discount amount">554</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> </p> <p id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zgiVJ3kI7xu3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under the Company’s convertible notes payable are as follows (amounts in 000’s except share amounts):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zZhHD2wYzpJe" style="display: none">Schedule of Secured Convertible Notes Payable</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20240331__us-gaap--DebtInstrumentAxis__custom--SecuredConvertibleNotesPayableMember_zoLeNo6SZXn7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20231231__us-gaap--DebtInstrumentAxis__custom--SecuredConvertibleNotesPayableMember_zG7T6JHfJsX3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--SecuredDebt_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotesPayableAMember_zrqYDfHTNygk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Secured Convertible “Original” Notes Payable (A)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,250</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SecuredDebt_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotesPayableBMember_zG2crsms7yUi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Secured Convertible “Option”” Notes Payable (B)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,050</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--SecuredDebt_iI_pn3n3_hus-gaap--DebtInstrumentAxis__custom--NotesPayableBMember_zEijOEdmfy4i" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left">Secured Convertible “Option”” Notes Payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,050</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_zgQFi9XTN0Ki" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,457</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,059</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--AccruedInterestOnExcessDebtBorrowing_iNI_pn3n3_di_zB6PUuxpr29k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued interest on excess debt borrowing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,989</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,824</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredFinanceCostsNet_iNI_pn3n3_di_zM8h4lZs5SZa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(554</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(572</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--ConvertibleDebt_iTI_pn3n3_zKmkrW6tlYfj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,192</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,611</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Secured Convertible Notes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2022, the Company issued $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--SecuredDebt_iI_pn3n3_c20220531__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zgfJa6H5aD68" title="Secured convertible promissory notes">11,250</span> of convertible notes payable (the “Original Notes”) to entities affiliated with Whitebox Advisors, LLC (collectively, “Whitebox”). <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--DebtInstrumentInterestRateTerms_c20220501__20220531__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zCQmFxkAumtb">The Original Notes bear interest at 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the notes), are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with Alterna Capital (ACS), the Company’s existing secured lender.</span> The Original Notes mature the earlier of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20220501__20220531__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z4XuumoFPikg">March 31, 2025</span> or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. The Original Notes together with the Option Notes are collectively referred to as the “Notes”. Upon conversion or early payment, holders of the Notes are entitled to receive an interest make-whole payment, as defined, equal to the sum of the remaining scheduled payments of interest on the Notes that would be due at maturity, payable, at the Company’s option, in cash or in shares of common stock. <span style="background-color: white">Effective August 11, 2022, the Notes were amended to add a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_pid_dp_uPure_c20220811__20220811_z0DVbhSeoB7f" title="Fee percentage">10</span>% fee for the amount that the Company’s line of credit with ACS exceeds $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--ProceedsFromLinesOfCredit_pn3n3_c20220811__20220811_zx7osvbXumYe" title="Credit exceeds">6,000</span>, as defined (the “Excess ABL Amount”). Effective June 30, 2023, the Excess ABL Amount was amended to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--DebtIssuanceCostsLineOfCreditArrangementsNet_iI_pn3n3_c20230630_zuyjNeQYXl8a">7,500</span>. </span> At March 31,2024 and December 31, 2023, the principal balance of the Original Notes was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240331_zzl0hf496zF9" title="Principal balance"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231231_z0we0SDzGwG3" title="Principal balance">10,250</span></span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Original Notes have an amortization feature which requires the Company to make monthly payments of principal of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zBqGjupEHHBe" title="Monthly payment">200</span> plus accrued interest, payable in cash or in shares of the Company’s common stock at the option of the Company, based on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zrvCLcREWbtk" title="Weighted average interest">90</span>% of the average prices of the Company’s common stock, as defined During 2023, Whitebox waived the requirement for the Company to pay the December 2022 to October 2023 monthly amortization payments on the Original Notes. The November 2023 amortization payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20231101__20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zrsEfKgFNlFi" title="Principal payment">200</span> principal was paid, and the amortization payment for December 2023 to May 2024 was waived. The parties agreed that amortization period shall resume on June 1, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The terms of the Original Notes contained conversion terms that are expected to be amended, subject to satisfaction of certain conditions. Under the revised terms, the conversion price of the Original Notes will be between <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionRatio1_pid_dp_uPure_c20231101__20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--RangeAxis__srt--MinimumMember_zkHfiAZK8Qcd" title="Debt conversion percentage">125</span>% and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionRatio1_pid_dp_uPure_c20231101__20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__srt--RangeAxis__srt--MaximumMember_zWkEBobmaGl7" title="Debt conversion percentage">145</span>% of the effective price of the company’s subsequent equity offering, with the premium set based on the aggregate gross proceeds realized by the company in the offering and the conversion price subject to a cap of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_z4kRSs9xUMQg" title="Debt conversion price">7.50</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition on February 12, 2024, subject to the satisfaction of certain conditions, the parties agreed that a portion of the outstanding ABL accrued fees will be satisfied through payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_902_eus-gaap--PaymentsForFees_pn3n3_c20240212__20240212__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zBII7dDdVmQj" title="Payment for fees">132</span> in cash and the issuance of shares of the Company’s common stock (up to the beneficial ownership limitation applicable to each holder) at a value per share equal to the lesser of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--SharePrice_iI_pid_c20240212__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zECWYRFtFEbg" title="Share price">1.50</span> or the per share price of securities issued in the Company’s subsequent equity offering. The remaining balance of any outstanding accrued ABL fees will be added to the principal amount of the Notes. The $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--PaymentsForFees_pn3n3_c20240101__20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zqnqwt38nlo1" title="Payment for fees">132</span> has not been paid nor any shares issued as of the date of these financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 8pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2023 and May 2023, the Company issued an aggregate of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn3n3_c20230228__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zJZKkVMY3tZ5" title="Convertiable notes payable"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn3n3_c20230531__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_ztopDZma10Pc" title="Convertiable notes payable">4,050</span></span> of additional Option Notes to Whitebox that substantially have the same terms as the Original Notes, except the Option Notes issued in 2023 do not require any amortization payments, initially were to bear interest at 10% payable in cash, and were initially due four months after issuance. On February 12, 2024, the parties agreed to change the terms so that the Option Notes shall bear interest at a rate of 10% per annum, with 5% per annum payable in cash and 5% per annum payable (“in kind” by adding such PIK interest to the unpaid principal amount. In addition, the parties agreed, subject to certain outstanding conditions, to amend the maturity date to the earlier of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20230201__20230531__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zzD7MK2gUQ48" title="Convertiable notes payable maturity date">March 31, 2025</span> or the scheduled maturity of any unsecured indebtedness incurred by the Company that is junior in right of payment to Note obligations. Once they are amended, the Company shall have the right at any time prior to the date that is the 180th day from the effective date to prepay the amended and restated Option Notes, in whole or in part, at a price equal to 102% of the principal amount plus all accrued and unpaid interest thereon to the date of prepayment. At March 31, 2024 and December 31, 2023, the principal balance of the Option Notes was $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240331__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zQfDiER1UWv4" title="Principal balance"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231231__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zTUhAqWX4dij" title="Principal balance">4,050</span></span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The terms of the Original Notes contained conversion terms that are expected to be amended , subject to the satisfaction of certain conditions by the Company. Under the revised terms, the conversion price of the Option Notes will be <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionRatio1_pid_dp_uPure_c20231101__20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zPQGv29mnRil" title="Debt conversion percentage">120</span>% of the arithmetic average of the Daily VWAP for the five (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFNlY3VyZWQgQ29udmVydGlibGUgTm90ZXMgUGF5YWJsZSAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_uInteger_c20231101__20231130__dei--LegalEntityAxis__custom--WhiteboxAdvisorsLLCMember__us-gaap--DebtInstrumentAxis__custom--AdditionalOptionNotesMember_zPLnAzejAxNb" title="Debt conversion trading days">5</span>) VWAP Trading Days beginning on, and including, the VWAP Trading Day immediately following the consummation of an equity offering undertaken for purposes of satisfying the terms and conditions of the Waiver and Amendment</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p> 10250000 10250000 4050000 4050000 4050000 4050000 1457000 1059000 -2989000 -2824000 554000 572000 18192000 17611000 11250000 The Original Notes bear interest at 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the notes), are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with Alterna Capital (ACS), the Company’s existing secured lender. 2025-03-31 0.10 6000000 7500000 10250000 10250000 200000 0.90 200000 1.25 1.45 7.50 132000 1.50 132000 4050000 4050000 2025-03-31 4050000 4050000 1.20 5 3000000 4100000 100000 3883000 563000 398000 165000 4446000 572000 86000 104000 554000 <p id="xdx_80D_eus-gaap--LesseeOperatingLeasesTextBlock_zpkYjWRGvzR3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_825_zTjAb0EBXpGa">Leases Liabilities</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2024 and 2023, lease costs totaled $<span id="xdx_906_eus-gaap--LeaseCost_pn3n3_c20240101__20240331_zxpcST8cS7Gg" title="Lease cost">39</span> and $<span id="xdx_905_eus-gaap--LeaseCost_pn3n3_c20230101__20230331_zTlTd9SHXwwk" title="Lease cost">32</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, operating lease liabilities totaled $<span id="xdx_90C_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20231231_zRyQHwz9X72g" title="Operating leases liability">207</span>. During the three months ended March 31, 2024, the Company made payments of $<span id="xdx_901_eus-gaap--OperatingLeasePayments_pn3n3_c20240101__20240331_zX0zn3WNObdi" title="Payments of operating lease liability">52</span> towards its operating lease liability. As of March 31, 2024, operating lease liabilities totaled $<span id="xdx_903_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20240331_zXvKYa2Dz1i7" title="Operating leases liability">155</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the weighted average remaining lease terms for an operating lease are <span id="xdx_908_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240331_zWbi7IXDmmzh" title="Weighted average remaining lease term for operating lease">0.75</span> years. As of March 31, 2024, the weighted average discount rate on the operating lease is <span id="xdx_902_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20240331_zCWIdkWpCMbk" title="Weighted average discount rate for operating lease">12.60</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 39000 32000 207000 52000 155000 P0Y9M 0.1260 <p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zAjupEoxuemi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_827_zzEMwNtlpjZb">Simple Agreements for Future Equity (“SAFE”) Investments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the first quarter of 2024, the Company received $<span id="xdx_903_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20240101__20240331__us-gaap--TypeOfArrangementAxis__custom--SimpleAgreementsForFutureEquityInvestmentsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StockholdersMember_z1PkxpEgZ4M6">4.1</span> million in gross proceeds from three significant stockholders of the Company, D&amp;D Source of Life Holding LTD (“D&amp;D”) and Union Square Park Partners LP, and John J. Bello, the Company’s Chairman, pursuant to Simple Agreements for Future Equity (“SAFE”) agreements. The SAFE investments will convert into the next equity financing of Reed’s on the same terms and conditions as investors in Reed’s next equity financing at the lesser of $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20240331__us-gaap--TypeOfArrangementAxis__custom--SimpleAgreementsForFutureEquityInvestmentsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StockholdersMember_z7YhjISG9xX5" title="Share price">1.50</span> per share or the per share price in the financing. Until such time as the SAFE investments convert to equity the approximately $<span id="xdx_90D_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20240101__20240331__us-gaap--TypeOfArrangementAxis__custom--SimpleAgreementsForFutureEquityInvestmentsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StockholdersMember_zEGtZaItpuYa">4.1</span> million received is recorded as a liability. D&amp;D was given the right to designate a second independent director nominee to the board of directors of Reed’s and the company agreed to limit the size of its board of directors to nine (9) for so long as D&amp;D owns 25% or more of the equity securities of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 4100000 1.50 4100000 <p id="xdx_80A_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z911ia6gNF2h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_82D_zCJWLpQ13XIl">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock Options</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zoP7z4XFLzfk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes stock option activity during the three months ended March 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zBkVWBYK6Axi" style="display: none">Schedule of Stock Option Activity</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-<br/> Average <br/> Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Terms <br/> (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate <br/> Intrinsic <br/> Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240101__20240331_zly4ak0Wn2Qc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">145,012</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240331_zhJKToQb1ri" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted-Average Exercise Price, Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.09</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zZToCvLUj5U5" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding">6.75</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20240101__20240331_zONTVcdmT0M1" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0752">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20240331_zV6VBG9DHFc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0754">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zH6iIq5EuYx6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0756">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240101__20240331_z7LszXr9xMWb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_z3kJ9EEHlWPi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unvested forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20240101__20240331_zUo4alwNvlV6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Unvested forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0762">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20240101__20240331_zVDpu7iNIJ94" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Unvested forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_pid_c20240101__20240331_zVCHIBNWBq46" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Vested forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zJ1m5Okz5DHa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Vested forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.05</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at March 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20240331_zQRQahYFR2Yf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,869</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240331_zieLvLPQ1dYd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.03</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331_zJcC4mGy9rBd" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding">6.50</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20240101__20240331_z9pM3NZ95Mk8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0776">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at March 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240101__20240331_zKw5AqzW8ptc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,583</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20240331_zqcv0NXuXXM8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.09</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240331_z6TXQkY2Idzb" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable">6.07</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20240101__20240331_zEppSMDWRJV7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zNwin1s6XAdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2024 and 2023, the Company recognized $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zg8Z5t0egVCa" title="Fair value of vested stock option">129</span> and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zCefh3kFqjC1" title="Fair value of vested stock option">229</span> of compensation expense relating to vested stock options. As of March 31, 2024, the aggregate amount of unvested compensation related to stock options was approximately $<span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20240331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zMlf0VwbUjoh" title="Aggregate value of unvested compensation">314</span> which will be recognized as an expense as the options vest in future periods through March 28, 2027.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the outstanding and exercisable options have no intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2024, which was $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20240331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z3j0nuu1LRB" title="Stock price">1.63</span>, and the exercise price of the outstanding stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zoP7z4XFLzfk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes stock option activity during the three months ended March 31, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zBkVWBYK6Axi" style="display: none">Schedule of Stock Option Activity</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-<br/> Average <br/> Exercise Price</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Terms <br/> (Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate <br/> Intrinsic <br/> Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240101__20240331_zly4ak0Wn2Qc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Shares Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">145,012</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240331_zhJKToQb1ri" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted-Average Exercise Price, Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.09</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zZToCvLUj5U5" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding">6.75</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20240101__20240331_zONTVcdmT0M1" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0752">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240101__20240331_zV6VBG9DHFc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0754">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zH6iIq5EuYx6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0756">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240101__20240331_z7LszXr9xMWb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0758">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_z3kJ9EEHlWPi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unvested forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20240101__20240331_zUo4alwNvlV6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Unvested forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0762">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20240101__20240331_zVDpu7iNIJ94" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Unvested forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_pid_c20240101__20240331_zVCHIBNWBq46" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Vested forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331_zJ1m5Okz5DHa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Vested forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.05</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at March 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240101__20240331_zQRQahYFR2Yf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">141,869</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240331_zieLvLPQ1dYd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.03</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331_zJcC4mGy9rBd" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding">6.50</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20240101__20240331_z9pM3NZ95Mk8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0776">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at March 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240101__20240331_zKw5AqzW8ptc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,583</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20240331_zqcv0NXuXXM8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-Average Exercise Price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.09</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240331_z6TXQkY2Idzb" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable">6.07</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20240101__20240331_zEppSMDWRJV7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0784">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 145012 45.09 P6Y9M -3143 45.05 141869 44.03 P6Y6M 111583 51.09 P6Y25D 129000 229000 314000 1.63 <p id="xdx_80B_ecustom--StockWarrantsTextBlock_zNzvlR4qhq29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_828_z7oL09HT0ZVj">Stock Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_ecustom--ScheduleOfNonOptionEquityInstrumentsRollForwardTableTextBlock_zl9e3Bosup0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s warrant activity during the three months ended March 31, 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_znB5EWF2RF0a" style="display: none">Schedule of Warrant Activity</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/> Average<br/> Exercise<br/> Price</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Terms<br/> (Years)</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/> Intrinsic<br/> Value</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUsvVtxtGpji" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Shares outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">549,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zn2AkHlmw5y5" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted average exercise price, outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.77</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z7lw6Rr5W3L9" title="Weighted average remaining contractual terms (years), outstanding">2.84</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_iS_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zkjJ40DOcQT2" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregate intrinsic value shares outstanding beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zcrIGuTyrzS7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0806">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zTw8HIvPgAkh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zfjhrK7yRtv6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zv9SRyWjdym8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zJkVpitjnhQf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zkv0kQNPiSE8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">             <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at March 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zsMWqvo2RqLe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">549,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zmvJo7Cns624" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.77</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPxrHBijHu02" title="Weighted average remaining contractual terms (years), outstanding">2.59</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_iE_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzokcO6Qv0Vh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate intrinsic value shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0824">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at March 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z7jACEvyhQp" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">549,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zsb2ZwHEPNxg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.77</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zpUZB52jnyW1" title="Weighted average remaining contractual terms (years), exercisable">2.59</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_iE_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zui3OC2UY6Rb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate intrinsic value shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0832">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_z6qgGEd2A8xa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the outstanding and exercisable warrants have no aggregate intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2024, which was $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240331__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z93S5kNKWQQ9" title="Warrants exerice price">1.63</span>, and the exercise price of the Company’s warrants to purchase common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_ecustom--ScheduleOfNonOptionEquityInstrumentsRollForwardTableTextBlock_zl9e3Bosup0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s warrant activity during the three months ended March 31, 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_znB5EWF2RF0a" style="display: none">Schedule of Warrant Activity</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/> Average<br/> Exercise<br/> Price</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Terms<br/> (Years)</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/> Intrinsic<br/> Value</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUsvVtxtGpji" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Shares outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">549,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zn2AkHlmw5y5" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted average exercise price, outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.77</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z7lw6Rr5W3L9" title="Weighted average remaining contractual terms (years), outstanding">2.84</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_iS_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zkjJ40DOcQT2" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Aggregate intrinsic value shares outstanding beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zcrIGuTyrzS7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0806">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zTw8HIvPgAkh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zfjhrK7yRtv6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zv9SRyWjdym8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_iN_pid_di_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zJkVpitjnhQf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0814">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zkv0kQNPiSE8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0816">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">             <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at March 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zsMWqvo2RqLe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">549,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zmvJo7Cns624" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.77</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPxrHBijHu02" title="Weighted average remaining contractual terms (years), outstanding">2.59</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_iE_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zzokcO6Qv0Vh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate intrinsic value shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0824">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at March 31, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z7jACEvyhQp" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">549,292</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zsb2ZwHEPNxg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.77</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms_dtY_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zpUZB52jnyW1" title="Weighted average remaining contractual terms (years), exercisable">2.59</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_iE_pn3n3_c20240101__20240331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zui3OC2UY6Rb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate intrinsic value shares exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0832">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 549292 8.77 P2Y10M2D 549292 8.77 P2Y7M2D 549292 8.77 P2Y7M2D 1.63 <p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zHhSxCE2p7Wa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_823_zDZuBjUkc13l">Transactions with California Custom Beverage, LLC, former related party</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2018, the Company signed a co-packing agreement with California Custom Beverage, LLC’s (“CCB”), an entity owned by Christopher J. Reed, a former related party, pursuant to which CCB agreed to produce certain products for the Company for agreed fees. The co-packing agreement, as amended, includes certain provisions for product inputs, shrinkage, and quality assurance. Also beginning in 2019, CCB agreed to pay the Company a <span id="xdx_906_ecustom--RoyaltyPercentage_iI_dp_uPure_c20181231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zRSw9KoGL1xg" title="Royalty percentage">5</span>% royalty through 2021 on certain private label sales made by CCB.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zKa49Ju6Axgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2024 and 2023, accounts receivable due from and accounts payable due to CCB were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z1WHKCNjIZ61" style="display: none">Schedule of Related Parties</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_499_20240101__20240331_z4adPIKXqJdc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_499_20230101__20231231_z9uOyoz2o8F5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_40C_eus-gaap--ProceedsFromRelatedPartyDebt_pn3n3_maRPTAOzUMH_zYETRvloZ0Yh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable, net of provision of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn3n3_c20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z0jPWWPiji7b" title="Net of provision">1,123</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn3n3_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zi9gdes2ORMf" title="Net of provision">1,123</span> at March 31, 2024 and December 31, 2023, respectively</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">264</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">259</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--RepaymentsOfRelatedPartyDebt_iN_pn3n3_di_msRPTAOzUMH_zUvf93jxvRCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(331</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(259</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_iT_pn3n3_mtRPTAOzUMH_z4CxNKFk6Txe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net (payable) receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(67</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zZoTXRVnX3xj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, on April 19, 2023, the Company received a letter from CCB demanding payment of various amounts, including the $<span id="xdx_900_eus-gaap--OtherLiabilities_iI_pn3n3_c20240331__us-gaap--RelatedPartyTransactionAxis__custom--CaliforniaCustomBeverageLLCMember_zJqUAVw8ouJg" title="Due to related party">452</span>] and $<span id="xdx_90C_eus-gaap--OtherLiabilities_iI_pn3n3_c20231231__us-gaap--RelatedPartyTransactionAxis__custom--CaliforniaCustomBeverageLLCMember_zwk7k8Jlr5ni" title="Due to related party">452</span> outstanding at March 31, 2024 and December 31, 2023, respectively. The Company has determined that the probability of realizing any loss on the demand from CCB is remote and therefore has not recorded any additional accruals related to the demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.05 <p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zKa49Ju6Axgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2024 and 2023, accounts receivable due from and accounts payable due to CCB were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_z1WHKCNjIZ61" style="display: none">Schedule of Related Parties</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_499_20240101__20240331_z4adPIKXqJdc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,<br/> 2024</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_499_20230101__20231231_z9uOyoz2o8F5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2023</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_40C_eus-gaap--ProceedsFromRelatedPartyDebt_pn3n3_maRPTAOzUMH_zYETRvloZ0Yh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable, net of provision of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn3n3_c20240331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z0jPWWPiji7b" title="Net of provision">1,123</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn3n3_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zi9gdes2ORMf" title="Net of provision">1,123</span> at March 31, 2024 and December 31, 2023, respectively</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">264</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">259</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--RepaymentsOfRelatedPartyDebt_iN_pn3n3_di_msRPTAOzUMH_zUvf93jxvRCd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(331</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(259</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--RelatedPartyTransactionAmountsOfTransaction_iT_pn3n3_mtRPTAOzUMH_z4CxNKFk6Txe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net (payable) receivable</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(67</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1123000 1123000 264000 259000 331000 259000 -67000 452000 452000 <p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zoGDc0Eqw9g9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_822_zCr0QP2bMw58">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2023, the firm engaged an investment bank to explore financing options for the Company. We have a maximum obligation of $<span id="xdx_901_eus-gaap--ProfessionalFees_pn5n6_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zmibRs0zzEE2" title="Fees">1.2</span>M in fees so far in this engagement. These fees will be recognized on a success basis and will be paid out only if a transaction is finalized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2018, CCB assumed the monthly payments on our lease obligation for a Los Angeles manufacturing plant for payments through September 2024, and our release from the obligation by the lessor, however, is dependent upon CCB’s deposit of $<span id="xdx_90C_eus-gaap--SecurityDeposit_iI_pn3n3_c20181231__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zv5Em58DPAv8" title="Deposit of security with lessor">1,200</span> of security with the lessor. As of March 31, 2024, $<span id="xdx_90A_eus-gaap--SecurityDeposit_iI_pn3n3_c20240331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zce12QcW9Nmi" title="Deposit of security with lessor">800</span> has been deposited with the lessor and Chris J. Reed has placed approximately <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zF9sL79BN052" title="Number of common stock value placed">7,260</span> shares of the Company’s common stock valued at $<span id="xdx_902_eus-gaap--EscrowDeposit_iI_pn3n3_c20240331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zOEHw9VO3zUh" title="Escrow deposits">12</span> that remain in escrow with the lessor.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, we are a party to claims and legal proceedings arising in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and provides for potential losses on such litigation if the amount of the loss is estimable and the loss is probable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe that there are no material litigation matters at the current time. Although the result of such litigation matters and claims cannot be predicted with certainty, we believe that the final outcome of such claims and proceedings will not have a material adverse impact on our financial position, liquidity, or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1200000 1200000 800000 7260 12000 <p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_zXlmkuDAFOk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. <span id="xdx_82A_zVKfypob7R5">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Secured Convertible Notes Payable</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not yet satisfied conditions required for issuance of the amended and restated Notes and equitization of certain interest and fees owing on the Notes. The conversion rate under the amended and restated Notes is to be based on the pricing and size of the Company’s proposed equity financing of a minimum of $<span id="xdx_902_eus-gaap--DebtConversionOriginalDebtAmount1_pn6n6_c20240101__20240331__us-gaap--ShortTermDebtTypeAxis__custom--SecuredConvertibleNotesPayableMember_zqRMzgYxoPmk" title="Minimum of conversion amount">3</span> million (which will include conversion of approximately $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn5n6_c20240101__20240331__us-gaap--ShortTermDebtTypeAxis__custom--SecuredConvertibleNotesPayableMember_zEgTW9mfW5a7" title="Conversion amount">4.1</span> million of previously funded SAFE investments into equity of the Company). Delays related to the Company’s evaluation of long term financing options have delayed the proposed financing. On May 17, 2024, Reed’s entered into a Limited Waiver, Deferral, and Amendment and Restatement Agreement (the “Waiver and Amendment”) with each holder. The holders agreed to temporarily waive certain specified events of default and the payment of Excess ABL Fees through June 10, 2024. Further, the holders agreed to waive the payment of monthly amortization payments through June 30, 2024. Amortization payments are scheduled to resume on July 1, 2024. The Company further remitted $<span id="xdx_902_eus-gaap--InterestPayableCurrent_iI_pn3n3_c20240701__us-gaap--ShortTermDebtTypeAxis__custom--SecuredConvertibleNotesPayableMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQQe3KiYxlOk" title="Interest payable">40</span> representing all interest (including default interest) to the holders and reimbursed the holders for certain fees and expenses.</span></p> 3000000 4100000 40000